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Chapter I: The role of non-pore-forming β subunits in physiology and 
pathophysiology of voltage-gated sodium channels 
A revised version of this chapter is in press at the Handbook of Experimental 
Pharmacology (Calhoun and Isom 2013). 
 
Abstract 
Voltage-gated sodium channel β1 and β2 subunits were discovered as auxiliary 
proteins that co-purify with pore-forming α subunits in brain. The other family members, 
β1B, β3, and β4, were identified by homology and shown to modulate sodium current in 
heterologous systems. Work over the past two decades, however, has provided strong 
evidence that these proteins are not simply ancillary ion channel subunits, but are 
multifunctional signaling proteins in their own right, playing both conducting (channel 
modulatory) and non-conducting roles in cell signaling. Here, we discuss evidence that 
sodium channel β subunits not only regulate sodium channel function and localization, 
but also modulate voltage-gated potassium channels. In their non-conducting roles, 
voltage-gated sodium channel β subunits function as immunoglobulin superfamily cell 
adhesion molecules that modulate brain development by influencing cell proliferation and 
migration, axon outgrowth, axonal fasciculation, and neuronal pathfinding. Mutations in 
genes encoding β subunits result in paroxysmal diseases including epilepsy, cardiac 
arrhythmia, and sudden infant death syndrome. Finally, β subunits may be targets for the 





Roles of Voltage-gated Sodium Channel β Subunits in Normal Physiology 
Sodium channel as signaling complex 
Voltage-gated sodium channel (VGSC) β subunits are multifunctional molecules 
with conducting and non-conducting roles. β subunits have conducting roles as ion 
channel regulatory subunits that form a complex with the pore-forming VGSC α subunit. 
Within this protein complex, β subunits modulate α subunit gating and cell surface 
expression as well as provide links to other channelome components. VGSC β subunits 
are unique among ion channel accessory subunits in that they contain an extracellular 
immunoglobulin (Ig) domain, thus placing them in the Ig superfamily of cell adhesion 
molecules (CAMs). Emerging evidence suggests that during brain development, β 
subunits function in non-conducting roles as CAMs in addition to their channel 
modulatory roles, and are subsequently involved in both extracellular and intracellular 
signaling pathways to help guide neuronal patterning (Brackenbury and Isom 2011). β 
subunits, especially those encoded by SCN1B, play important roles in cell proliferation 
and migration, axon outgrowth, pathfinding, and fasciculation in many central nervous 
system (CNS) areas including the hippocampus, cerebellum, and corticospinal tract 
(Brackenbury et al. 2008a; Brackenbury et al. 2013). As multifunctional molecules 
involved in a diverse set of cellular processes and signaling cascades, β subunits are 
unique, dynamic proteins which bridge the gap between two distinct signaling paradigms: 
electrical signaling via action potentials and cell adhesive signaling independent of ion 
conduction.  
There is increasing evidence that β subunits are involved in numerous 
pathophysiological processes, including but not limited to, epilepsy, cardiac arrhythmia, 
neuropathic and inflammatory pain, neurodegeneration, and cancer. Mutations in the 
genes encoding β subunits result in human disease. Of particular note, mutation of 




Febrile Seizures plus (GEFS+) spectrum (Patino and Isom 2010). Patients that inherit two 
loss-of-function mutant alleles of SCN1B have Dravet syndrome (DS), a severe pediatric 
epileptic encephalopathy, while patients who inherit a single mutant copy of SCN1B 
present with the milder GEFS+ or may not exhibit seizures. Genetic deletion of Scn1b in 
mice recapitulates the hallmark phenotypes associated with DS, suggesting that these 
mice are a DS model (Chen et al. 2004; Patino et al. 2009). Given the diverse role of β 
subunits in normal physiology and in disease processes, β subunits are potential targets 
for novel therapeutics. 
In this review, the conducting (canonical) and non-conducting (non-canonical) 
roles of VGSC β subunits will be discussed. The structure, expression profile, and 
regulation of the β subunits will be described. Finally, the impact of β subunits in 
pathophysiology and potential for novel therapeutics will be examined. 
VGSCs Are αββ Heterotrimers 
Heterotrimeric VGSC complexes initiate and propagate action potentials in most 
electrically excitable mammalian cells including neurons and cardiac myocytes. These 
heterotrimeric complexes are composed of a single pore-forming α subunit, a non-
covalently associated β subunit (β1 or β3), and a covalently associated β subunit (β2 or 
β4) (Figure 1.1). Two distinct gene families encode the 9 α subunit isoforms (SCNXA) 
and the 5 β subunit isoforms (SCNXB), respectively (Table 1.1). While there is 
significant evolutionary conservation and functional similarity within each gene family, 
each individual gene product is distinct in its properties and expression profile. For 
example, SCN5A is the predominant cardiac sodium channel, as its expression is enriched 
in cardiac tissue relative to other tissues, however, SCN1A, SCN3A, and SCN8A are also 
expressed in heart, although at lower levels (Westenbroek et al. 2013). Importantly, this 
diversity allows combinations of α and β isoforms to be expressed at different levels 























Figure 1.1. Topology of the voltage-gated sodium channel α and β subunits. VGSCs 
contain a pore-forming α subunit consisting of four homologous domains of six 
transmembrane segments (1-6). Segment 4 contains the voltage sensor (Catterall 2000). 
VGSCs also contain one or more β subunits. β1, β2, β3, and β4 contain an extracellular 
immunoglobulin (Ig) loop, transmembrane domain, and an intracellular C-terminal 
domain (Isom et al. 1994). β1B also contains an Ig loop, but lacks a transmembrane 
domain and is therefore a soluble, secreted protein (Patino et al. 2011). β1 contains a 
tyrosine phosphorylation site in its C-terminus (Malhotra et al. 2004). ψ denotes 
glycosylation sites. β1 and β3 are non-covalently linked to α, whereas β2 and β4 are 














VGSC α subunits  VGSC β subunits 
Gene Protein  Gene Protein 
SCN1A Nav1.1  SCN1B β1 
SCN2A Nav1.2  SCN1B β1B 
SCN3A Nav1.3  SCN2B β2 
SCN4A Nav1.4  SCN3B β3 
SCN5A Nav1.5  SCN4B β4 
SCN8A Nav1.6    
SCN9A Nav1.7    
SCN10A Nav1.8    
SCN11A Nav1.9    
 






the cell’s specific job within the overall tissue. An important distinguishing feature of 
VGSCs is whether they are sensitive or resistant to tetrodotoxin (TTX), a sodium channel 
specific pore-blocking toxin from Fugu, or pufferfish. Most VGSCs (Nav1.1, Nav1.2, 
Nav1.3, Nav1.4, Nav1.6, and Nav1.7) are blocked by low (nanomolar) concentrations of 
TTX and are referred to as TTX-sensitive channels (TTX-S) (Catterall 2012). The 
remainder (Nav1.5, Nav1.8, and Nav1.9) require significantly higher concentrations of 
TTX (micromolar) for blockade and are referred to as TTX-resistant (TTX-R) (Catterall 
2012). 
Given that voltage-dependent sodium current is an essential phase of the 
mammalian action potential, it comes as no surprise that perturbation of sodium channel 
function due to mutations results in human disease. Additionally, as discussed below, 
VGSC α subunits are pharmacologic targets for several interventions related to diseases 
including epilepsy and cardiac arrhythmia. 
β Subunit Structure 
Four genes in the mammalian genome encode five β subunit proteins (Isom et al. 
1992; Kazen-Gillespie et al. 2000; Isom et al. 1995a; Morgan et al. 2000; Qin et al. 2003; 
Yu et al. 2003). SCN1B encodes β1 and the splice variant β1B, SCN2B encodes β2, 
SCN3B encodes β3, and SCN4B encodes β4. Four of the VGSC β subunits (β1-β4) are 
transmembrane proteins with type I topology containing an extracellular N-terminus, a 
single transmembrane segment, and an intracellular C-terminus (Isom 2001). The 
exception, β1B, contains the same Ig loop domain as β1, but has an alternate C-terminal 
region that is the product of a retained intron (Figure 1.2) that lacks a transmembrane 
domain, resulting in a secreted, soluble molecule (Patino et al. 2011; Kazen-Gillespie et 
al. 2000). Figure 1.3 provides an overview of the functional architecture of β1/β1B. 
Structural differences underlie whether a β subunit interacts covalently or non-covalently 

























Figure 1.2. The genomic structure of SCN1B. Exons 1–6 constitute β1. Extension of 
exon 3 into intron 3 generates the variant, β1B. The novel 3′ end of β1B does not contain 
a transmembrane domain (TM). The asterisk (*) indicates the position of the G257R 







Figure 1.3. Functional architecture of β1/β1B. β1 contains residues responsible for 
interaction with α subunit in its intracellular and extracellular domains (McCormick et al. 
1998; Spampanato et al. 2004). Mutation sites responsible for causing epileptic 
encephalopathy, including Dravet syndrome, are located in the extracellular 
immunoglobulin loop (Meadows et al. 2002b; Wallace et al. 2002; Audenaert et al. 2003; 
Scheffer et al. 2007; Patino et al. 2009). Alternative splicing site for β1B (Kazen-
Gillespie et al. 2000; Qin et al. 2003; Patino et al. 2011), putative palmitoylation site 
(McEwen et al. 2004), ankyrin interaction site (Malhotra et al. 2002), tyrosine 
phosphorylation site (Malhotra et al. 2004), N-glycosylation sites [ψ] (McCormick et al. 
1998), α/β/γ-secretase cleavage sites (Wong et al. 2005), receptor protein tyrosine 
phosphatase β (RPTPβ) interaction (Ratcliffe et al. 2000), and putative fyn kinase 
interaction (Brackenbury et al. 2008a) are also marked. Figure reproduced from 





single disulfide bond (Messner and Catterall 1985; Chen et al. 2012; Buffington and 
Rasband 2013; Hartshorne et al. 1982; Hartshorne and Catterall 1984; Yu et al. 2003). 
Specifically, an N-terminal cysteine at position 26 in the extracellular domain of either β 
subunit forms a disulfide bond with one of multiple candidate cysteine residues in the S5-
S6 loops of the α subunit. β1 and β3 associate non-covalently with VGSC α subunits 
(Messner and Catterall 1985; Hartshorne et al. 1982; Hartshorne and Catterall 1984). 
Structure-function analysis of β1 suggests the involvement of both N- and C-terminal 
residues in non-covalent association with α subunits (McCormick et al. 1998; Meadows 
et al. 2001; Spampanato et al. 2004). The C-terminal domains of β1 and β2 serve as links 
to the cytoskeleton via interactions with ankyrinG or ankyrinB (Malhotra et al. 2000; 
Malhotra et al. 2002). The β1 subunit intracellular domain contains a single tyrosine 
residue that can be phosphorylated (Malhotra et al. 2002; Malhotra et al. 2004). Finally, β 
subunits are also targets for sequential proteolytic cleavage (Figure 1.4), resulting in 
release of N-terminal and C-terminal fragments (Wong et al. 2005). 
Analysis of genes homologous to mammalian sodium channels has yielded 
valuable information about the evolution of VGSC α and β subunits. NaChBac, an 
ancestral gene to mammalian VGSC α subunits, was discovered in bacteria (Ren et al. 
2001). Subsequently, additional prokaryotic VGSCs were discovered, including NavAb, 
NavB1, NavBp, NavPz, NavRd, NavSHp, and NavSIP (Payandeh et al. 2011; Ren et al. 
2001; Koishi et al. 2004; Ito et al. 2004; Irie et al. 2010). Interestingly, the genes coding 
for bacterial VGSCs encode proteins containing only 6 transmembrane domains rather 
than the 24 transmembrane domains found in mammalian VGSC α subunits 
(Charalambous and Wallace 2011). In order to form a sodium-conducting channel, 
bacterial sodium channel proteins must form homotetramers, similar to mammalian 
voltage-gated potassium channels. Mammalian SCNXA genes encode full channels (i.e. 
four tethered channel domains), suggesting the evolution of VGSC genes from encoding 






















Figure 1.4. Sequential cleavage of β subunits. Cleavage by (1) α -secretase or β -site 
amyloid precursor protein-cleaving enzyme (BACE1), followed by (2) γ -secretase yields 
soluble extracellular N-terminal domains and small intracellular C-terminal domains 
(Wong et al. 2005; Kim et al. 2005). The soluble immunoglobulin domains are 
responsible for regulation of adhesion and migration (Davis et al. 2004; Kim et al. 2005). 
β subunit intracellular domains regulate neurite outgrowth and are putative regulators of 
voltage-gated sodium channel gene transcription (Kim et al. 2007; Miyazaki et al. 2007). 





(24 transmembrane domains) VGSC α subunits have been identified in a diverse set of 
species, including drosophila, zebrafish, rodents, and humans (Goldin 2002). Genes 
encoding VGSC β subunits are present in species including zebrafish, rodents, and 
humans, but are notably absent in invertebrates (Isom et al. 1992; Fein et al. 2007; 
Chopra et al. 2007; Patino et al. 2009). This suggests that β subunits evolved later relative 
to pore-forming α subunits. Notably, sodium channels purified from the electroplax 
(electric organ) of the South American eel Electrophorus electricus contain only α 
subunits and not β subunits, which provides in vivo evidence that, similar to results 
obtained in Xenopus oocytes and transfected fibroblasts, α subunits are capable of 
functioning in the absence of β subunits (Miller et al. 1983; Noda et al. 1986; Goldin et 
al. 1986; Scheuer et al. 1990; Isom et al. 1995b). Interestingly, while the drosophila 
genome lacks genes encoding VGSC β subunits, it does contain tipE which acts as an 
auxiliary subunit to the pore-forming VGSC α subunit paralytic (Li et al. 2011). 
However, the structure of mammalian VGSC β subunits is distinct from tipE. 
VGSC β subunits are Ig-CAMs 
Each of the mammalian VGSC β subunits contains a single, extracellular Ig 
domain that is structurally homologous to the V-set of the Ig superfamily of CAMs (Isom 
et al. 1995a). The Ig loop domain of β1 participates in both homophilic (with itself) and 
heterophilic (with other CAMs) associations (Malhotra et al. 2000; McEwen and Isom 
2004) (Figure 1.3). Importantly, the cell adhesive properties of β1 and β2 are 
independent of α subunit expression in vitro, suggesting that β subunits may have channel 
independent functions in vivo. Sequence analysis of the extracellular domains of β1 and 
β3 show homology to the CAM myelin P0 (Isom et al. 1995a; McCormick et al. 1998; 
Morgan et al. 2000), which has provided useful guidance for structure-function 
predictions. While other members of the family of voltage-gated ion channels contain 




dependence, only the VGSC β subunits contain extracellular Ig domains. β subunits, 
particularly β1, function as CAMs. β1 participates in homophilic cell adhesion resulting 
in cellular aggregation and ankyrin recruitment (Malhotra et al. 2000). Homophilic β1 
cell adhesive interactions regulate neurite outgrowth in cerebellar granule neurons 
(CGNs) (Davis et al. 2004; Brackenbury et al. 2008a). Additionally, β1 interacts 
heterophilically with the neuronal and glial CAMs contactin, VGSC β2, N-cadherin, 
neurofascin-155 (NF155), neurofascin-186 (NF186), and NrCAM (McEwen and Isom 
2004; Malhotra et al. 2004; Ratcliffe et al. 2001). β1 interactions with contactin and 
NF186 result in increased α subunit cell surface expression, suggesting a relationship 
between CAM function and channel modulation (Kazarinova-Noyes et al. 2001). β1 also 
participates in cell-matrix adhesion, binding to the extracellular matrix protein tenascin-R 
to influence cell migration (Xiao et al. 1999). β2, like β1, participates in homophilic 
interactions, in heterophilic interactions with β1, and in cell-matrix interactions with 
ECM proteins tenascin-R and tenascin-C (Malhotra et al. 2000; Xiao et al. 1999; 
McEwen and Isom 2004; Srinivasan et al. 1998). While β3 contains an Ig domain, its 
capacity to engage in CAM interactions is unclear. Unlike β1 and β2, transfection of β3 
cDNAs into Drosophila S2 cells was not sufficient to induce cell aggregation, suggesting 
it does not engage in homophilic interactions (McEwen et al. 2009). Using soluble 
recombinant CAM binding assays, it was observed that heterophilic interactions between 
β3 and other CAMs are more limited compared to β1 (McEwen and Isom 2004; Ratcliffe 
et al. 2001). In contrast to (McEwen et al. 2009), Yereddi et al. reported evidence for 
trans β3-β3 homophilic adhesion using co-culture of cells expressing differentially 
epitope-tagged β3 constructs (Yereddi et al. 2013). Evidence for β4 as a CAM is limited, 
but it does appear to regulate filopodial morphology in transfected cells, suggesting CAM 
activity (Miyazaki et al. 2007). However, unlike experiments with 1, plating cerebellar 
CGNs on β4-expressing monolayers had no effect on neurite outgrowth (Davis et al. 




CAMs that provide a link between electrical excitability and extracellular adhesion or 
function independently of ion conduction.  
Regulation of VGSC β subunits 
Glycosylation 
Each β subunit Ig domain contains 3 or 4 N-linked glycosylation sites such that 
glycosylation accounts for approximately one-third of the total molecular weight of the 
protein (Messner and Catterall 1985; Isom et al. 1992). While the effects of glycosylation 
on sodium channel α and β subunits in vivo are not known, evidence from heterologous 
expression suggests these modifications may be important for α subunit cell surface 
expression and may influence the modulatory effects of β subunits on sodium current. In 
neuroblastoma cells expressing endogenous VGSCs, tunicamycin was used to study the 
channel under conditions of glycosylation inhibition (Waechter et al. 1983). Reduced 
glycosylation resulted in a reduction in the level of mature pore-forming α subunits 
detectable at the cell surface. The role of glycosylation in the interaction between α, β1, 
and β2 subunits has been studied in vitro using Chinese hamster ovary (CHO) cells that 
are either capable (Pro5) or incapable (Lec2) of sialylation, a type of glycosylation that is 
prevalent in VGSCs (Johnson et al. 2004; Johnson and Bennett 2006). Sialic acids are 
necessary for the modulation of α subunit (Nav1.2, Nav1.5, and Nav1.7) gating by β1 
(Johnson et al. 2004). However, the impact of sialic acid is context-dependent. β2 had 
sialic acid-dependent and -independent effects on α subunit gating, depending on which α 
subunit gene was co-expressed (Johnson and Bennett 2006). While the importance of 
glycosylation on the CAM function of β1 has not been tested directly, it is possible that 
glycosylation may be critical for cell adhesive interactions as well. Homophilic 
interactions of myelin P0, a CAM which shares homology with β1 and β3 (Isom et al. 
1995a), requires glycosylation of the P0 pair (Filbin and Tennekoon 1993). While more 








The β1 C-terminal domain serves as a link between VGSC complexes and the 
cytoskeleton. This domain contains sites for post-translational modification, including 
phosphorylation. An intracellular tyrosine residue (1Y181) is phosphorylated in vitro 
and basal tyrosine phosphorylation of β1 is detectable in rat brain membranes (Malhotra 
et al. 2002) (Figure 1.3). A β1 mutant that mimics phosphorylation (β1Y181E) shows 
normal β1-mediated cell-cell adhesion in a heterologous system, but disrupted β1-
mediated ankyrin recruitment normally observed in response to adhesion (Malhotra et al. 
2002). Similar to β1, β1Y181E increases cell surface α subunit expression in 
heterologous systems, but does not modulate sodium current in vitro (McEwen et al. 
2004). Finally, tyrosine phosphorylated β1 (pY-β1) has a distinct subcellular localization 
in cardiac myocytes. Nav1.5 and pY-β1 colocalize at intercalated disks, whereas non-
phosphorylated β1 colocalizes with TTX-S channels at the T-tubules (Malhotra et al. 
2004). These data suggest that phosphorylation of β1Y181 regulates its interaction with 
other proteins as well as its subcellular localization. Recently, a β1 peptide 
phosphorylated on intracellular threonine residues was reported in a screen for 
phosphorylated proteins in mouse synaptosomes (Trinidad et al. 2012). It will be 
interesting to determine the functional significance of this modification. 
 
Proteolytic processing 
All four VGSC β subunits are targets for sequential proteolytic cleavage, at least 
in vitro (Wong et al. 2005) (Figure 1.4). Similar to amyloid precursor protein (APP) 
(O'Brien and Wong 2011), β subunits are substrates for BACE1 (or β-secretase) and γ-




how β subunit cleavage is regulated in vivo. The initial β-secretase-mediated cleavage 
results in ectodomain shedding and the release of the Ig-loop containing extracellular 
domain of the β subunit (Wong et al. 2005). Upon release from the cell surface, the β 
subunit extracellular domain may function as a soluble CAM similar to the proposed 
function of an engineered soluble β1 extracellular domain construct, β1Fc, and β1B 
(Patino et al. 2011; Davis et al. 2004; McEwen and Isom 2004). Following ectodomain 
shedding, subsequent γ-secretase cleavage results in the release of a β subunit-
intracellular domain (ICD) into the cytoplasm (Wong et al. 2005). Interestingly, neurite 
outgrowth induced by homophilic β1 cell adhesive interactions is abrogated by 
pharmacological inhibition of γ-secretase, suggesting proteolytic cleavage of the β1 
intracellular domain may be critical in this signaling pathway (Brackenbury and Isom 
2011). Studies of the role of the β2-ICD suggest that it traffics to the nucleus where it 
functions to increase SCN1A mRNA and subsequent Nav1.1 protein levels without 
increasing sodium current (Kim et al. 2007). The functions of the other β subunit ICD 
fragments have not yet been studied. However, Scn1b null mice have increased Scn5a 
expression in heart, raising the intriguing possibility that the β1-ICD may normally 
translocate to the nucleus and negatively regulate Scn5a transcription (Lopez-Santiago et 
al. 2007). 
Expression of VGSC β subunits 
VGSC β subunits are expressed in excitable cells in the CNS, peripheral nervous 
system (PNS), skeletal muscle, and the heart (Isom et al. 1992; Isom et al. 1995a; Morgan 
et al. 2000; Yu et al. 2003; Maier et al. 2004; Lopez-Santiago et al. 2006; Lopez-Santiago 
et al. 2011; Brackenbury et al. 2010). While particular focus has been given to β subunit 
expressing neurons and myocytes, β subunits are also expressed in cells traditionally 
considered to be non-excitable such as astrocytes, radial glia, and Bergmann glia 




example, scn1bb, a zebrafish ortholog of SCN1B, was found to be expressed in zrf-1 
positive peripheral Schwann cells, supporting non-neuronal cells within olfactory pits and 
the inner ear, and myelinating glia surrounding the optic nerve (Fein et al. 2008). In 
contrast, scn1ba, another zebrafish ortholog of SCN1B, is largely expressed in excitable 
cells including neurons and skeletal muscle and may be localized to nodes of Ranvier in 
optic nerve (Fein et al. 2007). Table 1.2 summarizes expression data for the β subunits in 
nervous system and muscle. β subunit expression is developmentally regulated 
(Sutkowski and Catterall 1990). In general, β1B and β3 are most abundant during fetal 
development and their expression decreases after birth (Kazen-Gillespie et al. 2000; 
Patino et al. 2011; Shah et al. 2001). Expression of β1 and β2 increase during the course 
of postnatal development and dominate during adult life (Kazen-Gillespie et al. 2000; 
Patino et al. 2011; Isom et al. 1995a). Exceptions to these general rules exist, such as the 
observation that β1B expression is retained in postnatal and adult heart in contrast to the 
reduced expression observed in the postnatal brain (Kazen-Gillespie et al. 2000). 
Additionally, β3 is expressed in adult dorsal root ganglion neurons (DRGs) (Takahashi et 
al. 2003). β4 is expressed in postnatal tissues, though the developmental time course for 
β4 expression has not been determined (Yu et al. 2003). 
 
Subcellular localization of β subunits 
Electrically excitable cells contain specialized substructures that are critical to 
normal physiology. Immunolocalization studies demonstrate that β subunits often cluster 
at specialized, subcellular structures. CNS and PNS neurons develop a specialized 
subcellular domain at the soma-axon junction called the axon initial segment (AIS). The 
AIS, devoted to initiating action potentials, contains a high density of a molecular 
complex (a “channelome”) that includes the cytoskeletal adaptor protein ankyrinG and 
VGSC α and β subunits, including Nav1.1, Nav1.2, Nav1.6, and β1 (Rasband 2010). 









Tissue – cell type β1 β1B β2 β3 β4 
Central Nervous System      
Hippocampal neurons + [a]  + [l] + [b,o] + [l] 
Cortical neurons  + [j,k] + [l] + [b,o] + [l] 
Basal ganglia - [b]  + [l] + [b,o] + [l] 
Retinal ganglion cells + [c,d]  + [d]   
Cerebellar Purkinje cells + [h] + [j,k] + [l] + [o] + [l] 
Cerebellar granule neurons + [h]   - [b,o]  
Deep cerebellar nuclei  + [j] + [l]  + [l] 
Ventral horn neurons  + [j] + [l]  + [l] 
Astrocytes + [e,f]  + [m]   
Bergmann glia + [i] - [j] - [i] - [i] + [i] 
Radial glia + [g]     
      
Peripheral nervous 
system 
     
Dorsal root ganglia + [q] + [k] + [l,n] + [p] + [l] 
Peripheral nerves  + [k] + [n] + [p]  
Schwann cells + [g]     
      
Heart      
Ventricular myocytes + [r]  + [r] + [r] + [r] 
Atrial myocytes + [s]  + [s] + [s] + [s] 
 
Table 1.2. Expression of VGSC β subunits in the CNS, PNS, and heart. + denotes 
expression of specific β subunit protein or mRNA was detected. - denotes that expression 
of specific β subunit protein or mRNA was not detected. a: (Chen et al. 2004), b: 
(Morgan et al. 2000), c: (Fein et al. 2007), d: (Kaplan et al. 2001), e: (Aronica et al. 
2003), f: (Oh and Waxman 1995), g: (Fein et al. 2008), h: (Brackenbury et al. 2010), i: 
(Davis et al. 2004), j: (Kazen-Gillespie et al. 2000), k: (Qin et al. 2003), l: (Yu et al. 
2003), m: (Oh et al. 1997), n: (Pertin et al. 2005), o: (Shah et al. 2001), p: (Casula et al. 
2004), q: (Lopez-Santiago et al. 2006), r: (Maier et al. 2004), and s: (Kaufmann et al. 





nearest to the cell soma, and the distal end, which can differ in protein composition (Van 
Wart et al. 2007). Other CAMs, including the β1 cell adhesive binding partners NrCAM 
and NF186, are enriched at the AIS (Rasband 2010). β1 may influence channel gating 
and channel cell surface expression in this domain. Additionally, β1 plays important roles 
in stabilizing the subcellular localization of Nav1.6 at the AIS, at least in the cerebellum 
(Brackenbury et al. 2010). Evidence for this comes from the observation that Nav1.6 
localization to the AIS of cerebellar Purkinje neurons is reduced in Scn1b null mice 
(Brackenbury et al. 2010). β1 is predicted to function as a CAM at the AIS, although this 
possibility has not been tested. In addition to β1, β2 and β4 have been demonstrated to be 
localized to the AIS in specific neuronal subtypes (Chen et al. 2012; Buffington and 
Rasband 2013). 
Myelinated CNS and PNS neurons contain gaps in the myelin sheath called nodes 
of Ranvier, structures that are critical for saltatory conduction, the mechanism 
responsible for rapid electrical communication across long distances (Poliak and Peles 
2003). Nodes of Ranvier are composed of a high density of ion channels and CAMs 
arrayed in protein complexes in specific arrangements that differ somewhat between the 
CNS and PNS. In the CNS, β1 and β2 subunits are found to localize to optic nerve nodes 
of Ranvier in vivo (Patino et al. 2009; Kaplan et al. 2001). β4 localizes to a small subset 
of optic nerve nodes of Ranvier (Buffington and Rasband 2013). Likewise, in the PNS β1 
and β2 subunits localize to nodes of Ranvier in the sciatic nerve in vivo (Chen et al. 2004; 
Chen et al. 2002). β4 localizes to the majority of nodes of Ranvier in dorsal and ventral 
spinal cord roots (Buffington and Rasband 2013). What is the role of β subunits at the 
node of Ranvier? β subunits act as channel modulators and influence cell surface levels of 
pore-forming VGSC α subunits, which are present at high density in nodes (Chen et al. 
2004; Chen et al. 2002). Based on the observation that Scn1b null mice have reduced 




contacts, β subunits likely have cell adhesive roles in initiating or stabilizing nascent axo-
glial cell-cell contacts and developing nodes of Ranvier (Chen et al. 2004).  
Another important neuronal subcellular structure is the growth cone, which is 
located at the tip of developing neurites and is responsible for sensing signaling cues to 
direct the extension or retraction of the neurite (Lowery and Van Vactor 2009). Proteins 
involved in neurite outgrowth and pathfinding, including β1, localize to this domain 
(Brackenbury et al. 2010). Localization to the growth cone may be a requirement for the 
promotion of neurite outgrowth downstream of β1-β1 trans homophilic adhesion 
(Brackenbury et al. 2008a; Brackenbury et al. 2010). 
β2 localizes to the AIS of mature neurons in culture and to nodes of Ranvier 
formed in myelinating co-cultures. Interestingly, AIS and nodal localization of β2 
requires an intact disulfide bond between α and β2 (Chen et al. 2012). A recent report 
suggests that, like β2, the homologous cysteine residue on β4 allows it to target to the 
AIS and to nodes (Buffington and Rasband 2013). These data suggest a model whereby 
the covalently associated VGSC β subunit (β2 or β4) is dependent on its intermolecular 
disulfide bond to the α subunit for targeting to neuronal subcellular domains. Further 
experimentation will be needed to study the influence of VGSC β subunits on the 
subcellular localization of α subunits, however, VGSC α subunits target normally to 
nodes in Scn1b and Scn2b null mice (Chen et al. 2002; Chen et al. 2004). 
Two functionally important subcellular structures in ventricular cardiomyocytes 
are the intercalated disks and transverse (T)-tubules. Intercalated disks form at cell-cell 
junctions and are critical for mechanical and electrical coupling (Delmar 2004). T-tubules 
electrically link the plasma membrane to the sarcoplasmic reticulum such that an action 
potential can efficiently lead to calcium-induced calcium-release (Brette and Orchard 
2003). β1 localizes to both intercalated disks and T-tubules in the ventricle (Dhar 
Malhotra et al. 2001; Malhotra et al. 2004; Maier et al. 2004) and to intercalated disks in 




datasets regarding the subcellular localization of β2 subunits. β2 has been reported to 
localize to the T-tubules or intercalated disks in ventricular myocytes (Dhar Malhotra et 
al. 2001; Maier et al. 2004) and to the T-tubules in atrial myocardium (Kaufmann et al. 
2013). Experiments suggest that β3 localization is limited to T-tubules in ventricular 
myocytes (Maier et al. 2004) and to intercalated disks and cell surface puncta in atria 
(Kaufmann et al. 2013). β4 localizes primarily to the intercalated disk in ventricular 
myocytes (Maier et al. 2004) and to cell surface puncta in atrial myocyardium (Kaufmann 
et al. 2013). What functional roles are the β subunits playing at these critical cardiac 
structures? β1 likely functions as a channel modulator at T-tubules, but may act solely as 
a CAM at the intercalated disk, based on heterologous data showing the absence of 
channel modulation by β1Y181E (McEwen et al. 2004). In contrast, 1B, which regulates 
Nav1.5 currents in heterologous cells (Watanabe et al. 2008), may function as a channel 
modulator in this domain. The intercalated disk contains Nav1.5 α subunits as well as 
both homophilic and heterophilic adhesion partners, supporting the concept of a 
multifunctional VGSC complex at cardiomyocyte cell-cell junctions.  
Canonical role of VGSC β subunits as modulators of α subunit activity and 
localization  
Modulation of sodium current in heterologous systems 
Soon after the cloning of the first cDNAs encoding VGSC α and β subunits, 
heterologous expression systems were used to investigate critical questions like channel 
subunit topology, electrophysiology, and structure-function relationships. While these 
systems clearly did not mimic what we now understand to be multi-protein sodium 
channel signaling complexes in native cells, the resulting data were critical to advancing 
our understanding of these important molecules. Early work expressing VGSC Nav1.2 α 
subunits in Xenopus oocytes demonstrated non-physiological sodium currents that 




(Auld et al. 1988; Goldin et al. 1986; Joho et al. 1990). Co-injection of α subunit cRNA 
with low molecular weight mRNA isolated from rat brain into oocytes resulted in 
increased sodium current density, altered voltage-dependence of inactivation, and rapidly 
inactivating currents (Auld et al. 1988; Krafte et al. 1990). These results were more 
representative of physiological sodium currents and suggested that proteins encoded by 
the low molecular weight brain mRNA fraction are important interacting proteins that 
modulate pore-forming α subunits. β1 and β2, which were known to associate with 
VGSC α subunits purified to theoretical homogeneity and predicted to be included in the 
low molecular weight mRNA fraction, were strong candidates for the functional 
modulatory proteins in question (Hartshorne et al. 1982; Hartshorne and Catterall 1984). 
Indeed, after cloning the cDNAs encoding β1 and β2, we found that expression of 
mRNAs encoding these subunits recapitulated the effects of low molecular weight brain 
mRNA (Isom et al. 1992; Isom et al. 1995a). Specifically, when co-expressed with 
Nav1.2, β1 increased peak sodium current density, shifted the voltage-dependence of 
inactivation to more negative membrane potentials, and accelerated the rate of 
inactivation (Isom et al. 1992). Co-expression of β2 and Nav1.2 in oocytes led to 
increased sodium current density and acceleration in the rate of channel inactivation 
compared to cells injected with Nav1.2 alone (Isom et al. 1995a). β2-expressing oocytes 
display increased cell surface area, likely due to an increase in fusion of intracellular 
vesicles with the plasma membrane and predicting its role as a chaperone protein (Isom et 
al. 1995a). Importantly, the effects of β1 and β2 on Nav1.2 in oocytes were synergistic: 
Nav1.2, β1, and β2 expressing oocytes have higher sodium current density than oocytes 
expressing α subunits alone, α and β1 subunits, or α and β2 subunits (Isom et al. 1995a). 
Unlike sodium currents from oocytes expressing only VGSC α subunits, currents from 
oocytes expressing α, β1, and β2 subunits were rapidly inactivating and closely 




In addition to the oocyte system, much of the work done to characterize how β 
subunits affect pore-forming α subunits has utilized immortalized mammalian cell lines, 
with human embryonic kidney (HEK), Chinese hamster lung (CHL), and CHO cells 
being popular tools. Experiments co-expressing Nav1.2 and β1 in CHL cells confirmed 
the results in oocytes showing that β1 increases peak sodium current density and induces 
a negative shift in the voltage-dependence of activation and inactivation, although the 
effects on activation and inactivation were more subtle (Isom et al. 1995b; Patino et al. 
2009). In contrast to oocytes, β2 expression in mammalian cells requires co-expression of 
β1 to exert most of its modulatory effects on α subunits. When β2 is expressed with 
Nav1.2 α subunits in the absence of β1, sodium current is either unchanged or reduced 
(Kazarinova-Noyes et al. 2001; McEwen et al. 2004). However, when β2 is expressed 
with α in the presence of β1, β2 increases cell surface expression of α subunits beyond 
that observed in the presence of α + β1 (Kazarinova-Noyes et al. 2001). 
Work in transfected cell lines identified β1B as a secreted CAM with only subtle 
effects on sodium current in cells expressing TTX-S channels like Nav1.2 or Nav1.3 
(Kazen-Gillespie et al. 2000; Patino et al. 2011). Interestingly, Nav1.5 seems to sequester 
β1B at the cell surface in vitro and this interaction results in increased channel cell 
surface expression (Watanabe et al. 2008; Patino et al. 2011). These data suggest that 
β1B may function as a soluble CAM during brain development and as a sodium channel 
modulator and cell surface CAM in heart and other cell types that express Nav1.5. 
Work investigating β3 and β4 suggests that these subunits, like β1 and β2, act as 
sodium channel modulators in heterologous systems. β3 induces a negative shift in the 
voltage-dependence of inactivation of Nav1.3 (Meadows et al. 2002a).  Modulation of 
Nav1.3 is likely relevant as neuronal expression of β3 is highest early in development 
when Nav1.3 expression is also abundant (Shah et al. 2001). β3 also shifts the voltage-
dependence of inactivation to more negative membrane potentials when co-expressed 




Nav1.2 or Nav1.4 resulted in negative shifts in the voltage-dependence of activation (Yu 
et al. 2003). Studies on Nav1.1 suggested that, in addition to shifting the voltage-
dependence of activation to more negative membrane potentials, β4 increased the amount 
of non-inactivating current in vitro (Aman et al. 2009). β4 appears to affect Nav1.5 
channels differently by inducing a negative shift in the voltage-dependence of 
inactivation (Medeiros-Domingo et al. 2007).  Finally, β4 modulates resurgent sodium 
current, as discussed below. 
While oocytes and immortalized mammalian cell lines are obviously very 
different from neurons or myocytes and cannot replicate the situation in native cells, data 
collected from heterologous overexpression of VGSC α and β subunits made important 
predictions regarding the roles of β subunits in primary cells and tissues (Ragsdale 2008; 
Escayg and Goldin 2010). Cell background impacts the effects of β subunits in cell 
culture, along with the particular VGSC α subunit and specific channel interacting 
proteins that are co-expressed (Dib-Hajj and Waxman 2010; Abriel and Kass 2005), 
accurately predicting that β subunits have context-dependent effects in vivo. Factors 
contributing to these differences include specific combinations of VGSC α and β subunits 
expressed, relative expression levels of each VGSC gene product, molecular composition 
of the VGSC macromolecular complex including non-channel binding partners, 
subcellular distribution of VGSC complexes, and developmental maturity (e.g. immature 
vs. mature neurons). 
  
Modulation of sodium current and excitability in vivo 
The use of genetically engineered mouse models and viral-mediated gene transfer 
has allowed for the investigation of VGSC α and β subunit function in the whole animal, 
in acutely isolated primary cells, and in tissue slices. Observations using these methods 




subtler in nature than observed in heterologous systems, is critical for normal electrical 
excitability in the nervous system and heart. 
Sodium current and action potential recordings from Scn1b null mice have 
provided important insights into the role of β1/β1B in modulating electrical excitability in 
vivo. Recordings from acutely isolated hippocampal pyramidal or bipolar neuronal soma 
found no measurable differences in sodium current properties in P10-18 Scn1b null 
neurons relative to wildtype (Chen et al. 2004; Patino et al. 2009). However, recordings 
from Scn1b null brain slices from the same age range demonstrated hyperexcitability in 
the CA3 region of the hippocampus as well as epileptiform activity in the hippocampus 
and cortex (Patino et al. 2009; Brackenbury et al. 2013), suggesting that β1/β1B subunits 
in neuronal processes may be critical in regulating excitability. These excitability changes 
are proposed to contribute to the severe seizures observed in Scn1b null mice, that are a 
model of DS (Chen et al. 2004; Patino et al. 2009). The observation of altered sodium 
current and impaired excitability in Scn1b null CGNs suggests a role for Scn1b in 
regulating the excitability of the cerebellum (Brackenbury et al. 2010) that may 
contribute to the ataxic phenotype of Scn1b null mice (Chen et al. 2004). In contrast to 
reduced excitability observed in Scn1b null CGNs, Scn1b null DRG neurons are 
hyperexcitable, suggesting that these animals may have allodynia (Lopez-Santiago et al. 
2011). Recordings from Scn1b null ventricular myocytes demonstrated increased 
transient and persistent sodium current relative to wildtype cells, with prolonged QT and 
RR internals on the electrocardiogram (ECG) (Lopez-Santiago et al. 2007). Clearly, 
β1/β1B subunits have cell type specific context-dependent effects on electrical 
excitability in vivo. 
In addition to modulation of sodium current in primary cells, Scn1b gene products 
(β1 or β1B) regulate the expression and subcellular distribution of VGSC α subunit 
proteins in a cell-type specific manner. Scn1b null CA3 hippocampal neurons have 




as assessed by immunofluorescence, which may correspond to the overall developmental 
delay exhibited by these mice (Chen et al. 2004). Scn1b is required for localization of 
Nav1.6 to the AIS in a subpopulation of CGNs and a subpopulation of Scn1b null CGNs 
display increased levels of Nav1.1 channels at the AIS compared to wildtype 
(Brackenbury et al. 2010). 
Other members of the VGSC β subunit gene family are involved in modulation of 
electrical excitability in vivo. Sodium current recordings in Scn2b null hippocampal 
neurons demonstrate a negative shift in the voltage-dependence of inactivation relative to 
cells from WT littermates, resulting in increased channel availability (Chen et al. 2002). 
In contrast, Scn2b null small-fast DRG neurons display decreased TTX-S (Nav1.7) 
sodium current density and slowed rates of TTX-S sodium current activation and 
inactivation, with no measurable changes in TTX-R currents (Lopez-Santiago et al. 
2006), again demonstrating that β subunit effects in vivo are cell type specific. 
Experiments using transfection to knockdown or express β4 in primary neurons suggest 
that this subunit promotes persistent sodium current (Aman et al. 2009; Bant and Raman 
2010). Interestingly, β1 and β4 are proposed to play opposite roles in hippocampal 
neurons, such that β1 promotes channel inactivation, acting as a “brake” on excitability, 
whereas β4 promotes channel activation, acting as the “accelerator” (Aman et al. 2009). 
This is consistent with findings that Scn1b null mice are spontaneously epileptic (Chen et 
al. 2004; Brackenbury et al. 2013). 
In addition to their roles in the nervous system, β subunits are regulators of 
electrical excitability in the heart in vivo. Sodium current recordings from Scn1b null 
ventricular cardiomyocytes demonstrated increases in both transient and persistent 
sodium current density, resulting in prolongation of action potential repolarization and 
extension of the heart rate-corrected QT interval (Lopez-Santiago et al. 2007). Here, 
Scn5a mRNA, Nav1.5 protein, and 
3
H-saxitoxin (a potent sodium channel blocker also 




increased compared to wildtype, suggesting increases in both TTX-R and TTX-S VGSC 
expression in these cells. Mutations in SCN2B have been linked to atrial fibrillation (AF) 
and Brugada syndrome, suggesting a role for β2 in cardiac excitability (Watanabe et al. 
2009; Riuro et al. 2013). Cardiac excitability is also abnormal in Scn3b null mice, 
suggesting a role for β3 in the heart (Hakim et al. 2008; Hakim et al. 2010). Upon 
programmed electrical stimulation, ventricular tachycardia occurs in Scn3b null, but not 
wildtype, Langendorff-perfused hearts (Hakim et al. 2008). Scn3b null hearts display 
atrial tachycardia during atrial burst pacing (Hakim et al. 2010). Scn4b has been 
identified as a modifier gene for Long QT Syndrome (LQTS) resulting from a mutant 
Scn5a gene (Remme et al. 2009). While the 129P2/OlaHsd mice used in this study are 
cardiac Scn4b hypomorphs, expression in the brain is unaffected (Calhoun and Isom, 
unpublished observation), suggesting 129P2/OlaHsd mice harbor a mutation that 
abolishes a cardiac-specific cis regulatory element.  
 
Role of VGSC β subunits in resurgent sodium current 
Resurgent sodium current, defined as the influx of sodium through VGSC 
αsubunits during repolarization (Bean 2005), is an important adaptation for high-
frequency firing neurons such as cerebellar Purkinje neurons (Burgess et al. 1995; Raman 
et al. 1997). The intracellular domain of β4 was proposed to serve as the open-channel 
blocking particle that allows for resurgent sodium current in neurons (Grieco et al. 2005).  
Here, a β4 C-terminal peptide was shown to prevent the fast inactivation gate from 
closing, thus allowing for more rapid channel recovery. Subsequent knockdown of β4 
expression using siRNA in CGNs resulted in reduced resurgent sodium current and 
decreased repetitive firing, providing further evidence for β4 as the open-channel 
blocking particle (Bant and Raman 2010). A peptide corresponding to β4 was sufficient 
to invoke resurgent sodium current in HEK 293 cells (Theile and Cummins 2011), again 




Importantly, however, co-expression of full length β4 and Nav1.6 subunits was not 
sufficient to generate resurgent current (Chen et al. 2008), suggesting that key cellular 
processes, possibly including post-translational modification, that allow β4 subunits to 
participate as the open-channel blocking particle may be specific to neurons. In addition 
to β4, β1 or β1B play roles in regulating resurgent current, at least in the cerebellum. 
Scn1b null CGNs have normal transient sodium current but reduced resurgent sodium 
current and, importantly, 4 protein levels are not reduced (Brackenbury et al. 2010). 
These observations strongly argue that VGSC β subunits, in particular β4, play a role in 
regulating resurgent sodium current in vivo.  
 
VGSC β subunits modulate cell surface expression of α subunits 
In heterologous systems, β subunits increase the cell surface expression of α 
subunits. The final step in VGSC biosynthesis in vivo is concomitant α-β2 association 
and cell surface insertion (Schmidt et al. 1985; Schmidt and Catterall 1986). In vivo 
observations support this conclusion. Primary Scn2b null hippocampal neurons display 
reduced sodium current density compared to wildtype (Chen et al. 2002). In support of 
this, 
3
H-saxitoxin binding to cell surface VGSCs is reduced in whole brain neurons 
isolated from Scn2b null mice while total 
3
H-saxitoxin binding (intracellular plus cell 
surface) is unchanged (Chen et al. 2002). Interestingly, this is not the case for all brain 
areas. Neurons acutely dissociated from wildtype and Scn2b null dentate gyrus exhibit 
similar sodium current densities (Uebachs et al. 2010). This result suggests that, similar 
to β1, the effect of β2 on cell surface α subunit expression may be cell-type specific. In 
addition to being cell-type specific, β2 has VGSC-specific effects based on TTX 
sensitivity. For example, Scn2b null small-fast DRG neurons have reduced TTX-S 
sodium current, but unchanged TTX-R sodium current (Lopez-Santiago et al. 2006). 
 




β1 was originally discovered as a subunit of rat brain VGSCs purified to 
theoretical homogeneity (Hartshorne et al. 1982; Hartshorne and Catterall 1984).  In spite 
of this, 1 is promiscuous in its ability to modify ion channels. For example, when co-
expressed with Kv4.3 in Xenopus oocytes, 1 modulates potassium current (Deschenes 
and Tomaselli 2002). Subsequent experiments by this group using siRNA to knock down 
Scn1b expression in neonatal rat ventricular cardiomyocytes resulted in reduced sodium 
current and transient outward potassium current, demonstrating that Scn1b modulates 
multiple channel types in vivo (Deschenes et al. 2008). More recently, β1 has been shown 
to modulate potassium currents expressed by Kv1.1, Kv1.2, Kv1.3, Kv1.6, or Kv7.2 (but 
interestingly not Kv3.1) in oocytes (Nguyen et al. 2012). Importantly, 
immunoprecipitation from mouse brain revealed that β1 subunits associate with Kv4.2 
(Marionneau et al. 2012). This provides critical in vivo evidence for association of 
potassium channels and β1 in a neuronal protein complex. In this same study, shRNA-
mediated knockdown of Scn1b resulted in a reduction of Kv4-mediated current in 
neurons (Marionneau et al. 2012). Scn1b null mice show prolonged action potentials and 
increased repetitive firing in cortical pyramidal neurons, supporting not only changes in 
sodium current, as shown in (Brackenbury et al. 2013) but also a link between VGSC 
β1/β1B subunits and potassium channel activity (Marionneau et al. 2012). These 
observations suggest a novel role for VGSC β1/β1B subunits in interacting with and 
modulating potassium channels, suggesting, perhaps, that these multifunctional proteins 
should be re-classified independently from the VGSC family. 
Non-canonical roles of VGSC β subunits in brain development and cell signaling 
Neurite outgrowth 
VGSC β subunits are multifunctional molecules that do more than modulate 
channel expression and ionic currents. As CAMs, β subunits, especially β1, participate in 
































Figure 1.5. A model for β1-mediated neurite outgrowth. (A) In immature CGNs 
lacking AIS, complexes containing Nav1.6, β1, and contactin are present throughout the 
neuronal membrane in the soma, neurite, and growth cone. Localized sodium influx is 
necessary for β1-mediated neurite extension and migration (Brackenbury et al. 2010). 
VGSC complexes along the neurite are proposed to participate in cell–cell adhesion and 
fasciculation (Davis et al. 2004; Brackenbury et al. 2008a). (B) In 14 DIV CGNs, β1 is 
also required for Nav1.6 expression at the AIS (Brackenbury et al. 2010), and subsequent 
high-frequency AP firing through modulation of resurgent sodium current (Van Wart and 
Matthews 2006; Raman et al. 1997; Raman and Bean 1997). Electrical activity may 
further promote β1-mediated neurite outgrowth at or near the growth cone in vivo (Van 
Wart and Matthews 2006; Raman et al. 1997; Raman and Bean 1997). Thus, the 
developmental functions of β1 and Nav1.6 are complementary, such that sodium influx 
carried by Nav1.6 is required for β1-mediated neurite outgrowth and β1 is required for 
normal expression/activity of Nav1.6 at the AIS. Fyn kinase and AnkG also are likely 
present in all complexes, but they are only shown once in each panel for clarity. The 
FGF-mediated, β1-independent neurite outgrowth pathway is shown as well. Other 
CAMs that regulate neurite outgrowth and also may interact with β1 in this system, have 




fasciculation. The first evidence of involvement of β1 in neurite outgrowth came from the 
observation that CGNs develop longer neurites on β1-expressing fibroblast monolayers 
compared to mock transfected monolayers (Davis et al. 2004). To test the effects of other 
β subunits, CGNs were also plated on β2- or β4-expressing monolayers (Davis et al. 
2004). β4-expressing monolayers had no effect, whereas β2-expressing monolayers 
reduced, neurite length. Comparing CGNs isolated from Scn1b null mice with those from 
wildtype littermates demonstrated that β1-mediated neurite outgrowth required trans 
homophilic adhesion (Davis et al. 2004). This suggests a model where β1-β1 trans 
homophilic adhesion acts as the initiating event for a signaling cascade that results in 
neurite outgrowth. β1-mediated neurite outgrowth is abrogated in Fyn and Cntn1 null 
CGNs, implying that these molecules are key, (Brackenbury et al. 2008a). Cntn1 null 
mice are β1 hypomorphs, suggesting that Cntn1 and Scn1b are linked in some fashion 
(Brackenbury et al. 2008a). β1 expression levels are unchanged in Fyn null mice, 
suggesting that this member of the src family of tyrosine kinases may participate in a 
signaling cascade downstream of β1-β1 mediated cell-cell adhesion (Brackenbury et al. 
2008a). A portion of β1 and fyn co-localize in detergent resistant membrane (DRM) 
fractions in brain (Brackenbury et al. 2008a) and contactin has been identified in this 
fraction as well (Kramer et al. 1999). These results suggest that β1-mediated neurite 
outgrowth may occur through a lipid raft signaling mechanism that requires the presence 
of both fyn and contactin (Brackenbury and Isom 2011). β1-mediated neurite outgrowth 
in CGNs requires the expression of Nav1.6 and is inhibited by TTX, suggesting that 
TTX-S sodium current modulates β1-mediated neurite outgrowth (Brackenbury et al. 
2010). However, the location of these signaling events in the neuron may differ. It is 
proposed that sodium current initiated at the AIS (where β1 is also located) signals to β1 
subunits at the growth cone which may or may not be associated with α subunits 
(Brackenbury et al. 2010). Importantly, while TTX inhibits β1-mediated neurite 




Conversely, neither FGF nor EGF receptor kinase inhibitors affect 1-mediated neurite 
extension (Brackenbury et al. 2008a). Thus, these signaling cascades appear to involve 
different players.  
 
Brain Development 
The gene products of Scn1b are important for neuronal patterning during brain 
development. Immunohistological examination of wildtype and Scn1b null cerebellae 
demonstrated cerebellar microorganization defects in the null brain (Brackenbury et al. 
2008a). Specifically, in the cerebellum of Scn1b null mice, parallel fiber fascicles were 
less compact than in wildtype. In addition, the external germinal layer (EGL) was 
expanded in size in null mice relative to wildtype, suggesting that a defect in migration 
may have trapped granule precursors in the EGL, preventing them from migrating to the 
inner granule layer (IGL). In wildtype cerebellar sections, axon fibers traversing the 
molecular layer (ML) ran perpendicular to the parallel fibers. However, in Scn1b null 
cerebellar sections, some of the axons traversing the ML deviated from this perpendicular 
trajectory, suggesting axon outgrowth and pathfinding deficits. In the developing 
hippocampus, Scn1b null mice display a series of developmental defects, including 
elevated levels of cellular proliferation in the hilus, ectopic Prox1-expressing dentate 
granule neurons in the hilus, decreased neuronal density in the dentate gyrus granule cell 
layer, increased thickness of the dentate gyrus granule cell layer, and abnormal axon 
outgrowth and pathfinding (Brackenbury et al. 2013). Spontaneous seizures begin at 
approximately postnatal day 10 in Scn1b null mice (Chen et al. 2004). Importantly, 
developmental defects in the Scn1b null cerebellum and hippocampus precede the onset 
of seizures and are detectable at P5 (Brackenbury et al. 2013). Taken together, these 
observations suggest that β1 or β1B function as CAMs in the developing CNS and that 






Roles of Voltage-gated Sodium Channel β Subunits in Pathophysiology 
Epilepsy 
Epilepsy is a common neurological disorder defined by recurrent, unprovoked 
seizures due to abnormal surges of electrical activity in the brain. While epilepsy can be 
caused by injury or other disease, as many as 40% of epilepsy cases are idiopathic and 
presumed to stem from genetic anomalies. Not surprisingly, mutations in ion channels 
(‘channelopathies’) cause epilepsy. Of particular interest is the GEFS+ spectrum of 
epilepsy disorders which includes GEFS+ and DS. The GEFS+ epilepsy spectrum is a 
continuum of disease severity and includes pediatric epilepsies wherein febrile seizures 
persist beyond six years of age and are associated with generalized or partial epilepsy 
(Escayg and Goldin 2010). DS patients exhibit frequent febrile seizures which precede 
the development of other seizure types and are at risk for status epilepticus, 
developmental delay, and ataxia. DS patients are also at elevated risk of death, or Sudden 
Unexplained Death due to EPilespsy (SUDEP). While multiple mechanisms have been 
proposed for SUDEP, lethal cardiac arrhythmia is an interesting candidate as ion channel-
driven cellular excitability is a shared trait between the brain and the heart (Surges and 
Sander 2012). Mutations in the VGSC α subunits SCN1A and SCN2A are linked to 
GEFS+ and DS, with mutations in SCN1A causing haploinsufficiency being the 
predominant cause of DS (Meisler and Kearney 2005; Escayg et al. 2000; Claes et al. 
2001; Sugawara et al. 2001; Shi et al. 2009). 
Human SCN1B mutations are also linked to epilepsies on the GEFS+ spectrum, 
including GEFS+ and DS (Wallace et al. 1998; Wallace et al. 2002; Patino et al. 2009; 
Audenaert et al. 2003; Ogiwara et al. 2012). In addition to the GEFS+ spectrum, SCN1B 




epilepsy (EOAE) (Audenaert et al. 2003; Scheffer et al. 2007). To date, most known 
disease-related SCN1B mutations cluster in the Ig loop region of β1/1B (Brackenbury 
and Isom 2011). Probands in a number of GEFS+ pedigrees carry rare heterozygous 
SCN1B mutations (Wallace et al. 1998; Wallace et al. 2002; Audenaert et al. 2003; 
Scheffer et al. 2007; Fendri-Kriaa et al. 2011). A homozygous DS mutation in SCN1B 
was identified by screening candidate genes after the patient was found to lack mutations 
in SCN1A (Patino et al. 2009). Recently, another homozygous SCN1B mutation was 
discovered in a DS patient  (Ogiwara et al. 2012). While the majority of human mutations 
map to the Ig loop region that is shared by both β1 and β1B splice variants, a β1B-
specific mutation was recently identified in two unrelated pedigrees with idiopathic 
epilepsy (Patino et al. 2011). 
Mouse models support the link between Scn1b and epilepsy. Scn1b null mice 
display spontaneous generalized seizures and ataxia (a co-morbidity of DS), die by P21 
(Chen et al. 2004), and are proposed to be a model of DS (Patino et al. 2009). 
Characterization of Scn1b null mice has demonstrated defects in excitability and neuronal 
development (Patino et al. 2009; Brackenbury et al. 2008a; Brackenbury et al. 2013). 
Importantly, defects in neuronal patterning are observed at P5, prior to seizure onset, 
suggesting that this may be a cause, rather than an effect, of neuronal hyperexcitability 
(Brackenbury et al. 2013). A mouse model of SCN1B-related GEFS+, a knock-in of the 
β1 p.C121W mutation, recapitulates a number of aspects of the human disease (Wimmer 
et al. 2010). Both p.C121W heterozygous and homozygous mice are more susceptible to 
febrile seizures relative to wildtype littermates (Wimmer et al. 2010). Action potential 
recordings from subicular pyramidal neurons suggest p.C121W knock-in neurons are 
hyperexcitable (Wimmer et al. 2010). Immunoblots with an anti-β1 antibody suggest no 
change in β1 expression in C121W knock-in heterozygous or homozygous brains 
(Wimmer et al. 2010), however, the authors make note of a number of nonspecific 




antibody (Wimmer et al. 2010). Data suggest that heterozygous p.C121W knock-in mice, 
expressing a single mutant copy of Scn1b, display a GEFS+-like phenotype. At the 
cellular level, the p.C121W mutation results in a hyperexcitable phenotype in subicular 
pyramidal neurons, which may provide evidence toward the mechanism of febrile 
seizures resulting from this mutation. 
Studies of SCN1B mutants have yielded insight into the molecular mechanisms 
underlying the perturbed functionality of these alleles. β1 p.R125C is a trafficking 
deficient mutation which is retained intracellularly, resulting in a functional null 
phenotype (Patino et al. 2009). Importantly, the β1 p.R125C trafficking defect can be 
rescued by incubating cells at lowered temperature, opening the possibility of future 
development of novel therapeutics similar to those for CFTR and muscular dystrophy 
(Eckford et al. 2012; Cirak et al. 2011). β1 p.C121W disrupts a conserved intramolecular 
disulfide bond, a critical feature of the Ig loop structure. β1 p.C121W traffics normally to 
the cell surface and promotes VGSC α subunit expression in transfected cell lines, 
however, it does not participate in trans homophilic adhesion and does not modulate 
sodium current in vitro (Meadows et al. 2002b). The trafficking of β1 p.C121W was 
studied by viral expression of wildtype or mutant β1-eGFP fusion constructs in neurons. 
Under these conditions β1 p.C121W was excluded from the AIS, suggesting that the 
mutation affects β1 trafficking in vivo (Wimmer et al. 2010). Studies of the SCN1B 
GEFS+ mutations p.R85C and p.R85H in heterologous systems showed that these mutant 
β1 subunits fail to modulate VGSC α subunits due to reduced membrane and intracellular 
β1 expression (Xu et al. 2007). In contrast, we were able to detect p.R85H at the cell 
surface in transfected CHL cells (Patino et al. 2011). These results present a complex 
picture of SCN1B mutations with differential effects in different expression systems that 
may include defects in trafficking or sodium channel modulation.  Importantly, a gap in 
the literature is in understanding the role of these SCN1B mutations in vivo, including 




Thus far, data on SCN1B epilepsy mutations suggest a model in which gene 
dosage may determine the severity of disease presentation. For example, a single mutant 
SCN1B allele may result in the development of the milder disease GEFS+. In contrast, 
expression of two non-functional SCN1B alleles may result in the very severe disease DS. 
As more SCN1B mutant alleles associated with epilepsy are identified and studied, the 
picture will become clearer. The future identification of SCN1B modifier genes and gain-
of-function or dominant-negative SCN1B mutations will certainly revise this model.  
Ataxia 
Ataxia, or altered gait, largely resulting from abnormal electrical excitability in 
the cerebellum, is a comorbidity of DS. Scn1b null mice display ataxia (Chen et al. 2004) 
and the patient carrying two DS mutant SCN1B alleles (p.R125C), predicted to be a 
functional null, displayed psychomotor deterioration after 5 months of age (Patino et al. 
2009). Evidence from studying cerebellar microorganization of Scn1b null mice has 
yielded important information for the understanding of ataxia related to SCN1B. As 
described above, Scn1b null CGNs display reduced resurgent sodium current and 
impaired excitability (Brackenbury et al. 2010). Additionally, the developing Scn1b null 
cerebellum has defasciculated parallel fibers, abnormal migration of CGN precursors, and 
aberrant axon outgrowth and pathfinding of developing CGNs (Brackenbury et al. 
2008a). Finally, the expression of β1 subunits in Bergmann glia in the cerebellum raises 
the possibility that SCN1B mutations may result in altered axo-glial interations (Davis et 
al. 2004). Thus, the ataxic phenotype of Scn1b null mice and possibly of SCN1B-linked 
epilepsy patients likely results from a combination of developmental defects compounded 
by altered excitability. 
Cardiac arrhythmia 
Channelopathies increase the risk of abnormal heart rhythms, or cardiac 




example, mutations in the predominant cardiac sodium channel gene SCN5A are 
associated with LQTS, Brugada syndrome, and VF (Remme and Bezzina 2010). 
Mutations in VGSC β subunits SCN1B, SCN2B, and SCN3B are linked to Brugada 
syndrome, which confers increased risk of sudden cardiac death due to VF (Watanabe et 
al. 2008; Riuro et al. 2013; Ishikawa et al. 2013). Mutations in SCN1B, SCN2B, SCN3B, 
and SCN4B are linked to AF (Watanabe et al. 2009; Olesen et al. 2011; Li et al. 2013). A 
mutation in SCN4B has been linked to LQTS, in which impaired repolarization of the 
myocardium provides a substrate for arrhythmia that can result in heart palpitations, 
syncope, or sudden death due to VF (Medeiros-Domingo et al. 2007). 
Evidence in transgenic mice suggests an important role for VGSC β subunits in 
the heart. Scn1b null mice have abnormal cardiac action potentials evidenced by an 
elongated heart rate-corrected QT interval (Lopez-Santiago et al. 2007). Acutely 
dissociated ventricular cardiomyocytes from Scn1b null mice have increased peak and 
persistent sodium current relative to wildtype cells. Ventricular tachycardia is observed 
following programmed electrical stimulation in Scn3b null, but not wildtype, 
Langendorff-perfused hearts (Hakim et al. 2008). In hearts paced using atrial burst 
pacing, Scn3b null hearts were susceptible to atrial tachycardia (Hakim et al. 2010). A 
genetic modifier screen identified SCN4B as a genetic modifier for phenotype severity in 
a mouse model of an SCN5A allele which results in conduction disease and Brugada 
syndrome with variable severity in patients (Remme et al. 2009). 
 These results suggest VGSC β subunits are involved in normal cardiac function 
and that perturbation of these genes by mutation can result in disease. Given that β 
subunit mutations are linked to both brain and cardiac disease, one cannot help but 
consider the possibility of a link between these syndromes. Elucidation of this putative 





Sudden Infant Death Syndrome (SIDS) 
SIDS is characterized by the sudden death of an infant with no obvious trauma or 
identifiable underlying medical condition. Arrhythmia is emerging as one of the potential 
causes of SIDS (Towbin 2010). In addition to mutations of the predominant cardiac 
sodium channel gene SCN5A in SIDS, rare mutations have been identified in SCN3B and 
SCN4B in 3 cases (Tan et al. 2010; Wang et al. 2007; Arnestad et al. 2007). Biochemical 
characterization of the resulting β3 and β4 mutant proteins suggested that the mutations 
perturbed the normal function of the proteins. When co-expressed with Nav1.5, the β3 
mutant (p.V36M) decreased peak sodium current while wildtype β3 had no effect (Tan et 
al. 2010). In contrast, neither wildtype β4 nor the β4 mutant (p.S206L) had an effect on 
peak current (Tan et al. 2010). Importantly, the β3 and β4 mutants both resulted in 
increased persistent sodium current (Tan et al. 2010). Expression of β4 p.S206L in adult 
rat ventricular cardiomyocytes also led to increased persistent sodium current, suggesting 
the presence of substrates for lethal arrhythmias in these SIDS patients (Tan et al. 2010). 
These results suggest the possibility of common molecular mechanisms between 
epilepsy, SUDEP, cardiac arrhythmia, and SIDS, and provide further evidence that 
treatment of arrhythmia may be a potential avenue for preventing both SUDEP and SIDS. 
Neuropathic Pain 
Neuropathic pain can be caused by genetic mutation or nerve injury, resulting in 
elevated pain sensation, or allodynia, in individuals due to disruptions in nociception, the 
normal neuronal pathways involved in the sensation of noxious stimuli. VGSC β subunits 
are expressed in multiple cell types involved in nociception, including DRG neurons and 
peripheral nerves, and animal studies suggest the involvement of β subunits in 
nociception. Specifically, Scn1b null DRG neurons are hyperexcitable (Lopez-Santiago et 
al. 2011). While the early postnatal lethality of Scn1b null mice has complicated 




sensitivity to stimulation and result in allodynia. The role of Scn2b in nociception has 
also been explored. As described above, β2 modulates TTX-S but not TTX-R VGSC α 
subunits and currents in small-fast DRG neurons. Scn2b null mice are less sensitive than 
wildtype mice in the late phase of the formalin test, suggesting a role for β2 in 
inflammatory pain (Lopez-Santiago et al. 2006). β2 protein expression increases with 
nerve injury and this expression is required for the development of mechanical allodynia 
in a rodent model (Pertin et al. 2005). Finally, β3 is expressed in small-diameter c-fiber 
DRG neurons and the expression of β3 is upregulated in a chronic constriction rat 
neuropathic pain model (Shah et al. 2000). These results suggest β subunits play 
important roles in nociception and are potential therapeutic targets in neuropathic pain. 
Neurodegenerative disease 
Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s 
disease (PD), Multiple sclerosis (MS), and Huntington’s disease (HD), are characterized 
by a progressive loss of neuron function over time and often involve neuronal cell death. 
Accumulation of intra-axonal sodium ions resulting in calcium overload is an emerging 
mechanism for axonal loss and cell death in neurodegenerative disease, suggesting a 
potential link between VGSCs and neurodegeneration (Waxman 2006). Importantly, 
pharmacological inhibition of VGSCs is neuroprotective in experimental autoimmune 
encephalomyelitis (EAE), a model of MS (Lo et al. 2002; Lo et al. 2003). This result 
suggested that a reduction in sodium current might be a general mechanism for 
neuroprotection. Scn2b null mice (lacking β2) display reduced sodium current density in 
CNS and PNS neurons. Thus, it was hypothesized that these mice display protection from 
neurodegeneration (Chen et al. 2002; Lopez-Santiago et al. 2006). Using the EAE model, 
it was demonstrated that Scn2b null mice have higher rates of survival and lower rates of 




raised the possibility that in, addition to VGSC α subunits, β2, and possibly other β 
subunits, may be targets for therapeutic intervention in neurodegenerative disease. 
β4 is down-regulated in the striatum of HD patients (Oyama et al. 2006). 
However, whether loss of β4 expression is relevant to the HD disease process or a 
secondary effect of the disease is unknown. Given the role of β4 in sodium current 
modulation, resurgent sodium current generation, and potentially as a CAM, it seems 
plausible that down-regulation of β4 could have a significant impact on brain function. A 
recent report investigating PD identified glycosylated β4 in patient cerebral spinal fluid 
(CSF) (Zhou et al. 2012), suggesting that the ectodomain of β4 may be released into the 
CNS during the disease process. However, additional evidence is needed to implicate β4 
in the pathogenesis of neurodegenerative disease. At this time, the possibility that altered 
proteolytic cleavage of β4 is a secondary byproduct of disease progression cannot be 
excluded. Even if β4 is not directly involved in the disease mechanism, it may be useful 
as a biomarker.  
Potential role of VGSC β subunits in cancer 
Increasing evidence implicates ion channels, including VGSCs, in carcinogenesis 
(Prevarskaya et al. 2010). Much of the research on the role of VGSCs in cancer has 
focused on α subunits as molecules which promote metastatic potential, the ability of a 
cancer cell to release from the primary tumor and form secondary tumors (Brackenbury 
2012). Importantly, pharmacologic inhibition of sodium current inhibits cancer cell 
invasion in vitro, raising the possibility that VGSCs may be novel targets for treating 
metastatic cancer (Brackenbury et al. 2007; Yang et al. 2012). Less is known about 
VGSC β subunits in cancer, though a few studies have been performed which suggest 
context-specific roles for these molecules. SCN1B mRNA transcripts have been detected 
in prostate cancer and may correlate with high metastatic potential (Diss et al. 2008). In 




metastatic cells and low in strongly metastatic cells (Chioni et al. 2009). In cell culture 
models, β1 acts to limit metastatic potential, suggesting it may be a novel therapeutic 
target (Chioni et al. 2009). These results suggest a cell type-specific function for SCN1B 
in cancer, however, they must be interpreted with caution until in vivo evidence emerges. 
In addition, SCN3B may play a novel role as a p53-inducible proapoptotic gene that may 
partially mediate the tumor suppressor function of p53 (Adachi et al. 2004). However, a 
putative molecular mechanism for how SCN3B functions in apoptosis remains elusive. 
Therapeutic potential of VGSC β subunits 
As discussed above, VGSC β subunits may be drug targets for a variety of 
diseases including epilepsy, cardiac arrhythmia, neuropathic pain, migraine, multiple 
sclerosis, and cancer. How to target these molecules remains unknown, although 
emerging clues, as discussed below, may provide important insights. 
 
β subunits alter VGSC pharmacology 
Perhaps the observation with most immediate ramifications for therapeutics is the 
finding that β subunits affect VGSC pharmacology. In Xenopus oocytes, co-expression of 
β1or β3 with Nav1.3 abrogates the inhibitory effect of lidocaine, a sodium channel 
blocker utilized as an antiarrhythmic and local anesthetic (Lenkowski et al. 2003). In 
addition, in a heterologous system the β1 p.C121W GEFS+ mutation diminishes tonic 
and use-dependent channel block induced by phenytoin, a sodium channel blocker used 
as an anticonvulsant (Lucas et al. 2005). The efficacy of the anticonvulsant 
carbamazepine, a sodium channel blocker, relies on the expression of Scn1b in vivo 
(Uebachs et al. 2010). In contrast, the anticonvulsant lacosamide functions normally in 
this model (Uebachs et al. 2012). These studies emphasize the importance of 
understanding how drugs interact not only with the pore-forming α subunits in isolation, 




subunits can be altered by pathophysiology, understanding how sodium channel 
compounds work in the absence and presence of β subunits is clinically relevant 
(Ellerkmann et al. 2003). 
 
Rescuing trafficking deficient α subunits 
Some SCN1A epilepsy mutations result in trafficking deficient Nav1.1 channels 
that can be rescued by modulatory proteins, including VGSC β subunits, or by a number 
of VGSC targeting compounds (Rusconi et al. 2007; Rusconi et al. 2009; Thompson et al. 
2012). In addition to providing a model for heterogeneity of disease severity in which 
genetic background may influence the level of mutant Nav1.1 channel proteins trafficked 
to the cell surface, this suggests a novel treatment strategy. Utilizing VGSC targeting 
drugs or gene therapy to deliver modulatory β subunits may correct channel trafficking in 
this patient cohort and provide a viable therapeutic intervention. A potential caveat here 
is that forcing channels with gain-of-function mutations to the neuronal cell surface may 
exacerbate, rather than ameliorate, disease (Thompson et al. 2012).  
 
Modulation of SCN2B expression in neurodegenerative disorders and neuropathic pain 
Scn2b deletion is neuroprotective in EAE, a model of MS (O'Malley et al. 2009). 
It is interesting to consider the possibility that reducing the expression of β2 in patients, 
through small molecules or gene therapy, may be neuroprotective and a potential 
therapeutic approach to neurodegeneration in MS. Because Scn2b null mice are healthy 
and live normal lifespans, the safety risks of targeting β2 in limited brain areas may be 
acceptable. In addition, β2 may be a potential therapeutic target in the treatment of 
neuropathic pain. As discussed above, global Scn2b deletion modulates TTX-S VGSC α 
subunit expression and function in small-fast DRG neurons as well as the animal’s 
response to an inflammatory pain model (although these mice are more sensitive to acute 




expression of β2 increases with nerve injury and β2 upregulation is necessary for the 
development of mechanical allodynia (Pertin et al. 2005). A small molecule or gene 
therapy approach to reduce the expression of β2 in neurons within the nociceptive 
pathway may be a viable strategy to treat neuropathic pain. 
 
Concluding Remarks 
SCN1B: A tale of two splice variants 
SCN1B encodes both the transmembrane protein β1 and the secreted protein β1B 
(Patino et al. 2011). Importantly, both splice variants are CAMs (Malhotra et al. 2000; 
Patino et al. 2011). A critical gap in our knowledge is how each splice variant contributes 
to normal development and thus how mutations in only one of the gene products but not 
the other might contribute to pathophysiology. Most of the disease-related SCN1B 
mutations cluster in or near the extracellular Ig loop, which is common to both β1 and 
β1B (Brackenbury and Isom 2011). Scn1b null mice, which exhibit spontaneous seizures 
and premature lethality and are a DS model, lack expression of both splice variants and 
thus imply the importance of both in establishing and maintaining normal physiology 
(Chen et al. 2004). Further, mutations that affect β1B and not β1 have been identified in a 
case of Brugada syndrome and two pedigrees of idiopathic epilepsy (Watanabe et al. 
2008; Patino et al. 2011), suggesting that both splice variants of SCN1B play important 
roles in normal physiology. 
Characterization of Scn1b null mice suggests that β1 or β1B subunits are critical 
for normal brain development. But what about adult brain function? It has been 
demonstrated that proteins involved in tissue development can be co-opted and utilized 
for adult tissue maintenance. While much of the focus on studying β subunits has focused 




critical in later adulthood. If the β1/1B subunits play important roles at later time points, 
this may open up a new avenue to investigate the potential involvement of these proteins 
in aging, dementia, or neurodegeneration, as has been suggested for β2 and β4. 
Functional redundancy – a putative model for disease severity 
Perturbation of β1/β1B function, either in inherited human disease or by genetic 
deletion of Scn1b in mice, may be more harmful to the organism than perturbation of 
other VGSC β subunits. While Scn1b null mice model DS and SUDEP, Scn2b null mice 
and Scn3b null mice do not have seizures and live normal life spans. Thus, SCN1B is 
essential for life while SCN2B and SCN3B are not. Currently, the lack of a Scn4b null 
mouse model prevents us from understanding the role of β4 in vivo and represents a 
major gap in our knowledge. A theory that might explain the apparent discrepancy in 
functional importance of the  subunits, at least in brain, is functional redundancy. It is 
possible that compensation is poorly achieved with altered SCN1B function since β3, the 
other transmembrane VGSC β subunit that non-covalently associates with α, has a 
different developmental expression profile and may have altered CAM functions in 
developing brain compared to β1/1B. Also, because a secreted splice variant of β3 has 
not been identified, the loss of secreted β1B, especially during brain development, may 
be an important factor. Scn3b null mice are relatively healthy, thus Scn1b may be 
compensatory in this model. In Scn2b null mice, which are also generally healthy, Scn4b 
(encoding the other disulfide-liked β subunit, β4) may provide functional redundancy, for 
example, serving as a chaperone for the remaining (~50% of control levels) VGSCs 
detected at the cell surface of Scn2b null neurons. If so, then a double null mouse 
(Scn2b/Scn4b) is predicted to have little to no cell surface VGSCs, and result in a lethal 
phenotype. Interestingly, Scn2b may not reciprocally compensate for Scn4b, considering 
the role of β4 as a key player in the generation of resurgent sodium current in high-




deleterious to neuronal circuits that rely on resurgent sodium current for which Scn2b 
cannot compensate. Development of a Scn4b null mouse model will be essential to 
addressing these questions. Additionally, characterizing mice with multiple null Scnxb 
alleles will shed important light on this ongoing area of investigation. For example 
Scn1b/Scn2b null mice (Aman et al. 2009) have a more severe phenotype and die at a 
younger age than Scn1b null mice (Chen and Isom, unpublished observations). While 
anecdotal due to a limited sample size, this observation illustrates the potential utility of 
using such genetic approaches to answer questions about β subunit functional 
redundancy. 
Modifier genes – a model for disease heterogeneity 
The existence of modifier genes may explain heterogeneity in disease severity 
within epilepsy, cardiac arrhythmia, and other channelopathies between families and even 
within the same family. Based on the topics reviewed here about the multifunctional 
VGSC β subunits, it seems reasonable to predict that β subunit gene variants/mutations 
may be disease modifying in addition to disease causing. For example, SCN4B has been 
identified as a modifier gene in a mouse model of SCN5A-linked LQTS (Remme et al. 
2009). Conversely, it is likely that other genes may modify the severity of disease-
causing VGSC β subunit gene mutations, for example, genes encoding some of the key β 
subunit interacting proteins discussed here. Future discovery of these genetic 
relationships will not only shed light on disease mechanisms but will provide critical new 
information regarding the biology of VGSC β subunit-containing protein complexes in 
normal development and physiology.  
Anything but Auxiliary: The future of VGSC β subunits 
While originally discovered as ancillary proteins that co-purify with pore-forming 
VGSC α subunits, there is growing evidence that the β subunits are multifunctional 




homophilic and heterophilic cell adhesion, regulation of gene transcription, and 
modulation of potassium currents. Importantly, SCN1B-linked channelopathies may be 
diseases of brain or heart development, resulting from impaired β1/β1B-mediated cell 
adhesion leading to altered neuronal circuitry or cardiac cell-cell junctions. This 
fascinating VGSC β subunit field now looks forward to the use of tissue- and 
developmental time-specific null mouse models, knockin mouse models of human 
mutations, the identification of modifier genes, the development of novel therapeutics, 
and the use of patient-specific human induced pluripotent stem cell models to investigate 
genetic background issues in personalized medicine.  
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Thesis Goals 
The overall goal of my thesis work was to improve our understanding of how 
VGSC β subunits regulate important cell processes such as cell motility. In addition, I 
endeavored to improve our knowledge regarding how β subunits, in turn, are regulated by 
other proteins. 
Specifically, for the work described in Chapter II, our objective was to determine 
the role of VGSC β subunits, in particular β1, in human breast cancer cell motility and 
metastatic potential in vitro. In addition to studying the expression of β subunit mRNA 
and β1 protein expression, we used complementary approaches to examine the effects of 
β1 knockdown and β1 expression in human breast cancer cell lines in vitro. We observed 




β1 expression resulted in increased cell motility. Conversely, β1 is weakly expressed in 
highly metastatic MDA-MB-231 cells, and stable transfection of β1 increases cell-cell 
adhesion and reduces cell motility. 
For the study described in Chapter III, we used CGNs as a model system to 
investigate the role of β1 tyrosine phosphorylation in β1-mediated neurite outgrowth. We 
postulated that tyrosine phosphorylation of β1 may act as a molecular switch for 
downstream signal transduction in response to β1-β1 trans homophilic adhesion. In this 
study, a BacMam baculovirus system was used to express β1 WT or β1Y181E (a 
phosphomimetic substitution) in Scn1b null CGNs to ask if the tyrosine phosphomimetic 
mutation affected neurite outgrowth in the absence of β1-β1 trans homophilic adhesion. 
We observed that expression of β1Y181E resulted in significantly increased neurite 
length relative to the expression of β1 WT. In addition, we found that cells grown as 
aggregates displayed increased levels of tyrosine phosphorylated β1 compared to cells 
grown as monolayers. Importantly, we observed tyrosine phosphorylation of a β1 peptide 
in a cell-free fyn kinase assay, suggesting that β1 is a putative substrate for fyn. 
For the project discussed in Chapter IV, the goal was to determine the cysteine 
residue(s) of β2 involved in covalent linkage with α subunits and ask whether this linkage 
affected protein trafficking. Using a mutagenesis based approach, we were able to 
identify cysteine residue 26 (β2C26) as the cysteine residue that covalently links to the α 
subunit. Interestingly, we observed that α-β2 disulfide-linkage is important for the proper 






Chapter II: A novel adhesion molecule in human breast cancer cells: 
Voltage-gated sodium channel β1 subunit 
Chapter II was published in The International Journal of Biochemistry & Cell 
Biology (Chioni et al. 2009). My primary contributions to this study include: (1) 
generation of the MDA-MB-231 cell lines stably expressing GFP or β1-GFP and (2) 
characterization of in vitro cell behaviors of MDA-MB-231 stable cell lines including cell 
motility, cell-cell adhesion, morphology, and proliferation. 
 
Abstract 
Voltage-gated sodium channels (VGSCs), predominantly the ‘neonatal’ splice 
form of Nav1.5 (nNav1.5), are upregulated in metastatic breast cancer (BCa) and 
potentiate metastatic cell behaviors. VGSCs comprise one pore-forming α subunit and 
one or more β subunits. The latter modulate VGSC expression and gating, and can 
function as cell adhesion molecules of the immunoglobulin superfamily. The aims of this 
study were (1) to determine which β subunits were expressed in weakly metastatic MCF-
7 and strongly metastatic MDA-MB-231 human BCa cells, and (2) to investigate the 
possible role of β subunits in adhesion and migration. In both cell lines, the β subunit 
mRNA expression profile was SCN1B (encoding  β1) » SCN4B (encoding β4) > SCN2B 
(encoding  β2); SCN3B (encoding β3) was not detected. MCF-7 cells had much higher 
levels of all β subunit mRNAs than MDA-MB-231 cells, and β1 mRNA was the most 
abundant. Similarly, β1 protein was strongly expressed in MCF-7 and barely detectable 




was reduced by 35%, while migration was increased by 121%. The increase in migration 
was reversed by tetrodotoxin (TTX). In addition, levels of nNav1.5 mRNA and protein 
were increased following β1 down-regulation. Stable expression of β1 in MDA-MB-231 
cells increased functional VGSC activity, process length and adhesion, and reduced 
lateral motility and proliferation. We conclude that β1 is a novel cell adhesion molecule 




Voltage-gated sodium channels (VGSCs) are classically responsible for action 
potential generation and conduction in excitable cells (Catterall 2000). VGSCs contain 
one pore-forming α subunit and one or more β subunits (Catterall 1992). VGSCs are also 
widely expressed in cells from a range of human cancers, including breast cancer (BCa) 
(Fraser et al. 2005; Roger et al. 2003), prostate cancer (PCa) (Laniado et al. 1997), 
lymphoma (Fraser et al. 2004), lung cancer (Onganer and Djamgoz 2005; Roger et al. 
2007), mesothelioma (Fulgenzi et al. 2006), neuroblastoma (Ou et al. 2005), melanoma 
(Allen et al. 1997), and cervical cancer (Diaz et al. 2007). In addition, VGSCs are 
upregulated in line with metastasis in BCa, PCa, and small-cell lung cancer (SCLC) in 
vivo (Onganer et al. 2005; Fraser et al. 2005; Diss et al. 2005). 
In human and rodent cell models of BCa, PCa and lung cancer, the specific VGSC 
blocker tetrodotoxin (TTX) suppresses a variety of in vitro metastatic cell behaviors 
including invasion (Grimes et al. 1995; Bennett et al. 2004; Laniado et al. 1997; Roger et 
al. 2003), migration (Brackenbury and Djamgoz 2006), galvanotaxis (Djamgoz et al. 
2001), morphological development and process extension (Fraser et al. 1999), endocytic 
membrane activity (Onganer and Djamgoz 2005), lateral motility (Fraser et al. 2003), 




Strongly metastatic MDA-MB-231 human BCa cells express a TTX-resistant (IC50 in µM 
range) VGSC current that is absent in weakly metastatic MCF-7 cells (Fraser et al. 2005; 
Roger et al. 2003). In MDA-MB-231 cells, the predominant α subunit (Nav1.5; gene: 
SCN5A) is expressed primarily in its ‘neonatal’ D1:S3 5’-splice form (nNav1.5) (Chioni 
et al. 2005; Fraser et al. 2005). nNav1.5 is primarily responsible for the VGSC-dependent 
enhancement of migration and invasion of MDA-MB-231 cells (Brackenbury et al. 
2007). However, the possible functional involvement of β subunits in potentiation of 
metastatic cell behaviors is not yet known. 
So far, four VGSC β subunits (β1–β4; genes: SCN1B–SCN4B) have been 
identified. β1 and β3 are non-covalently associated with the α subunit (Morgan et al. 
2000; Isom et al. 1992), whereas β2 and β4 are disulfide linked (Isom et al. 1995a; Yu et 
al. 2003). VGSC β subunits are multifunctional molecules (Brackenbury and Isom 2008). 
These are unique among ion channel auxiliary subunits in that they are homologous to the 
immunoglobulin superfamily of cell adhesion molecules (CAMs) (Isom 2001; Isom et al. 
1994). β subunits also direct α subunit insertion into the plasma membrane and permit 
interaction of the channel with other signaling proteins. For example, β1 and β2 interact 
with the extracellular matrix proteins tenascin-C and tenascin-R, influencing migration 
(Xiao et al. 1999; Srinivasan et al. 1998). In addition, β1 and β2 participate in homophilic 
cell adhesion, resulting in cellular aggregation and ankyrin recruitment (Malhotra et al. 
2000; Malhotra et al. 2002). Furthermore, β1 interacts heterophilically with N-cadherin, 
contactin, neurofascin-155, neurofascin-186, NrCAM, and β2 (Malhotra et al. 2004; 
Kazarinova-Noyes et al. 2001). β1 promotes process extension, migration and 
pathfinding in neurons (Brackenbury et al. 2008a; Davis et al. 2004). β1 can also 
influence intracellular mechanisms, e.g. a site within the cytoplasmic domain of β1 
interacts with receptor tyrosine phosphatase β (Ratcliffe et al. 2000). At least some of 
these functional roles may be independent of α subunits; in fact, it has been suggested 




Fein et al. 2008). β subunits may have direct involvement in pathophysiologies, e.g. 
cardiac arrhythmia, epilepsy and pain (Brackenbury and Isom 2008) and indirect 
involvement, via interacting partners, e.g. contactin, as in metastasis (Su et al. 2006). A 
recent study on human prostate cancer found (i) that the β subunit mRNA level in vitro 
was positively correlated with metastatic potential and (ii) that SCN1B was most 
abundant of the β subunits (Diss et al. 2008). β subunit expression in human BCa has not 
previously been studied. 
The main aims of the present study were 2-fold: (1) to investigate β subunit 
expression in two human BCa cell lines of contrasting metastatic potential: MCF-7 
(non/weakly metastatic) and MDA-MB-231 (strongly metastatic) in a comparative 
approach; and (2) to explore the involvement of the β subunit(s), mainly β1, in cellular 




MDA-MB-231 and MCF-7 cells were cultured in Dulbecco’s modified Eagle’s 
medium supplemented with 5–10% fetal bovine serum (FBS) and 4mM l-glutamine, as 
described previously (Fraser et al. 2005). 
Real-time PCR 
RNA extraction, cDNA synthesis and real-time PCR were performed as described 
previously (Brackenbury et al. 2007). Primers for Cytb5R and nNav1.5 were as described 
previously (Diss et al. 2001; Brackenbury et al. 2007). The following primer pairs and 
annealing temperatures were also used: 
1. SCN1B: 5’-AGAAGGGCACTGAGGAGTTT-3’ and 5’-




2. SCN2B: 5’-GAGATGTTCCTCCAGTTCCG-3’ and 5’-
TGACCACCATCAG-CACCAAG-3’ (62 ◦C). 
3. SCN3B: 5’-CTGGCTTCTCTCGTGCTTAT-3’ and 5’-
TCAAACTCCCGGGA-CACATT-3’ (60 ◦C). 
4. SCN4B: 5’-TAACCCTGTCGCTGGAGGTG-3’ and 5’-
TGAGGATGAGGAG-CCCGATG-3’ (60 ◦C). 
Threshold amplification cycles were determined using the Opticon Monitor 2 
software (MJ Research,Waltham, MA) and analysed by the 2
-ΔΔCt
 method (Livak and 
Schmittgen 2001). 
RNA interference 
RNA interference was performed with a pool of siRNAs (Genome smart pool for 
human SCN1B NM 001037; Dharmacon, Lafayettte, CO), as described previously 
(Brackenbury et al. 2007). mRNA and protein levels were measured 4–12 days after 
transfection, and compared with two controls: 
1. ‘Mock’. Transfection without siRNA. 
2. ‘siControl’. Transfection with siControl non-targeting siRNA pool 
(Dharmacon). 
Transfection efficiency was assessed independently using a positive control 
siRNA targeting Lamin A/C (Dharmacon), which significantly reduced the lamin A/C 
protein level by ≥70% after 4 days, compared to siControl non-targeting siRNA. 
Creation of a stable MDA-MB-231 line expressing β1 
Cells (50% confluent) were transfected overnight with cDNA (2 µg) using 
Fugene6 reagent (Roche, Nutley, NJ, USA). cDNA encoding eGFP was subcloned from 
pEGFPN1 into pcDNA3.1+ (Invitrogen). β1-GFP was generated by inserting β1 cDNA 
lacking the stop codon into pEGFPN1 to create a C-terminal fusion protein. The β1-eGFP 




with 400 µg/ml geneticin. One clone was derived and maintained in 200 µg/ml geneticin. 
β1-eGFP-transfected cells were selected with 200 µg/ml hygromycin B. One clone was 
derived and maintained in 100 µg/ml hygromycin B. 
Western blotting 
Total cell lysate preparation, cell membrane preparation, SDS polyacrylamide gel 
electrophoresis, transfer to nitrocellulose and chemiluminescent detection were 
performed as described previously (Lopez-Santiago et al. 2006; McEwen et al. 2004; 
Laniado et al. 1997; Chioni et al. 2005; Fraser et al. 2005). The following primary 
antibodies were used: 
1. Pan-VGSC α subunit antibody (1 µg/ml; Millipore, Watford, UK). 
2. NESO-pAb antibody (1 µl/ml) (Chioni et al. 2005). 
3. Anti-β1ex antibody (1:500) (Malhotra et al. 2002). 
4. Anti-actin antibody (1:700; Sigma, Dorset, UK). 
5. Anti-actinin antibody (1 µl/ml; Sigma). 
6. Anti-GFP A-11121 (1:1000; Invitrogen). 
Densitometric analysis was performed using the Image-Pro Plus software (Media 
Cybernetics, Bethesda, MD, USA). Signal density was normalized to anti-actinin or anti-
actin antibody as a loading control/reference, for at least three separate experiments. For 
each antibody, linearity of signal intensity with respect to increasing protein loading in 
the range 20–80 µg was ensured using a standard dilution of MDA-MB-231 cell extract. 
Immunocytochemistry and confocal microscopy and image analysis 
Cells (2×10
4
) grown on poly-l-lysine-coated glass coverslips were fixed in 
paraformaldehyde (2%) and labelled with fluorescein isothiocyanate (FITC)-conjugated 
concanavalin A (conA; Sigma) as plasma membrane marker (Brackenbury and Djamgoz 
2006). Nonspecific binding sites were blocked with 5% FBS prior to incubation with 




(Dako). Cells were mounted in Vectashield (Vector Laboratories, Peterborough, UK). 
Fluorescence was detected using a Leica (Wetzlar, Germany) DM IRBE microscope with 
TCS-NT confocal laser scanner. GFP was detected using an Olympus (Tokyo, Japan) 
Fluoview 500 confocal laser-scanning microscope. Densitometric analysis was performed 
as described previously (Brackenbury and Djamgoz 2006). Measurements were taken 
from at least 50 cells per condition, for three repeat treatments. 
Electrophysiology 
Whole-cell recording of sodium currents from cells grown on glass coverslips was 
performed as described previously, with some modifications (Brackenbury et al. 2007). 
Patch pipettes (TW150F-3, WPI, Sarasota, FL, USA) were pulled using a Model P-97 
puller (Sutter Instruments, Novato, CA, USA) and fire-polished to give resistances of 2–
3MΩ when filled with internal solution. Voltage-clamp recordings were performed using 
a Multiclamp 700B amplifier (Molecular Devices, Union City, CA, USA) compensating 
for series resistance by 60%. Currents were digitized using a Digidata 1320 interface 
(Molecular Devices), low-pass filtered at 10 kHz, sampled at 50 kHz and analyzed using 
pClamp 9.2 software (Molecular Devices). Linear components of leak were subtracted 
using a standard P/6 protocol (Armstrong and Bezanilla, 1977). Data manipulation and 
curve fitting were performed as described previously (Ding and Djamgoz 2004). 
Morphometric analysis 
Transfected cells were viewed under a Zeiss Axioplan fluorescent microscope at 
The University of Michigan Microscopy and Image Analysis Laboratory. Images 
captured at 40× were exported into the NIH ImageJ software for analysis. The following 
measurements were taken for both monopolar and bipolar cells, as described previously 
(Fraser et al. 1999): 
1. Process length. 




3. Cell body diameter. 
Measurements were recorded from 40 cells from each class, for each cell line. 
Single-cell adhesion 
Measurements were performed on cells 48 h after plating into 35 mm dishes at a 
density of 2.5×104 cells/ml, using the single-cell adhesion measuring apparatus 
(SCAMA), as described previously (Palmer et al. 2008). The peak detachment negative 
pressure (DNP), measured digitally for each cell, was converted to kPa. 
Cell–cell adhesion 
The cell–cell adhesion assay was performed as described previously, with some 
modifications (Wong and Filbin 1996). Suspensions of single cells (2×10
6
 cells/ml) were 
allowed to aggregate at 37 °C with gentle rocking (25 rpm). The particle number of 
aliquots was determined with a Coulter counter (ZBI; Beckman Coulter, Fullerton, CA, 





 cells/ml) were seeded in triplicate wells of a 12-well plate for 24 h. 
The number of cells per well after 24 h was determined using the thiazolyl blue 
tetrazolium bromide (MTT) assay, as described previously (Grimes et al. 1995). Results 




 cells/ml) were plated onto 12 µm-pore Transwell migration filters in 
12-well plates (Corning, NY, USA). siRNA-treated or control cells were incubated with 
or without TTX (10 µM, applied once at the beginning of the assay), in a 1–10% 




determined using the MTT method (Grimes et al. 1995). Results were compiled as the 
mean of ≥ four repeats. 
Lateral motility 
Wound-heal assays were performed as described previously (Fraser et al. 2003). 
Measurements of wound width (15 per wound) were made at wound formation (W0) and 
24 h later (Wt). The motility index (MI) was calculated as MI = 1−(Wt/W0). Means were 
compiled from three repeat experiments. 
Data analysis 
All quantitative data are presented as means ± standard errors, unless stated 
otherwise. Statistical significance was determined with Student’s t-test, Mann–Whitney 
rank sum test, one-way analysis of variance (ANOVA) followed by Newman–Keuls test, 
or two-way ANOVA, as appropriate. Results were considered significant at P < 0.05 (*). 
 
Results 
We evaluated the expression of VGSC β subunits in weakly metastatic MCF-7 
and strongly metastatic MDA-MB-231 cells in a comparative approach. β1 was then 
downregulated in MCF-7 cells, and stably expressed in MDA-MB-231 cells in order to 
elucidate its functional involvement in the cells’ adhesion and migration. 
Expression of VGSC α and β subunits in human BCa cell lines 
Both MCF-7 and MDA-MB-231 cell lines expressed SCN1B (encoding β1), 
SCN2B (encoding β2) and SCN4B (encoding β4) mRNAs; SCN3B mRNA (encoding β3) 
was not detected in either line but could be detected in human prostate cancer PC-3M 
cells (Figure 2.1A). Two products were amplified using the SCN4B primers: the full-












































Figure 2.1. β subunit expression in MCF-7 and MDA-MB-231 cells. (A) Typical gel 
images of PCR products, taken at the end of the PCR, for SCN1B, SCN2B, SCN3B, 
SCN4B and cytochrome b5-reductase (Cytb5R) from MCF-7, MDA-MB-231 and PC-3M 
cells. The PC-3M cell line was used as a positive control for SCN3B expression (Diss et 
al., 2008). (B) Relative mRNA levels of SCN1B, SCN2B, SCN3B and SCN4B, normalized 
to Cytb5R by the 2
-ΔΔCt
 method, and expressed as a percentage of the SCN1B mRNA 






 analysis (n = 3). Significance is shown in Table 2.1. (C) Western blot 
with 70 µg of total protein per lane from MCF-7 and MDA-MB-231 cells, using β1ex 






revealed that MCF-7 cells had 40–50-fold higher levels of all β subunit mRNAs than 
MDA-MB-231 cells (Table 2.1A; Figure 2.1B). In both cell lines, SCN1B was expressed 
at the highest level of any β subunit (Figure 2.1B). The relative levels of mRNA in both 
cell lines were SCN1B » SCN4B > SCN2B (Table 2.1B). Western blot analysis using 
anti-β1ex antibody confirmed that β1 polypeptides were highly expressed in MCF-7 and 
barely detectable in MDA-MB-231 cells (Figure 2.1C). 
The mRNA level of nNav1.5, the predominant α subunit in MDA-MB- 
231 cells (Fraser et al. 2005), was ∼4200-fold higher than in MCF-7 cells (P < 0.05, n=4; 
Figure 2.2A). Both the total α subunit and nNav1.5 protein levels were ∼4-fold higher in 
MDA-MB-231 than MCF-7 cells (P < 0.01, n=6; Figure 2.2B). 
In conclusion, β1, the most highly expressed VGSC β subunit in both MDA-MB-
231 and MCF-7 cells, was significantly more abundant in the latter, non/weakly 
metastatic line, especially at the protein level. 
Silencing of β1 expression in weakly metastatic MCF-7 cells by RNAi 
Cells were transfected with a pool of siRNAs targeting SCN1B. In siRNA-treated 
cells, the SCN1B mRNA level was reduced by 76% after 4 days (P < 0.01, n=3; Figure 
2.3A and B). β1 protein was reduced by 18% after 5 days and 40% after 8 days (P < 
0.05, n = 6 and P < 0.05, n = 8, respectively; Figure 2.3C and D). In contrast, after 4 
days, mRNA levels of SCN2B and SCN4B were unaffected (P = 0.71 and P = 0.97, 
respectively; n=3; Figure 2.3B). 
Five days after transfection with siRNA targeting SCN1B, the nNav1.5 mRNA 
level increased by 280% (P < 0.05, n=3; Figure 2.3B). However, there was no change in 
either the total VGSC α subunit or nNav1.5 protein levels (P = 0.93 and P = 0.42, 
respectively, n=4; Figure 2.4A and B). In contrast, 8 days after transfection, when the β1 
protein level was lowest, both the total VGSC α subunit and nNav1.5 protein levels were 










A. Fold differences in expression compared between cell lines 




SCN1B 40 < 0.001 
SCN2B 20 < 0.01 
SCN4B 50 < 0.001 
 
B. Fold differences within given cell lines. 
Cell line SCN1B >> SCN2B SCN4B > SCN2B SCN1B >> SCN4B 
MCF-7 1500-fold 4-fold 450-fold 
MDA-MB-231 800-fold 2-fold 500-fold 
 
Table 2.1. VGSC β subunit mRNA expression in MCF-7 and MDA-MB-231 human 












































Figure 2.2. Expression of nNav1.5 mRNA and protein in MCF-7 and MDA-MB-231 
cells. (A) Relative mRNA levels of nNav1.5, normalized to cytochrome b5-reductase 
(Cytb5R) by the 2
-ΔΔCt
 method, and expressed as a percentage of the level in MDA-MB-
231 cells (fixed as 100%). Errors are propagated through the 2
-ΔΔCt
 analysis (n = 4). Inset, 
typical gel images of nNav1.5 and Cytb5R real-time PCR products, taken at the end of 
the PCR. (B) Relative nNav1.5 and total VGSC α subunit protein levels in MDA-MB-
231 and MCF-7 cells. For each antigen, the expression level in MDA-MB-231 cells was 




to the actinin control. Inset, Western blot with 60 µg of total protein per lane from MCF-
7 and MDA-MB-231 cells, using NESO-pAb, pan-VGSC α subunit antibody, and actinin 
antibody as a control for loading. The same membrane was stripped and re-blotted. Each 
histobar indicates mean + S.E.M. (n = 6). Significance: (*) P < 0.05, (**) P < 0.01; 












































Figure 2.3. Effects of silencing SCN1B on VGSC expression in MCF-7 cells. (A) 
Typical gel images of PCR products, taken at the end of the PCR, for SCN1B, SCN2B, 
SCN4B, nNav1.5 and cytochrome-b5 reductase (Cytb5R) from MCF-7 cells 4 days after 
transfection with siControl (lane 1), or siRNA targeting SCN1B (lane 2). NTC (lane 3), 
no-template controls for PCR amplification. (B) Relative (%) mRNA levels of SCN1B, 
SCN2B, SCN4B and nNav1.5. Control (black bar – 100%): MCF-7 cells treated with 




SCN1B. β subunit and nNav1.5 mRNA levels were normalized to Cytb5R by the 2
-ΔΔCt
 
method. Errors are propagated through the 2
-ΔΔCt
 analysis (n = 3). (C) Western blots with 
70 µg of total protein per lane from cells 5, 8 and 12 days after treatment. For each case, 
lane 1, treatment with ‘mock’ control (no siRNA); lane 2, treatment with non-targeting 
siControl siRNA; and lane 3, treatment with siRNA targeting SCN1B. The β1ex antibody 
and an anti-actin antibody were used for β1 and for loading control, respectively (the 
same membrane was stripped and re-blotted). (D) Quantification of the data shown in 
(C). Relative total β1 protein levels were normalized to the actin control. Data are 
presented as mean and S.E.M. (n≥4). Significance: (×) P > 0.05; (*) P < 0.05; (**) P < 














































Figure 2.4. Effect of RNAi targeting SCN1B on the nNav1.5 protein level in MCF-7 
cells. (A) Western blots with 80 µg of total protein per lane from cells 5, 8 and 12 days 
after treatment. For each case, lane 1, treatment with ‘mock’ control (no siRNA); lane 2, 
treatment with non-targeting siControl siRNA; and lane 3, treatment with siRNA 




nNav1.5 and an actinin antibody for loading control. The same membrane was stripped 
and re-blotted. (B) Quantification of the data shown in (A). Relative total VGSC α 
subunit and nNav1.5 protein levels normalized to the actinin control. (C) Typical 
confocal XZY images of non-permeabilised MCF-7 cells 8 days after transfection with (i) 
non-targeting siControl siRNA or (ii) siRNA targeting SCN1B double-immunolabelled 
with conA plasma membrane marker (left) and NESO-pAb (right); (iii), Relative 
peripheral nNav1.5 level, measured from the confocal XZY images. Data are presented 
as mean and SEM [(B) n = 4; (C) n = 3]. Significance: (*) P < 0.05; (B) ANOVA with 






Furthermore, 12 days post-transfection, when SCN1B mRNA had returned to normal, 
total VGSC α subunit and nNav1.5 protein levels remained elevated by 99% and 117%, 
respectively (P < 0.05, n≥3; Figure 2.4A and B). Confocal microscopy revealed a 39% 
increase in nNav1.5 immunoreactivity towards the cell periphery defined by conA 
labelling, 8 days after RNAi treatment (P < 0.05, n=3; Figure 2.4C).  
In conclusion, the RNAi reduced SCN1B mRNA and β1 protein levels in MCF-7 
cells, but increased nNav1.5 mRNA and protein levels. 
Effects of β1 silencing on metastatic cell behaviors of MCF-7 cells 
MCF-7 cells are significantly more adhesive to substrate than MDA-MB-231 cells 
(Palmer et al. 2008), consistent with the relatively higher level of SCN1B in the former 
(Figure 2.1) and the role of β1 as a CAM (Davis et al. 2004; Malhotra et al. 2000; 
Malhotra et al. 2002). Measurements of single-cell adhesion of SCN1B siRNA-treated 
MCF-7 cells revealed a significant reduction in adhesion of 25% (P < 0.05, n=3) and 35% 
(P < 0.001, n = 6) after 5 and 8 days, respectively (Figure 2.5A). However, by 12 days 
post-transfection, when levels of SCN1B mRNA had returned to normal, the cells’ 
adhesive capability had recovered such that there was no significant difference (P=0.13, 
n=3; Figure 2.5A), consistent with the interpretation that β1 normally functions as a 
CAM in these cells. Pre-treatment of cells for 48 h with TTX (10 µM, continued during 
the assay) increased the adhesion of control cells by 16% (P < 0.01, n=4; Figure 2.5B, 
bars 1 vs. 3). Similarly, TTX increased the adhesion of SCN1B siRNA-treated cells by 
28% (P < 0.05, n=4; Figure 2.5B, bars 2 vs. 4). In conclusion, downregulation of β1 
reduced adhesion of MCF-7 cells, and this effect was partially reversed by TTX. 
Eight days following transfection with siRNA targeting SCN1B, the number of 
migrating MCF-7 cells increased by 121% (P < 0.05, n=8; Figure 2.5C, bars 1 vs. 2), 
again suggesting that β1 normally functions as a CAM in these cells. Pre-treatment with 








































Figure 2.5. Effects of β1 downregulation on adhesion and migration of MCF-7 cells. 
(A) Time-course of reduction in relative detachment negative pressure (DNP) of MCF-7 
cells following transfection with siRNA targeting SCN1B. Circles, ‘mock’ control 
(without siRNA); triangles, siControl non-targeting siRNA; squares, siRNA targeting 
SCN1B. (B) Absolute DNP values (in kPa) of MCF-7 cells 8 days after transfection with 
siControl non-targeting siRNA (bar 1) or siRNA targeting SCN1B (bar 2). In a separate 
experiment, cells were pre-treated with TTX (10 µM for 48 h), continued during the 
assay for cells transfected with siControl non-targeting siRNA (bar 3) or siRNA targeting 
β1 (bar 4). (C) Relative number of cells migrating through a transwell chamber over 12 h, 




SCN1B (bar 2). In a separate experiment, cells were pre-treated with TTX (10 µM for 48 
h), continued during the assay for cells transfected with siControl non-targeting siRNA 
(bar 3) or siRNA targeting SCN1B (bar 4). (D) Relative mRNA levels of SCN1B, SCN2B, 
and SCN4B in MCF-7 cells after 48 h treatment with/without TTX (10 µM), normalized 
to cytochrome b5-reductase (Cytb5R) by the 2
-ΔΔCt
 method. Errors are propagated 
through the 2
-ΔΔCt
 analysis (n = 3). Data in (A)–(C) are presented as mean ± S.E.M. 
(n≥3). Significance: (×) P > 0.05; (*) P < 0.05, (**) P < 0.01, (***) P < 0.001; (A)–(C) 





27% (P < 0.05, n=8; Figure 2.5C, bars 1 vs. 3). Similarly, TTX also reduced migration of 
siRNA-treated cells by 43% (P < 0.05, n=8; Figure 2.5C, bars 2 vs. 4). Importantly, there 
was no difference in migration between TTX-pretreated siControl or siRNA-treated cells 
(P > 0.05, n=8; Figure 2.5C, bars 3 vs. 4). TTX had no effect on SCN1B or SCN4B 
mRNA levels (P = 0.85 and P = 0.70, respectively, n=3; Figure 2.5D), although SCN2B 
mRNA was reduced by 55% (P < 0.05, n=3; Figure 2.5D). 
In conclusion, downregulation of β1 reduced adhesion but increased migration of 
MCF-7 cells. Both effects were sensitive to TTX, consistent with involvement of VGSC 
activity. 
Effects of stably expressing β1 in MDA-MB-231 cells 
β1 protein is detectable in MCF-7 cells, but not MDA-MB-231 cells (Figure 2.1). 
Further, MCF-7 cells exhibit enhanced adhesion and reduced migration compared to 
MDA-MB-231 cells, suggesting that β1 expression influences these properties (Figure 
2.5). Thus, we next investigated whether overexpression of β1 in MDA-MB-231 cells 
might increase their adhesion and reduce cellular migration. β1-eGFP was transfected 
into MDA-MB-231 cells and stable expression was monitored by epifluorescence 
(Figure 2.6A). For all experiments, the effects of β1 were compared with control cells 
expressing eGFP alone. Western blot analysis confirmed expression of eGFP protein (30 
kDa) in the control cell line, and revealed the expected increase of 37 kDa in molecular 
weight of eGFP in cells expressing the β1-eGFP fusion protein (Figure 2.6B). 
Expression of β1 protein in MDA-MB-231 cells increased peak sodium current 
density by 34%, from−34.5±4.2 mV, to−46.4±4.1mV (P < 0.05, n = 20; Figure 2.7A and 
B; Table 2.2). In addition, β1 accelerated the kinetics of activation, reducing the time to 
reach peak current (Tp), from 0.73±0.03ms to 0.65±0.02ms (P < 0.05, n = 20; Table 2.2). 
In contrast, the whole-cell capacitance, persistent current, voltage-dependence of 

































Figure 2.6. Stable expression of β1 in MDA-MB-231 cell lines. (A) Typical confocal 
XY (i) and merged bright-field images (ii) of MDA-MB-231 cells stably transfected with 
eGFP (‘Control’) and β1 with an eGFP C-terminal fusion (‘β1’). (B) Western blot of 
protein from MDA-MB-231 cells stably transfected with eGFP (‘Control’; total cell 
lysate) and β1 with an eGFP C-terminal fusion (‘β1’; membrane preparation) using an 






































Figure 2.7. Effects of β1 over expression on VGSC activity in MDA-MB-231 cells. 
(A) Typical whole-cell sodium currents elicited by 60ms depolarizing voltage pulses 
between −80mV and +30mV applied from a holding potential of −100mV: (i) a control 
cell expressing eGFP; (ii) a cell expressing β1-eGFP. (B) Current -voltage relationship. 
Peak sodium current density was plotted as a function of voltage for control cells 
expressing eGFP (filled circles) and cells expressing β1-eGFP (open circles). (C) 
Activation. Normalized conductance (G/Gmax), calculated from the current data, plotted 
as a function of voltage for control cells expressing eGFP (filled circles) and cells 
expressing β1-eGFP (open circles). (D) Steady-state inactivation. Normalized current 
(I/Imax), elicited by 60ms test pulses at −10mV following 1 s conditioning voltage pulses 
between −120 and −10 mV, applied from a holding potential of −100mV, plotted as a 
function of the prepulse voltage for control cells expressing eGFP (filled circles) and 




Recovery from inactivation. The fraction recovered (It/I0) was determined by a 25ms 
pulse to 0mV (I0), followed by a recovery pulse to −100mV for 1–500ms, and a 
subsequent 25ms test pulse to 0mV (It), applied from a holding potential of −100 mV, 
and plotted as a function of the recovery interval for control cells expressing eGFP (filled 
circles) and cells expressing β1-eGFP (open circles). Inset, typical recording from a 
control cell. (F) Use-dependent rundown. Current (I), elicited by 50 Hz pulse trains to 
0mV, applied from a holding potential of −100mV, normalised to the current evoked by 
the first pulse plotted as a function of the pulse number for control cells expressing eGFP 
(filled circles) and cells expressing β1-eGFP (open circles). Control (solid lines) and β1-
eGFP (dashed lines) data are fitted with Boltzmann functions (C) and (D); and double 



















Parameter Control β1 
   
Cm (pF) 22.4 ± 1.8 19.8 ± 0.9 
Ip (pA/pF) 34.5 ± 4.2 46.4 ± 4.1* 
Iper at 35 mV (pA/pF) 1.6 ± 0.4 2.2 ± 0.3 
Va (mV) 54.0 ± 0.8 54.5 ± 0.9 
Vp (mV) 1.0 ± 1.2 4.5 ± 1.5 
Activation, V1/2 (mV) 21.3 ± 0.9 23.3 ± 2.6 
Activation, k (mV) 10.2 ± 0.5 10.0 ± 0.7 
Inactivation, V1/2 (mV) 83.6 ± 0.8 84.8 ± 0.6 
Inactivation, k (mV) 7.9 ± 0.8 6.5 ± 0.3 
Tp at 0 mV (ms) 0.73 ± 0.03 0.65 ± 0.02* 
τf at 0 mV (ms) 0.51 ± 0.03 0.50 ± 0.03 
τs at 0 mV (ms) 3.7 ± 0.4 3.7 ± 0.4 
 
Table 2.2. Effect of β1 overexpression on sodium current characteristics in MDA-
MB-231 cells. Abbreviations: Cm, membrane capacitance; Ip, peak current density; Iper, 
persistent current density; Va, activation voltage; Vp voltage at current peak; V1/2, half 
(in)activation voltage; k, slope factor; Tp time to peak; τf/s , fast/slow time constant of 






inactivation, and use-dependent rundown at 50 Hz were unchanged (Figure 2.7C–F; 
Table 2.2). In summary, β1 increased peak VGSC current density and reduced Tp, 
without affecting other sodium current characteristics. 
The distribution of β1-eGFP fusion protein in transfected cells was detected 
throughout the cell body and processes, with high expression observed in perinuclear 
clusters (Figure 2.6A). β1-eGFP transfected cells had significantly increased process 
length and this was observed in cells with both monopolar and biopolar morphologies (P 
< 0.01 for both, n = 40; Figure 2.8A). The thickness of processes on β1-eGFP-expressing 
monopolar cells was significantly reduced compared to cells expressing eGFP alone (P < 
0.01, n = 40; Figure 2.8B). In contrast, the process thickness on bipolar cells was 
unchanged (P = 0.46, n = 40; Figure 2.8B). The cell body diameter of β1-eGFP-
transfected cells was unchanged in both monopolar and bipolar cells compared to eGFP 
alone (P = 0.26 and 0.91, respectively, n = 40; Figure 2.8C). In conclusion, β1 
overexpression appeared to increase process extension in MDA-MB-231 cells. While the 
mechanism of this effect is not clear for BCa cells, we have shown previously that β1–β1 
cell adhesive interactions result in increased process length in neurons (Brackenbury et 
al. 2008a; Davis et al. 2004). 
Cell–cell adhesion was measured using a cellular aggregation assay. β1-eGFP 
overexpression increased cell–cell adhesion of MDA-MB-231 cells compared to cells 
expressing eGFP alone following 30 min of shaking, and this effect persisted for 2 h (P < 
0.05, n=3; Figure 2.8D). This result is consistent with the proposed role for β1 in trans-
homophilic cell adhesion, described previously (Malhotra et al. 2000). 
The lateral motility of MDA-MB-231 cells was measured using a wound-healing 
assay. β1-eGFP expression reduced the motility index by 21% from 0.68±0.01 to 
0.53±0.01 compared to cells expressing eGFP alone (P < 0.001, n > 320; Figure 2.8E). 
In addition, the proliferation of cells expressing β1-eGFP was reduced by 19% compared 

































Figure 2.8. Effects of β1 over expression on morphology, adhesion, migration and 
proliferation of MDA-MB-231 cells. (A) Process length of MDA-MB-231 cells stably 
transfected with eGFP (‘Control’) and β1 with eGFP C-terminal fusion (‘β1’). (B) 
Process thickness of MDA-MB-231 cells stably transfected with eGFP (‘Control’) and β1 
with eGFP C-terminal fusion (‘β1’). (C) Cell body diameter of MDA-MB-231 cells 
stably transfected with eGFP (‘Control’) and β1 with eGFP C-terminal fusion (‘β1’). In 
(A)–(C), cells were defined as having monopolar or bipolar morphologies and analyzed 
separately (n = 40). (D) Cell–cell adhesion. Single MDA-MB-231 cells stably transfected 
with eGFP (‘Control’) and β1 with eGFP C-terminal fusion (‘β1’) were incubated with 
gentle agitation for 2 h. The number of particles was monitored every 30 min and 
expressed as a percentage of the starting value. As cells adhered to one-another and 
formed aggregates, the particle number decreased (n = 3 repeat experiments). (E) Motility 
index (MI) of MDA-MB-231 cells stably transfected with eGFP (‘Control’) and β1 with 
eGFP C-terminal fusion (‘β1’) in a wound-heal assay. Wound width was measured at 0 h 
(W0) and 24 h (Wt). MI was calculated as 1−(Wt/W0) (n = 135). (F) Proliferation of MDA-
MB-231 cells stably transfected with eGFP (‘Control’) and β1 with eGFP C-terminal 




the MTT assay (n = 3 repeat experiments). Data are presented as mean ± S.E.M. 
Significance: (×) P > 0.05; (*) P < 0.05, (**) P < 0.01, (***) P < 0.001; (A)–(C), (E) 





reduce wound closure by enhancing cell–cell or cell–matrix adhesion. However, the 
reduced proliferation of these cells may also have contributed to this effect. 
  
Discussion 
This study is the first investigation of the role of VGSC β subunits in BCa cells 
and provides new insights into the potential role of these multifunctional molecules in 
cancer metastasis. The main findings of this study are as follows: (i) Weakly metastatic 
MCF-7 cells expressed considerably higher levels of SCN1B, SCN2B, and SCN4B 
mRNAs than metastatic MDA-MB-231 cells. (ii) SCN1B was the most abundant VGSC β 
subunit mRNA expressed in both MCF-7 and MDA-MB-231 cell lines. (iii) β1 silencing 
experiments suggested that β1 normally increases adhesion and attenuates transwell 
migration of MCF-7 cells. (iv) β1 silencing positively regulated nNav1.5 mRNA and 
plasma membrane protein levels in MCF-7 cells. (v) TTX partially reversed the effects of 
β1-silencing on adhesion and migration in MCF-7 cells, suggesting that VGSC 
expression and resulting changes in electrical activity may influence metastasis. A 
potential caveat to this interpretation is the observation that TTX reduced SCN2B mRNA 
expression. β2 has also been shown to play roles in cell adhesion in vitro, including 
attenuating neurite outgrowth and thus may also contribute to the observed changes in 
adhesion and migration. (vi) Overexpression of β1 inMDA-MB-231 cells increased 
sodium current density, cell process length, and cell–cell adhesion, and reduced cellular 
lateral motility and proliferation. Taken together, these results suggest that β1 expression 
enhances adhesiveness and attenuates migration of BCa cells. The cell adhesive effects of 
β1 overexpression in MDA-MB-231 cells were observed concomitantly with β1-
mediated upregulation of sodium current density, suggesting that the cell adhesive effects 
of β1 may be independent of changes in excitability and supporting the notion that β1 




(Brackenbury and Isom 2008; Brackenbury et al. 2007). The regulation of nNav1.5 
expression/activity by β1 silencing in MCF-7 cells further suggests that β1 may control 
VGSC-dependent electrical signal transduction in BCa. 
Expression of β subunits in human BCa cell lines 
We used RNAi to downregulate SCN1B in MCF-7 cells. The siRNAs reduced 
SCN1B mRNA by 75% after 4 days, without affecting SCN2B or SCN4B. β1 protein 
levels were reduced to a lesser extent, by 40% after 8 days. The reduced and delayed 
protein reduction could be due to incomplete downregulation of the target gene (Jackson 
et al. 2003). Although dynamics of α and β subunit mRNA/protein expression in cancer 
cells are not known, it is possible that large intracellular protein stores or slow turnover 
may also contribute to the difference in time course (Brackenbury et al. 2007; Li et al. 
2004). Also, increasing evidence suggests that VGSC mRNA and protein levels do not 
correlate (Lopez-Santiago et al. 2006; Brackenbury and Djamgoz 2006). Nonetheless, a 
small reduction in protein level can still result in significant functional changes. For 
example, 40–60% silencing of nNav1.5 was enough to critically disrupt cancer cell 
migration (Brackenbury et al. 2007).  
SCN4B mRNA was present in both MCF-7 and MDA-MB-231 cells in a longer 
and a shorter form. A similar situation has been found in a human prostate cancer cell 
line (LNCaP) (Diss et al. 2008). In addition, we found that SCN3B mRNA was not 
detectable in either MCF-7 or MDA-MB-231 cells. Given that the SCN3B gene contains 
two p53 response elements and may be involved in p53-dependent apoptosis (Adachi et 
al. 2004), the absence of SCN3B in BCa cells may promote oncogenesis. This is an 
interesting possibility that would be worthy of further investigation.  
Effect of VGSC activity on β subunit expression 
TTX had no effect on SCN1B or SCN4B mRNA levels in MCF-7 cells. However, 




dynamic and, in the case of SCN2B, may be controlled by β subunit activity. In 
agreement with this, electrical activity affects L1 CAM expression in mouse sensory 
neurons (Itoh et al. 1995). In addition, α subunit activity regulates SCN9A mRNA levels 
in metastatic PCa cells (Brackenbury and Djamgoz 2006). Interestingly, VGSC α subunit 
mRNA levels are regulated by a cleavage product of β2 protein in neurons (Kim et al. 
2007). Thus, VGSC α and β2 transcription and translation may be tightly and reciprocally 
regulated. 
Regulation of metastatic cell behaviors by β1 
Downregulation of β1 in MCF-7 cells reduced single-cell adhesion, while 
overexpression of β1 in MDA-MB-231 cells increased cell–cell adhesion and process 
length. These results are consistent with the hypothesis that β1 functions as a CAM in 
BCa cells. β1 participates in homophilic adhesion in vitro and in vivo, resulting in cellular 
aggregation, ankyrin recruitment, neurite outgrowth, fasciculation, and migration (Davis 
et al. 2004; Malhotra et al. 2000; Malhotra et al. 2002; Brackenbury et al. 2008a). In 
addition, given that β1 can interact with other CAMs, as well as the extracellular matrix 
protein tenascin-R (Malhotra et al. 2004; Kazarinova-Noyes et al. 2001; Xiao et al. 
1999), it is likely that β1 could play a significant adhesive role in BCa. For example, 
contactin, known to interact with β1, is involved in invasion and metastasis of lung 
adenocarcinoma cells (McEwen et al. 2004; Brackenbury et al. 2008a; Su et al. 2006). 
SCN1B siRNA increased the transwell migration of MCF-7 cells. We propose that 
downregulation of β1 reduced the cells’ adhesion, and in doing so, rendered them more 
capable of migration. Consistent with this result, overexpression of β1 in MDA-MB-231 
cells reduced their lateral motility. As with the MCF-7 cells, β1 may reduce MDA-MB-
231 motility via enhanced adhesion. However, β1 also reduced the proliferation ofMDA-
MB-231 cells, which could also contribute to the reduced MI. Thus, β1 may also regulate 




Interestingly, TTX partially reversed the effects of SCN1B silencing on the 
adhesion and migration of MCF-7 cells. Thus, the reduction in adhesion, and increase in 
migration in the absence of β1 is, at least in part, dependent on α subunit activity. TTX 
has been shown to inhibit a variety of behaviors associated with the metastatic cascade 
(Brackenbury et al. 2008b). It is possible that metastatic cell behaviors dependent on 
VGSC α subunit activity may also require concomitant downregulation of β1. 
Regulation of nNav1.5 functional expression by β1 
Overexpression of β1 in MDA-MB-231 cells increased sodium current density 
and reduced Tp. The effects of β1 on Nav1.5, the predominant α subunit expressed in 
MDA-MB-231 cells (Fraser et al. 2005), appear to be controversial, and dependent on the 
cell type studied. Consistent with the present findings, some studies report that β1 
increases Nav1.5 current density without affecting gating (Nuss et al. 1995; Qu et al. 
1995). However, other reports suggest that β1 does not affect Nav1.5 function (Makita et 
al. 1994; Yang et al. 1993), or shifts voltage-dependence of steady-state inactivation (An 
et al. 1998; Dhar Malhotra et al. 2001), or affects recovery from inactivation (Fahmi et al. 
2001). In contrast to these previous studies, Nav1.5 is primarily expressed in MDA-MB-
231 cells as the D1:S3 nNav1.5 splice variant (Brackenbury et al. 2007; Fraser et al. 
2005). Given that nNav1.5 exhibits subtly different gating and kinetics compared to the 
‘adult’ splice variant (Onkal et al. 2008), it is possible that β1 may modulate nNav1.5 in a 
different manner. 
Downregulation of β1 in MCF-7 cells resulted in upregulation of nNav1.5 mRNA 
and protein. Scn1b null mice have increased Scn5a mRNA and Nav1.5 protein in 
cardiomyocytes (Lopez-Santiago et al. 2007). Therefore, β1 may be a novel regulator of 
Scn5a/Nav1.5 expression in multiple tissues. Emerging evidence suggests that β subunits 
may function as transcription factors. For example, β subunits can be cleaved by 




2005). In the case of β2, the ICD increases Scn1a mRNA and Nav1.1 protein levels (Kim 
et al. 2007). The β1-ICD may normally participate in repression of SCN5A transcription, 
such that the SCN1B null mutation results in SCN5A overexpression. In an alternative 
scenario, β1 in MCF-7 cells may serve to negatively regulate nNav1.5 expression 
indirectly, via adhesion. Downregulation of β1 would reduce the cells’ adhesion, in turn 
enhancing metastatic behaviors including migration, concomitant with nNav1.5 
upregulation. nNav1.5 is primarily responsible for the VGSC-dependent enhancement of 
invasive behavior in metastatic MDA-MB-231 cells (Brackenbury et al. 2007). The 
mechanism(s) underlying VGSC α subunit upregulation in metastatic cancer cells is not 
understood, although serum and growth factors are important (Pan and Djamgoz 2008; 
Uysal-Onganer and Djamgoz 2007; Ding et al. 2008; Ding and Djamgoz 2004; 
Brackenbury and Djamgoz 2007). Given that β1 increased sodium current density in 
MDA-MB-231 cells, but reduced lateral motility, this would suggest that the steady-state 
contribution of basal α subunit activity to enhancing motility in MDA-MB-231 cells is 
maximal. However, it is not yet clear whether nNav1.5 expression is required for the 
acquisition of metastatic capability, or whether it is upregulated once the BCa cells have 
become highly metastatic. 
Concluding remarks 
This work further supports the proposed role of VGSCs in the cancer process and 
may have important clinical implications. Loss of β1 expression in line with acquisition 
of metastatic capability may provide a novel prognostic marker for BCa progression 
(Brackenbury and Isom 2008). Furthermore, β1 may provide a target for gene therapy, 
whereby its overexpression could enhance adhesion, resulting in reduction of metastatic 
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Chapter III: Tyrosine phosphorylation of sodium channel β1 regulates 
neurite outgrowth 
The work described within this chapter is entirely my own. 
 
Abstract 
The voltage-gated sodium channel (VGSC) β1 subunit is critical for neuronal 
migration, axon outgrowth, and axonal pathfinding in the cerebellum during postnatal 
development. Scn1b null mice, which lack β1 subunits, exhibit ataxia as a result of 
cerebellar dysfunction. β1-β1 trans homophilic adhesion initiates a signaling cascade in 
cerebellar granule neurons (CGNs) that results in neurite outgrowth. A number of critical 
cofactors for β1-mediated neurite outgrowth, including fyn kinase, contactin, γ-secretase 
activity, sodium current, and Nav1.6 expression, have been previously identified. Here we 
used biochemical techniques and functional neurite outgrowth assays to demonstrate that 




Voltage-gated sodium channels (VGSCs) are responsible for action potential 
initiation and propagation in excitable cells. Mammalian VGSCs are heterotrimers 
containing a single pore-forming α subunit, a non-covalently linked β subunit (β1 or β3), 
and a disulfide-linked β subunit (β2 or β4) (Isom 2001). VGSCs are unique with respect 




subunits that not only modulate channel kinetics, but also function as cell adhesion 
molecules (CAMs) that direct channel insertion into the plasma membrane and channel 
interaction with other signaling proteins (Isom 2001). VGSC β subunits are type 1 
membrane proteins and are immunoglobulin (Ig)-superfamily CAMs that participate in 
homophilic and heterophilic interactions (Malhotra et al. 2000; McEwen and Isom 2004). 
As multifunctional molecules which play important roles in electrical conduction and 
adhesion, VGSC β subunits provide an important link between these processes during 
brain development. 
SCN1B, encoding the β1 and β1B subunits, plays important roles in brain 
development. Perturbation of SCN1B function or expression can result in pathologies in 
human patients that include epilepsy and ataxia (Patino et al. 2009). In mice, genetic 
deletion of Scn1b results in multiple forms of seizures, ataxia, growth retardation, 
neuronal pathfinding abnormalities, and early death (Chen et al. 2004; Brackenbury et al. 
2013). Inherited homozygous mutations in SCN1B have been linked to Dravet Syndrome 
(DS), an intractable pediatric epileptic encephalopathy that involves comorbidities 
including mental retardation, developmental delay, and ataxia, in two independent 
pedigrees (Patino et al. 2009; Ogiwara et al. 2012). The severe epileptic and ataxic 
phenotype of Scn1b null mice demonstrates that these mice are a model of DS.  
β1 and β1B polypeptides are expressed in neurons and glia during postnatal 
development through adulthood in mammals (Table 1.2). Defects in cerebellar, 
corticospinal tract, and hippocampal microorganization in Scn1b null mice suggest a role 
for these β subunits in neuronal migration, axon outgrowth, and axonal pathfinding 
(Davis et al. 2004; Brackenbury et al. 2008a; Brackenbury et al. 2013). β1 and β1B 
promote neurite outgrowth of isolated cerebellar granule neurons (CGNs) in vitro through 
trans homophilic cell-cell adhesion (Davis et al. 2004; Patino et al. 2011). Work focusing 
on the β1 subunit signaling cascade has shown that this mechanism requires contactin, 




activity (Davis et al. 2004; Brackenbury et al. 2008a; Brackenbury et al. 2010; 
Brackenbury and Isom 2011). We have suggested that β1 subunits expressed in cerebellar 
Bergmann glia adhere in trans to β1 subunits expressed in CGNs, resulting in a signal 
transduction mechanism to promote neurite extension (Davis et al. 2004). Similarly, we 
have proposed that secreted β1B subunits bind to transmembrane β1 subunits on adjacent 
cells or on the same cell, through paracrine or autocrine actions, respectively (Patino et 
al. 2011). 
The work in this chapter focuses on the β1-mediated signaling cascade. β1 is 
known to be subject to post-translational modification, including tyrosine 
phosphorylation (Malhotra et al. 2002). An intracellular tyrosine residue in the β1 
polypeptide (Y181) is phosphorylated in vitro and in vivo (Malhotra et al. 2002). A β1 
mutant construct that mimics phosphorylation (β1Y181E) shows normal β1-mediated 
cell-cell adhesion in vitro, but disrupted β1-mediated ankyrin recruitment that is normally 
observed in response to adhesion (Malhotra et al. 2002). Similar to β1, β1Y181E 
increases cell surface VGSC expression in heterologous systems, but does not modulate 
sodium current in vitro (McEwen et al. 2004). Tyrosine phosphorylated β1 (pYβ1) has a 
distinct subcellular localization from β1 in highly polarized cardiac ventricular myocytes 
(Malhotra et al. 2004).  
We postulated that tyrosine phosphorylation of β1 may act as a molecular switch 
for downstream signal transduction in response to β1-β1 trans homophilic adhesion 
leading to neurite outgrowth. To test this, we used CGNs as a model system to investigate 
the role of β1 tyrosine phosphorylation in β1-mediated neurite outgrowth. We 
demonstrate that expression of a construct mimicking the tyrosine phosphorylated form 
of β1 drives neurite outgrowth independent of trans homophilic cell-cell adhesion. In a 
heterologous system, cellular aggregation resulted in elevated levels of β1 tyrosine 
phosphorylation. A peptide representing the intracellular domain of β1, including residue 




model where β1 tyrosine phosphorylation is a critical step in signal transduction from 
trans homophilic cell-cell adhesion to neurite outgrowth. 
 
Methods 
Antibodies and Reagents 
For immunoprecipitation, primary antibodies used included mouse monoclonal 
anti-GFP obtained from Invitrogen (A-11120; 2 to 10 µg per IP) and mouse monoclonal 
anti-PY20 antibody obtained from Invitrogen (AHO0681; 10 µg per IP). For Western 
blot studies, primary antibodies included rabbit GFP antiserum obtained from Invitrogen 
(A6455; 1:500 dilution). For immunofluorescence studies, primary antibodies used 
included mouse monocolonal anti-Tuj1 obtained from Covance (MMS-435P; 1:1000 
dilution) and rabbit anti-β1 (kind gift from Dr. Nobuyuki Nukina; 1:1000 dilution). 
Protease inhibitors were Complete EDTA free obtained from Roche (11873580001). 
BacMam 2.0 virus 
BacMam 2.0 baculovirus preparations encoding GFP, human WT β1, or human 
β1Y181E were obtained through a collaboration with Life Technologies. We performed 
the cloning steps for each viral construct. These plasmids were then sent to Life 
Technologies for viral preparation. To infect mammalian cell lines, virus was added at 
10% v/v at cell plating. To infect CGNs, virus was added at 3% v/v at cell plating. Cells 
were subsequently incubated for 10 min at RT in the dark and then transferred to a cell 
culture incubator (37°C, 5% CO2) for 24 or 48 h prior to experimentation for mammalian 





To obtain CGNs, cerebella from Scn1b null mice (P14 to P16) were dissected and 
minced in HibernateA (BrainBits) containing B27 (Life Technologies). Tissue was 
trypsinized in dissociation buffer (6 mL of HibernateA/B27 and 5 mL of 0.25% trypsin) 
for 30 min at 37°C. Tissue was transferred to fresh HibernateA/B27 and triturated 9 
times. After allowing tissue to settle for 2 min, the cell suspension was collected and 
pelleted at 150 x g for 5 min. Cells were resuspended in NeurobasalA (Life 
Technologies) containing B27 and plated onto poly-D lysine coated glass coverslips. 
Neurite Outgrowth 
Virally transduced Scn1b null CGNs were cultured for 48 hr and fixed for 20 min 
with 4% paraformaldehyde. Neurons were processed for immunofluorescence to label 
Tuj1-positive neurons and for β1 expression using a previously described protocol (Davis 
et al. 2004). Images were captured using Nikon Elements software and a Nikon A1R 
confocal microscope using a 20x objective and 2x digital zoom (40x final) in the 
Department of Pharmacology at the University of Michigan. At least 10 neurites were 
measured per experiment and at least three independent experiments were performed. 
Statistical significance was determined using the Mann-Whitney rank sum test. 
Cell Culture and Protein Sample Preparation 
MDA-MB-231 β1GFP cells were described previously in Chapter 2 (Chioni et al. 
2009). Cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with 
5% fetal bovine serum (FBS) and 4 mM L-glutamine, as described previously (Fraser et 
al. 2005). The media was also supplemented with 100 µg/ml hygromycin to maintain 
β1GFP expression. Cultured cells were washed with cold PBS and detached from the 
culture dishes using a cell scraper in ice-cold homogenization buffer (HB: 50 mM Tris, 
10 mM EGTA, pH 8) containing protease inhibitors and 1 mM sodium orthovanadate. 




were pelleted by a 3500 rpm centrifugation in a microfuge for 10 min. The supernatant 
was collected and membranes were pelleted at 16,000 x g in a microfuge for 20 min. 
Membrane proteins were solubilized for 30 min in dilution buffer (DB: 50 mM Tris/HCl 
pH 8.0, 180 mM NaCl, 1% Triton X-100, 10 mM EGTA containing protease inhibitors 
and 1 mM sodium orthovanadate). After solubilization, a 20 min centrifugation at 16,000 
x g in a microfuge was performed to remove insoluble material. For both membrane 
proteins and total cell lysates, protein yield was determined using a BCA assay (Pierce). 
All centrifugation steps were performed at 4°C. 
Immunoprecipitation 
Protein G-Sepharose beads (Sigma) were washed with PBS and resuspended in 
500 μl of dilution buffer at 4°C. The beads were then incubated overnight at 4°C with 10 
μg of immunoprecipitating (IP) antibody (anti-PY20). Protein samples were obtained 
from membrane preparations as described above. BCA assays (Pierce) were performed 
according to the manufacturer’s recommendation for each membrane preparation prior to 
IP to ensure equal amounts of protein were used for each assay. For each IP reaction, 500 
µl of 0.8 to 1.0 µg/µl of protein solubilized in dilution buffer were incubated with 
antibody-conjugated beads by gentle end-over-end rotation for 4 to 6 hr at 4°C. The 
beads were then washed twice with washing buffer (50 mM Tris pH 7.5, 150 mM NaCl, 
0.1% Triton X-100, 0.02% SDS, 10 mM EGTA pH 8 containing protease inhibitors). 
Proteins were eluted from the beads by addition of Laemmeli buffer and 10 min 
incubation at 80°C. 
Immunoblotting 
Samples were separated by SDS-PAGE on 12 or 15% polyacrylamide gels and 
transferred to nitrocellulose for Western blot analysis. Western blotting was performed 
using the SnapId system (Millipore). Immunoblots were probed with antibody as 




using a LI-COR Odessey® Fc imaging system. All results presented are representative of 
three independent repeats. 
Fyn kinase assay 
A fyn kinase assay was performed according to the manufacturer’s 
recommendations (Fyn kinase assay kit, Promega). Reactions were performed in 
triplicate and each reaction contained 200 ng of active GST-tagged Fyn kinase, 50 µM 
Ultrapure ATP, 0.2 mg/mL peptide substrate, 50 µM DTT diluted in a standard kinase 
reaction buffer (contents of 5X buffer: 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL 
BSA). β1 peptides corresponded to the intracellular domain of β1 surrounding residue 
Y181 (amino acids 175 to 185; β1 peptide, QENASEYLAITC; pYβ1 peptide, 
QENASE[pY]LAITC) and were generated by Pierce. The pYβ1 peptide was synthesized 
using a pre-phosphorylated tyrosine amino acid. The Poly E4Y1 peptide, used as a 
positive control, is a well-characterized substrate of fyn kinase. Kinase reactions lacking 
substrate were used to normalize the kinase activity in substrate containing reactions. 
Three independent experiments were performed. Statistical significance was determined 
using the Student’s t-test with significance defined as p < 0.05. 
PolyHEMA aggregate cultures 
Cell culture plates were coated with polyHEMA using standard coating methods 
(Vinci et al. 2012) to prevent cell attachment and thus promote cellular aggregation. Cells 






Characterization of BacMam 2.0 constructs 
To assess the functional consequence of tyrosine 181 phosphomimetic β1 
expression in neurons, we chose to use BacMam 2.0 viruses because they robustly 
transduce mammalian cells, including neurons, and result in little to no cytotoxicity 
within a wide range of transduction conditions. Further, unlike adenovirus or herpes viral 
vectors (Sato et al. 2009; Storey et al. 2002), they have little to no effect on sodium 
current (personal communication, Dr. James Offord). Preparations of virus were obtained 
that encoded wildtype (WT) β1 or β1Y181E or GFP. Expression of β1 WT or β1Y181E 
was initially characterized in four different mammalian cell lines, including Chinese 
hamster lung (not shown), Chinese hamster ovary (not shown), B35 (not shown), and 
MDA-MB-231 (Figure 3.1). Induced expression of β1 WT and β1Y181E in MDA-MB-
231 cells are shown in Figure 3.1C and Figure 3.1E, respectively. Transduction 
efficiency increased with increasing virus concentration and it was possible to achieve 
100% transduction efficiency (data not shown). While we observed generally even 
expression of β1 WT throughout the cell (Figure 3.1C), β1Y181E appeared to cluster at 
the leading edge of the filopodia (Figure 3.1 E, arrow). These results suggest that, similar 
to our previous data in cardiac myocytes (Malhotra et al. 2004), β1 WT and β1Y181E are 
differentially localized in breast cancer cells. 
β1Y181E induces neurite outgrowth independent of cell-cell adhesion  
We demonstrated previously that β1 subunits promote neurite extension in CGNs 
via trans homophilic cell adhesion in vitro between β1 subunits expressed on the 
substrate monolayer and β1 subunits expressed by the neuron (Davis et al. 2004; 
Brackenbury et al. 2008a). We have proposed that similar events occur in the cerebellum 











































Figure 3.1. Characterization of BacMam virus. MDA-MB-231 cells were infected 
with 10% v/v of BacMam virus and fixed 24 hr post transduction. Cells infected with 
GFP BacMam virus were immunolabeled with a GFP antibody (A). Cells infected with 
β1 WT virus were immunolabeled with anti-β1intra antibody (C). Cells infected with 
β1Y181E virus were immunolabeled with anti-β1intra antibody. Preliminary results 
suggest that β1 expression is distributed evenly throughout the cell while β1Y181E is 
found at the leading edge (arrow). (E). Corresponding DAPI staining for A, C, and E are 




CGNs (Brackenbury et al. 2008a; Brackenbury et al. 2013). Further, we have proposed 
that β1-β1 adhesion leads to β1 tyrosine phosphorylation and that this event serves as a 
key event to initiate a signaling cascade that ultimately promotes neurite extension. Here, 
to investigate whether tyrosine phosphorylation of β1 residue Y181 is sufficient to induce 
neurite outgrowth in the absence of trans homophilic cell-cell adhesion, we utilized 
BacMam2.0 baculovirus encoding β1WT or β1Y181E to transduce cultures of Scn1b null 
CGNs. We found that expression of β1Y181E resulted in increased neurite length in 
Scn1b null CGNs compared to β1 WT. Importantly, this occurred in Scn1b null CGNs 
that were plated without a substrate monolayer as a source of β1 subunits for cell-cell 
adhesion (Figure 3.2). Thus, phosphomimetic β1Y181E induces neurite extension to a 
greater extent than β1 WT in the absence of β1-β1 trans homophilic adhesion. 
Aggregate culture enhances tyrosine phosphorylation of β1 
To analyze levels of tyrosine phosphorylated β1 subunits biochemically, we 
utilized the human metastatic breast cancer cell line (MDA-MB-231) stably transfected 
with β1GFP (MDA-MB-231-β1GFP cells) that was described in Chapter II. In the 
construct used to generate this cell line, GFP was fused to the β1 C-terminus, resulting in 
an intracellular epitope tag. MDA-MB-231-β1GFP cells were grown as monolayers or in 
aggregate culture on polyHEMA-coated tissue culture plates. Cells grown on 
polyHEMA-coated tissue culture plates did not attach and grew in suspension, readily 
forming large aggregates visible by the naked eye. Membrane preparations were 
generated and tyrosine phosphorylated proteins were subsequently immunoprecipitated 
from Triton X-100 solubilized fractions using anti-PY20 antibody. The 
immunoprecipitated proteins were separated by SDS-PAGE, transferred to nitrocellulose, 
and immunoblotted with anti-GFP antibody to detect GFP-tagged pY-β1 subunits. 
Immunoreactive bands corresponding to the predicted MW of full-length β1 + GFP (64 






















Figure 3.2. β1Y181E increases neurite length in cultured CGNs in the absence of 
trans homophilic adhesion. Acutely isolated Scn1b null CGNs were transduced with 3 
% (v/v) of  β1 WT BacMam 2.0 or β1Y181E BacMam 2.0 directly after plating onto 
poly-D-lysine coated coverslips. After 48 hr of culture, cells were fixed and labeled with 
antibodies to detect neuronal marker Tuj1 (mouse; Covance, not shown) or β1 (rabbit; 
kind gift of Dr. Nobuyuki Nukina). A. Representative images of transduced Scn1b null 
CGNs expressing  β1 WT (top) or β1Y181E (bottom) labeled with anti-β1 antibody. B. 
Mean length of longest neurite measured from CGNs expressing β1 WT or β1Y181E. A 
minimum of 30 neurites were measured for each condition (N = 3 independent 
experiments). * denotes p < 0.05. Statistical significance was determined using the Mann-






Figure 3.3. Cellular aggregation increases tyrosine phosphorylation of β1. Tyrosine 
phosphorylated proteins were immunoprecipitated (using anti-PY20 antibody) from equal 
aliquots of Triton X-100 solubilized membrane preparations collected from confluent 
monolayers or polyHEMA-plated aggregates of MDA-MB-231 cells stably transfected 
with β1GFP. As a negative control, non-immune mouse IgG2b was used as the 
immunoprecipitating antibody. Samples were separated by SDS-PAGE, transferred to 
nitrocellulose, and immunoblotted with anti-GFP antibody. (A) Tyrosine phosphorylated 
β1 subunits (pY-β1GFP, arrow) are detected in cells grown as confluent monolayers and 
in polyHEMA aggregates. Levels of pY-β1GFP are 1.9-fold higher in cells grown as 
polyHEMA aggregates, suggesting that cell-cell aggregation promotes β1 tyrosine 
phosphorylation. (B) Representative examples of β1GFP protein in control IgG2b flow-
through samples following the immunoprecipation step, indicating β1 expression 
increases 2-fold as a result of aggregate culture in cells grown on polyHEMA-coated 
dishes. Quantification of data in panels A and B are provided in panels C and D, 
respectively. * denotes P < 0.05. Statistical significance was determined with Student’s t-





cells were grown on polyHEMA-coated dishes to prevent attachment and promote 
aggregation, the extent of tyrosine phosphorylation increased 1.9-fold, suggesting that β1 
tyrosine phosphorylation occurs as a result of β1-β1 adhesion (Figure 3.3A and 3.3C). 
Total expression of β1 was similarly increased (2-fold) in cells grown on polyHEMA-
coated dishes (Figure 3.3B and 3.3D). 
Identification of the β1 intracellular domain as a potential substrate of fyn kinase 
In silico analysis suggested that β1 residue Y181 might be a target for fyn kinase 
(data not shown), in agreement with our previous work (Malhotra et al. 2002). Here, we 
used a commercially available cell-free kinase assay to test whether a peptide 
representing the β1 intracellular domain and including residue Y181, could be 
phosphorylated by fyn (Figure 3.4). Robust tyrosine phosphorylation was detected when 
either the β1 or poly E4Y1 peptides were incubated in the presence of fyn kinase (Figure 
3.4). Importantly, we did not observe tyrosine phosphorylation when the pYβ1 peptide 
(chemically tyrosine phosphorylated at Y181) was incubated in the presence of fyn. The 
signal displayed in the presence of fyn kinase but absence of substrate is likely due to a 
low level of autophosphorylation. We observed a significant increase in signal between 
reactions lacking substrate (containing fyn kinase; lacking substrate) compared to 




To investigate the functional relevance of tyrosine phosphorylation of β1, we used 
BacMam 2.0 virus to express β1 WT or the phosphomimetic β1Y181E construct in 
neuronal cultures that were plated on poly-D-lysine. We observed that expression of 






































Figure 3.4. A peptide representing the intracellular domain of β1, containing residue 
Y181, is a substrate for fyn kinase. Fyn kinase assay was performed according to 
manufacturer’s recommendations (Promega ADP-Glo kit). Each reaction contained 200 
ng of active GST-tagged fyn kinase, 50 µM Ultrapure ATP, 0.2 mg/mL peptide substrate, 
50 µM DTT diluted in a standard kinase reaction buffer (contents of 5X buffer: 40 mM 
Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA). β1 peptides corresponded to the 
intracellular domain of β1 surrounding Y181 (amino acids 175 to 185; β1 peptide, 
QENASEYLAITC; pYβ1 peptide, QENASE[pY]LAITC). The Poly E4Y1 peptide, used 
as a positive control and provided in the kit, is a well-characterized substrate for fyn 
kinase. Kinase reactions lacking substrate were used to normalize the kinase activity in 
substrate containing reactions. N = 3. * denotes P < 0.05. Statistical significance was 




Importantly, β1Y181E-induced neurite extension occurred in the absence of a substrate 
that expressed β1. These results suggest that, under normal conditions, tyrosine 
phosphorylation of β1 in response to β1-β1 trans homophilic adhesion is a critical first 
step in the signal transduction cascade leading to β1-mediated neurite outgrowth. 
We next postulated that β1-β1 trans homophilic adhesion might regulate the 
phosphorylation state of β1. To test this, we utilized MDA-MB-231-GFP cells. The 
parental MDA-MB-231 cell line was originally selected because it shares some qualities 
of electrically excitable cells including expression of nNav1.5, a neonatal splice variant of 
the major cardiac sodium channel (Brackenbury et al. 2007). In addition, MDA-MB-231 
cells have low endogenous cell adhesive activity and we demonstrated that cellular 
aggregation is enhanced in this line by stable expression of β1 (Chioni et al. 2009). We 
utilized an immunoprecipitation method to ask whether β1 is phosphorylated in MDA-
MB-231 β1GFP monolayers and in aggregates formed subsequent to plating of cells on 
polyHEMA-coated dishes. We detected pY-β1-GFP in membrane preparations from cells 
cultured under both conditions. Interestingly, we detected enhanced levels of 
phosphorylated β1 subunits in cells grown in aggregate culture, in agreement with the 
idea that β1-β1 trans homophilic adhesion regulates the extent of tyrosine 
phosphorylation of β1. The level of β1 expression similarly increased in aggregate 
culture, suggesting that stabilization of β1 at the cell membrane by increased points of 
homophilic adhesive contact results in increased total β1 expression in the cell. Taken 
together, these data suggest a possible molecular mechanism for the regulation of 
tyrosine phosphorylation of β1. The stabilization of cell surface β1 due to homophilic β1-
β1 adhesion may mediate tyrosine phosphorylation of β1 by membrane-associated 
kinases such as fyn.  
Previously, we identified fyn, a src family kinase, as a critical component of the 
β1-mediated neurite outgrowth signaling cascade in vivo (Brackenbury et al. 2008a). We 




substrate for fyn-mediated phosphorylation. To test this hypothesis, we used a 
commercially available cell-free kinase assay. We found that a peptide representing the 
β1 intracellular domain is a fyn substrate in vitro, suggesting that fyn-mediated 
phosphorylation of β1 may be an important step within the β1-mediated neurite 
outgrowth signaling cascade in vivo.  We propose that this event may occur directly 
downstream of β1-β1trans homophilic adhesion. 
The results presented here augment the early steps of our β1-mediated neurite 
outgrowth model (Davis et al. 2004; Brackenbury et al. 2008a). We propose that the 
initiating event for this signal transduction cascade is extracellular β1-β1 trans 
homophilic adhesion or binding of soluble β1B to β1, at the growth cone plasma 
membrane (Davis et al. 2004; Patino et al. 2011). This initiating event is then proposed to 
result in two consecutive events: (1) the recruitment of ankyrin to the point of cell-cell 
contact (Malhotra et al. 2000) and (2) tyrosine phosphorylation of β1Y181 via fyn kinase. 
We showed previously that β1Y181 expression in place of β1 disrupts the interaction 
between β1 and ankyrin (Malhotra et al. 2002). These dueling events suggest a signaling 
mechanism in which ankyrin is recruited to points of contact in response to β1-β1 trans 
adhesion or β1B binding to β1 and subsequently released by β1 tyrosine phosphorylation, 
resulting in a dynamic cycle. We envision that β1 subunits located at the neuronal growth 
cone initiate points of contact with β1 subunits expressed on the plasma membranes of 
adjacent glia or neurons or with soluble β1B in the extracellular matrix. Following this 
interaction, we propose that ankyrin initially colocalizes transiently with β1 but then this 
association is disrupted when β1 becomes phosphorylated. This scheme would allow 
ankyrin to continually be recruited to new points of cell-cell contact or areas of β1B 
secretion as the growth cone moves and extends along a cellular substrate or through the 
extracellular matrix. An additional possibility is that pY-β1 can act as an activator of fyn 




tyrosine phosphorylated proteins can result in increased src family kinase activity 
(Harrison 2003). 
In conclusion, we propose that tyrosine phosphorylation of β1 by fyn kinase 
following trans homophilic adhesion is a key regulatory step in neurite outgrowth. These 
data, taken together with the identification of other key factors regulating β1-mediated 
neurite outgrowth, including contactin, γ-secretase activity, Nav1.6 expression, and 
sodium channel activity (Brackenbury et al. 2010; Brackenbury and Isom 2011), 
demonstrate that a complex signaling cascade ties together disparate cell processes, 
including ion flux, kinase signaling, and cell-cell adhesion. Understanding how β1 acts as 
a channel modulator and as a CAM to modulate cell migration, axon outgrowth and 
pathfinding, and fasciculation is critical to understanding its contribution to brain 










Chapter IV: Identification of the cysteine residue responsible for 
disulfide linkage of sodium channel α and β2 subunits 
Chapter IV was published in the Journal of Biological Chemistry (Chen et al. 
2012). My primary contributions to this work include: (1) generation of all in silico 
datasets, (2) significant intellectual contributions to the experiment design and data 
interpretation, in particular overcoming a critical technical problem which hindered the 
progress of the study, and (3) generation of an immunocytochemistry dataset to assess 
protein expression and subcellular localization.  
 
Abstract 
Voltage-gated sodium channels in brain are composed of a single pore-forming α 
subunit, one non-covalently linked β subunit (β1 or β3), and one disulfide-linked β 
subunit (β2 or β4). The final step in sodium channel biosynthesis in central neurons is 
concomitant α-β2 disulfide linkage and insertion into the plasma membrane. Consistent 
with this, Scn2b (encoding β2) null mice have reduced sodium channel cell surface 
expression in neurons and action potential conduction is compromised. Here we 
generated a series of mutant β2 cDNA constructs to investigate the cysteine (C) 
residue(s) responsible for α-β2 subunit covalent linkage. We demonstrate that a single 
cysteine-to-alanine (A) substitution at extracellular residue C26, located within the 
immunoglobulin (Ig) domain, abolishes the covalent linkage between α and β2 subunits. 
Loss of α-β2 covalent complex formation disrupts the targeting of β2 to nodes of Ranvier 




hippocampal neurons, suggesting that linkage with α is required for normal β2 subcellular 
localization in vivo. Wildtype (WT) β2 subunits are resistant to live cell Triton X-100 
detergent extraction from the hippocampal AIS, while mutant β2 subunits, that cannot 
form disulfide bonds with α, are removed by detergent.  Taken together, our results 
demonstrate that α-β2 covalent association via a single, extracellular disulfide bond, is 
required for β2 targeting to specialized neuronal subcellular domains and for β2 
association with the neuronal cytoskeleton within those domains. 
 
Introduction 
Voltage-gated sodium channels are heterotrimeric complexes containing a single 
pore-forming α subunit, a non-covalently linked β1 or β3 subunit, and a covalently linked 
β2 or β4 subunit (Catterall 2012). While sodium channel β subunits are non-pore-
forming, they play essential roles in channel targeting, regulation of channel gating and 
voltage-dependence, and channel-independent roles in cell adhesion (Brackenbury and 
Isom 2011). Sodium channel β2 subunits (encoded by Scn2b) are disulfide-linked to the 
ion-conducting α subunit and are expressed in brain, peripheral nerve, and heart (Isom et 
al. 1995a; Dhar Malhotra et al. 2001; Lopez-Santiago et al. 2006).  Similar to the other 
sodium channel β subunit family members, β2 is a type 1 transmembrane protein 
containing an extracellular N-terminal V-set Ig domain, a single transmembrane segment, 
and an intracellular C-terminal domain. In Xenopus oocytes, β2 modulates Nav1.2 
channel gating and increases functional channel expression through promotion of 
intracellular vesicle fusion with the plasma membrane as measured by changes in cell 
capacitance (Isom et al. 1995a). In transfected fibroblasts, β2 increases Nav1.2 cell 
surface expression only if β1 is also expressed (Kazarinova-Noyes et al. 2001).  β2 
functions as a trans homophilic cell adhesion molecule in vitro, resulting in recruitment 




domain associates with the extracellular domain of β1 in an in vitro cell adhesion assay, 
suggesting that these two subunits may associate via cell adhesive interactions in vivo 
(McEwen and Isom 2004). Similar to the other sodium channel β subunits, β2 can be 
detected in detergent-resistant membrane preparations from primary neurons and is 
sequentially cleaved by β and γ secretases (Wong et al. 2005). The cleaved intracellular 
domain of β2 is postulated to translocate to the nucleus to modulate Scn1a α subunit gene 
transcription (Kim et al. 2007), however, the regulation of this process is not understood. 
A series of studies has demonstrated that β2 plays important roles in vivo in both neurons 
and cardiac myocytes. Scn2b null mice have significantly reduced (~50-60%) 
tetrodotoxin-sensitive (TTX-S) sodium
 
current density in brain and small dorsal root 
ganglion (DRG) neurons, altered voltage dependence of sodium current inactivation, 
reduced sensitivity to pain and increased susceptibility to seizures (Chen et al. 2002; 
Lopez-Santiago et al. 2006). Scn2b has been implicated in disease: Scn2b expression is 
upregulated in a neuropathic pain model (Pertin et al. 2005) and Scn2b null mice have a 
neuroprotective phenotype in a model of demyelinating disease (O'Malley et al. 2009). 
The Scn2b null mutation has been proposed to prevent pathologic sodium channel 
upregulation along axons in response to demyelination, thus attenuating the extent of 
neuronal degeneration. While SCN2B has not yet been linked to human brain disease, 
mutations in SCN2B are associated with atrial fibrillation in heart (Watanabe et al. 2009). 
Concomitant covalent linkage of α to β2 through disulfide bonding and insertion 
into the plasma membrane are the final steps in sodium channel biosynthesis in primary 
neurons (Schmidt and Catterall 1986).  These results suggested that covalent linkage of α 
to β2 may occur at the extracellular face of the plasma membrane, however, the specific 
cysteine residue(s) involved have not been identified. Here we show, using a mutagenesis 
study, that a single cysteine-to-alanine substitution at the β2 extracellular residue C26 is 
sufficient to disrupt the formation of α-β2 covalent complexes in vitro. While β2WT 




system, co-expression of Nav1.1 with β2C26A results in decreased sodium current 
compared to α alone, suggesting that β2C26A may cause intracellular retention of a 
population of α subunits. Using a primary myelinating co-culture system, we demonstrate 
that, while β2WT traffics to nodes of Ranvier and heminodes, β2C26A is targeted to the 
axonal compartment but is not detectable at nodes or heminodes. In cultured hippocampal 
neurons, β2WT is enriched in the AIS, as defined by anti-ankyrin G staining whereas 
β2C26A is expressed in a non-polarized distribution in all of the neuronal processes. 
Thus, covalent linkage of β2 to α is essential for proper targeting of this subunit to 
specialized subcellular neuronal compartments. Finally, β2WT subunits are resistant to 
live cell detergent extraction from the hippocampal AIS, while mutant β2 subunits, that 
cannot form disulfide bonds with α are removed by detergent.  Taken together, our results 
demonstrate that α-β2 covalent association via a single, extracellular disulfide bond, is 
required for β2 targeting to specialized neuronal subcellular domains and for β2 




For immunoprecipitation and Western blot studies, primary antibodies used 
included rabbit polyclonal anti-pan-VGSC antibody obtained from Sigma (S6936; 1:200 
dilution) and mouse monoclonal anti-V5 antibody obtained from AbD Serotec 
(MCA1360; 1:300 dilution). For immunofluorescence studies, primary antibodies used 
included rabbit antibody against ankyrin G (S. Lux, Yale University School of Medicine, 
New Haven, CT, 1:4,000 dilution), goat antibody against GFP (AbD Serotec, 1:4,000 
dilution), guinea-pig antibody against Caspr/Neurexin IV (1:4000 dilution, M. Bhat, 




Temecula, CA, 1:100 dilution) and MAP2 (Covance, 1:10,000 dilution). Secondary 
donkey antibodies conjugated to Rhodamine Red-X, Alexa Fluro488, AMCA, or 
DyLight 649 were obtained from Jackson ImmunoResearch Laboratories (West Grove, 
PA) and used at 1:200 dilution. 
Plasmids and Cell Culture 
To generate a C-terminal 2V5 epitope tagged expression plasmid, cDNA 
encoding rat 2 (minus the termination codon) was cloned into the multiple cloning site 
of pcDNA3.1/V5-His (+) using standard TA cloning. This plasmid is referred to here as 
β2V5. Mutagenesis of 2 cysteine residues to alanine within this vector was performed 
using the Quikchange II site-directed mutagenesis kit (Stratagene). A subset of β2 
constructs, including β2WT, Ф (the construct with all cysteine residues mutated to 
alanine), and β2C26A, were subcloned into pEGFP-N1 to add a C-terminal GFP epitope 
tag. The integrity of all plasmids was confirmed by DNA sequencing at the University of 
Michigan DNA Sequencing Core. HEK-293 cells stably expressing human Nav1.1 
(GenBank accession number NP_008851.3; HEKhNav1.1) were obtained from Glaxo-
SmithKline under a materials transfer agreement as previously described (Patino et al. 
2011).  
Co-immunoprecipitation 
Co-immunoprecipitation was performed similar to (Rusconi et al. 2007). Briefly, 
HEKhNav1.1 cells cultured as described (Patino et al. 2011) were transfected with 4 μg of 
β2WT or mutant plasmid using Fugene 6 as recommended by the manufacturer. Protein 
A-Sepharose beads (Sigma) were washed with PBS and resuspended in 500 μl of dilution 
buffer (DB: 60 mM Tris/HCl pH 7.5, 180 mM NaCl, 1.25% Triton X-100, 6 mM EDTA 
pH 8 containing Complete Mini protease inhibitor tablets (Roche) at 2x the 
manufacturer’s recommended concentration) at 4°C. The beads were then incubated 




were detached from the culture dishes using 50 mM Tris, 10 mM EGTA (pH 8) and 
centrifuged at 5,000 rpm in a microfuge for 5 min at 4°C. The cell pellet was resuspended 
in DB for cell lysis. After 30 min of lysis on ice, a 10 min centrifugation at 10,000 rpm in 
a microfuge was performed to remove insoluble material. The resulting supernatant was 
added to the beads and incubated by rotating end-over-end for 5 h at 4°C. The beads were 
then washed twice with washing buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.1% Triton 
X-100, 0.02% SDS, 5 mM EDTA pH 8 containing Complete Mini protease inhibitor 
tablets at 2x the manufacturer’s recommended concentration) followed by one wash with 
the same buffer lacking Triton X-100. Samples were then separated by SDS-PAGE on a 
5 % polyacrylamide gel and transferred to nitrocellulose for Western blot analysis. 
Western blotting was performed using the SnapId system (Millipore). Immunoblots were 
probed with anti-V5 or anti-pan-VGSC antibody as indicated, detected with Westfemto 
Chemiluminescent reagent (Pierce), and imaged using autoradiography film (Denville 
Scientific) or using the LI-COR Odessey® Fc imaging system. All results presented are 
representative of at least two independent repeats, as specified in the figure legends. 
Surface Biotinylation 
Surface biotinylation of β2WT or mutant proteins was performed as in (Patino et 
al. 2011). Briefly, membrane proteins were biotinylated using the Cell Surface Labeling 
Accessory Pack (Pierce) following the manufacturer's instructions utilizing Complete 
Mini (Roche) as protease inhibitor. Samples were separated on 12% SDS PAGE gels. 
Proteins were transferred to nitrocellulose membranes that were processed for Western 
blotting using the SnapId system (Millipore). Anti-V5 immunoreactive signals detecting 





subunit, a loading control for cell surface protein preparations (Patino et al. 2011). All 





Immunocytochemical analysis of 2 expression in HEK cells 
HEKhNav1.1 cells were transiently transfected with GFP alone, β2WT-GFP, 
β2C26A-GFP, or Ф-GFP using Fugene 6 following the manufacturer’s recommendations. 
Twenty four h post-transfection, cells were replated onto 8-well glass chamber slides (BD 
Falcon). Twenty four h later, cells were fixed for 20 min at RT with 4% 
paraformaldehyde. After a 1 h blocking step (PBSTGS: dPBS containing 10% goat serum 
and 0.3 % Triton X-100), cells were incubated overnight at RT with rabbit anti-GFP 
antibody (Invitrogen; A6455; 1:1000) diluted in PBSTGS. Following 3 - 10 min washes 
with dPBS, cells were incubated 2 h at RT with Alexafluor568 goat anti-rabbit secondary 
antibody (Invitrogen; A-11011; 1:500) diluted in PBSTGS. After 3 - 10 min washes with 
dPBS, slides were allowed to dry for 20 min and coverslipped using mounting media 
(Invitrogen; ProLong Gold Antifade Reagent with DAPI; P36931). Slides were imaged 
using a Nikon A1R confocal microscope utilizing Nikon NIS-Elements software located 
in the Department of Pharmacology at the University of Michigan. 
Whole-cell patch-clamp recording and analysis 
HEKhNav1.1 cells were transfected with V5- or GFP-tagged β2 subunits as 
described above and plated for electrophysiological analysis. To detect cells that were 
transfected with V5-tagged plasmids, a 1:10 ratio of GFP:β2 cDNA was used such that 
β2-expressing cells could be detected by epifluorescence. Aliquots of each transfection 
were analyzed for protein expression by Western blot to confirm protein expression. 
Micropipettes were obtained from capillary glass tubing (Warner Instruments) using a 
horizontal P-97 puller (Sutter Instruments). Micropipette resistance was between 1.5 and 
3.5 MΩ, when filled with intracellular solution containing the following (in mM): 10 
NaCl, 10 CsCl, 105 (Cs)Aspartate, 10 EGTA, and 10 HEPES, pH 7.4 with CsOH. And 
the extracellular solution containing (in mM): 130 NaCl, 4 KCl, 1.5 CaCl2, 1 MgCl2, 5 




using Clampex 9.2 or 10, Axopatch 200B or 700B amplifier and a Digidata 1322A 
digitizer (Molecular Devices). Pipette and whole cell capacitance were fully 
compensated. When appropriated, series resistance compensation was set to 
approximately 40-70% with the lag set to 10 μs. Signals were low-pass filtered at 5 kHz, 
and data were sampled at 40 kHz online. To determine the sodium current amplitude and 
voltage dependence of activation, sodium currents were evoked by 250 ms depolarizing 
test pulses (from -110 to 40 mV at 5 and 10 mV intervals) from a holding potential of -80 
mV and a hyperpolarizing -120 mV, 250 ms prepulse. Peak sodium current was 
normalized to cell capacitance and used to plot I–V curves; also to calculate conductance 
(g=I/(V-Vrev), where V is the test potential, and Vrev is the measured reversal potential). 
Voltage dependence of inactivation was determined by applying a 50 ms test pulse to 0 
mV after 250 ms prepulses to the same voltages as described for the voltage dependence 
of activation. Peak currents were normalized to the maximum peak INa amplitude. 
Normalized activation and inactivation curves were fit with a Boltzmann equation 
1/[1+exp(V-V1/2)/κ], where V1/2 is the membrane potential in the midpoint of the curve, 
and κ as the slope factor. The kinetics of inactivation was measured on the test pulse to 0 
mV from the same protocol used for voltage dependence of activation. The current, from 
90% of the peak amplitude to 20 ms after the test pulse was initiated, was fitted to a 
double exponential equation of the form I=(Ff* exp(-τ/τf))+(Fs*exp(-τ/τs)+C using the 
Chebyshev method, where I is the current, τf and τs are the time constants for the fast and 
slow inactivation component, and C is the steady-state persistent current. Analysis of the 
recorded sodium current was performed using the software packages Clampfit 10 
(Molecular Devices) and SigmaPlot 11.2 (Systat Software, Inc., San Jose, CA). The 
statistical significance of differences between mean values for β2C26A-GFP or Ф-GFP 
compared with β2WT-GFP was evaluated using Student’s unpaired t test, with p < 0.05 





Co-cultures of rat Schwann cells and dorsal root ganglion (DRG) neurons were 
established as described previously (Zhang et al. 2012). Briefly, DRGs were removed 
from E15 or E16 rat spinal cords, dissociated with 0.25% trypsin, and plated onto 
Matrigel (BD Bioscience) coated coverslips. After cycling with antimitotics to eliminate 
non-neuronal cells, Schwann cells were added to the cultures and maintained in C media 
(containing 10% fetal bovine serum, 50 ng/ml 2.5S nerve growth factor, 0.4% glucose, 
and 2 mM L-glutamine in minimum essential medium) for 1-3 days before adding 50 
µg/ml ascorbic acid to allow myelination to ensue. 
Primary hippocampal neuron cultures 
Primary cultures of hippocampal neurons were established essentially as 
described previously (Dzhashiashvili et al. 2007). Briefly, hippocampi from E18 rat were 
treated with 0.05% trypsin (Invitrogen) in dissecting solution (0.6% glucose, 10 mM 
HEPES in PBS) for 30 min at 37°C and cells were dissociated by repeated passage 
through a fire-polished constricted Pasteur pipette and then plated onto 12 mm coverslips 
coated with poly-L-lysine (0.1 mg/ml in PBS) in MEM containing Earles’ salts and 
glutamine with 10% FBS, 0.45% glucose, 1 mM pyruvate, and penicillin and 
streptomycin.  After 2 hours, the medium was replaced by Neurobasal medium 
(Invitrogen) with 2% B-27, and 0.5 mM L-glutamine.  Cultures were maintained at 37°C 
in a humidified 5% CO2 atmosphere until used.   
Nucelofection 
Nucleofector™ Technology was used to introduce β2-GFP constructs into DRG 
neurons prior to co-culture with Schwann cells or into hippocampal neurons. 
Nucleofection was performed with Amaxa Rat Neuron Nucleofector Kit (Lonza) by 




Immunofluorescence and Imaging 
Hippocampal neurons or myelinating co-cultures were fixed in 4% 
paraformaldehyde for 10 min, permeabilized and blocked with buffer containing 1% 
donkey serum, 5% BSA, and 0.2% Triton X-100 in 1X PBS for 30 min, then stained with 
primary and secondary antibodies diluted in blocking buffer. Immunofluorescence 
images of cultures were taken with a Zeiss LSM 510 Meta confocal microscope. 
Triton extraction 
Live hippocampal cultures were incubated in extraction buffer (30 mM PIPES, 1 
mM MgCl2, 5 mM EDTA, 0.5% Triton X-100) for 20 min at 37 ºC, and then rinsed in 
PBS, fixed in 4% PFA and processed for immunofluorescence. 
Protein structure modeling 
The extracellular domain of β2 was modeled based on the reported crystal 
structure for rat myelin P0ex (Shapiro et al. 1996) using PyMOL (PyMOL Molecular 
Graphics System, Version 1.5.0.4 Schrödinger, LLC.). 
Multiple alignments of sodium channel sequences 
Multiple alignments of sodium channel polypeptide sequences were performed 
using MEGA version 5 (Tamura et al. 2011) utilizing the ClustalW methodology 
(Thompson et al. 1994). 
 
Results 
Sodium channel β2 subunits contain five extracellular cysteine residues (C21, C26, C43, 
C46, C98) and one intracellular cysteine residue (C143) (Isom et al. 1995a). Two of the 
extracellular cysteine residues form an intramolecular disulfide-bridge as part of the Ig-




β4, we found that β2C21 and β2C98 were conserved among the three β subunits, 
suggesting that these residues are responsible for formation of the Ig loop intramolecular 
disulfide bridge that is common to all three (Figure 4.1A). β3 was not included in this 
alignment because evidence suggests that it does not participate in homophilic cell-cell 
adhesion and thus may have a slightly different Ig domain structure (McEwen et al. 
2009). β2C98 aligns with β1C121, which is proposed to be critical to formation of the 
disulfide bridge in the Ig loop domain. β1C121 is mutated to tryptophan in human 
epilepsy, resulting in disruption of β1-mediated cell-cell adhesion (Meadows et al. 
2002b). These data support the idea that β2C21 and β2C98 participate in intramolecular 
disulfide bond formation in the Ig domain. Comparing β2 with β4 (Yu et al. 2003), the β 
subunits that are disulfide-linked to α, we found that β2C26 is conserved between 
subunits, whereas β2C43 and β2C46 are not conserved, suggesting that C26 may be 
involved in disulfide linkage to α. In previous studies we used the crystal structure of the 
myelin P0 extracellular domain to model the sodium channel β1 Ig loop (McCormick et 
al. 1998). Employing a similar strategy here for the related β2 extracellular domain, we 
show that β2C21 and β2C98 are optimally aligned to form an intramolecular disulfide 
bond (Figure 4.1B, left and right panels). In contrast, β2C26 is located in the linker 
region between the B and C faces of the Ig loop (McCormick et al. 1998), in a position 
that is more accessible for association with sodium channel α subunits (Figure 4.1B, left 
panel). Thus, we hypothesized that β2C26 was the most logical candidate to form an 
intermolecular disulfide bridge between β2 and α.  
β2C26 mediates the disulfide-linkage between β2 and α 
To identify the β2 cysteine residue(s) responsible for α-β2 linkage, β2 mutant 
expression constructs were generated substituting each single cysteine to alanine. In 






































Figure 4.1. Structural predictions for β2. A. Alignment of the N-terminal regions of 
human β2, β4, and β1 with conserved cysteine residues highlighted in bold.  Residue 
numbering corresponds to 2. B. Left: The crystal structure of the Ig loop of human 
myelin P0 (Liu et al. 2012) was used as a template to show the predicted position of 
2C26 (cyan), β2C21 (magenta), and β2C98 (magenta).  Right: The crystal structure of 
the Ig loop of human myelin P0 (Liu et al. 2012), was used as a template to show the 





generated, in the event that multiple cysteine residues were involved in α-β2 linkage. 
Each construct was engineered to contain carboxyl-terminal V5 epitope tag to facilitate 
biochemical identification. β2WT or cysteine-to-alanine β2 mutant constructs were then 
expressed separately in HEKhNav1.1 cells. Nav1.1 was immunoprecipitated with anti-
pan-VGSC α subunit antibody and α-β2 protein complexes (MW > 250 kDa) were 
detected by non-reducing SDS-PAGE followed by immunoblotting with a mouse 
monoclonal anti-V5 antibody to label V5-tagged β2 subunits. As expected (Schmidt and 
Catterall 1986), co-expression of β2WT with Nav1.1 resulted in detection of a high MW 
α-β2 channel complex (Figure 4.2A and B). Mutation of all 6 cysteine residues within 
β2 (Ф) completely disrupted α-β2 association (Figure 4.2A). A single alanine 
substitution, C26A, was sufficient to disrupt the α-β2 linkage (Figure 4.2A). Of all of the 
possible β2 cysteine-to-alanine mutant constructs, only those with the β2C26A mutation 
abolished β2-Nav1.1 association under non-reducing conditions (Figure 4.2B, Table 
4.1). Importantly, mutation of β2C21 or β2C98, the residues proposed to form the 
intramolecular Ig loop disulfide bond, to alanine did not disrupt intermolecular α-β2 
subunit association. All of the cysteine-to-alanine mutant β2 constructs displayed robust 
expression levels in cell lysates collected post-transfection (β2WT, Ф, and β2C26A 
shown in Figure 4.2C, others not shown). These data suggest that a single extracellular 
cysteine residue, β2C26, mediates the disulfide linkage between β2 and α.   
Cell surface expression and modulation of sodium currents 
The β2 mutant polypeptides Ф and β2C26A do not form disulfide bonds with 
Nav1.1.  Nevertheless, these subunits traffic to the cell surface where they may be 
available to modulate sodium currents through non-covalent association with α. Surface 
biotinylation analyses, shown in Figure 4.3A and B, demonstrated that β2WT, Ф, and 
β2-C26A are expressed at the cell surface. Fluorescence immunocytochemical data 





































 channel β2 and  subunits are disulfide linked at 2 residue C26. 
Coimmunoprecipitation was performed with HEKhNav1.1 cells transiently transfected 
with V5-tagged β2WT or various β2 cysteine-to-alanine mutants, as indicated. 
Solubilized Nav1.1 complexes were immunoprecipitated with anti-pan-Na
+
 channel 
antibody and separated on non-reducing SDS-PAGE gels as described in Experimental 
Procedures. Western blots were detected with anti-V5 antibody to visualize high α-β2 
protein complexes (arrows). A. Disulfide-linked -β2WT complexes are detected, 
whereas -ϕ and -β2C26A are not detectable, indicating that disulfide linkage between 
subunits was lost. B. (Lane 1) α-β2WT, (Lane 2) α-β2C43A, and (Lane 7) α-
β2C43AC46AC143A complexes are detected.  In contrast, (Lane 4) α-β2C26AC43A and 
(Lane 5) α-β2C26AC43AC46AC143A complexes are not detectable, indicating that 
disulfide linkage between subunits was lost. Lanes 3 and 6 were left empty.  Results of 
similar experiments for the remaining 2 constructs are summarized in Table 4.1. C.  
Western blot analysis shows robust expression of 2WT and mutant constructs: Top 




GFP alone, as indicated. Cells were then were solubilized and analyzed by Western blot 
with anti-V5 antibody to confirm subunit expression.  Lower panel: The blot was stripped 
and reprobed with anti--tubulin as a loading control. Results presented in this figure are 








Detection of immunoreactive 


















Table 4.1. Detection of 2-Nav1.1 disulfide-linkage by coimmunoprecipitation. 
Coimmunoprecipitation was performed with HEKhNav1.1 cells transiently transfected 
with V5-tagged β2WT or various β2 cysteine-to-alanine mutants, as indicated. 
Solubilized Nav1.1 complexes were immunoprecipitated with anti-pan-Na
+
 channel 
antibody and separated on non-reducing SDS-PAGE gels as described in Experimental 
Procedures. Western blots were detected with anti-V5 antibody to visualize high α-β2 
protein complexes, as demonstrated in Figure 4.2. Results presented in this table are 
representative of 2 independent experiments, except for β2WT ϕ, β2C26A, β2C43A, 
β2C43AC46AC143A, β2C26AC43A, and β2C26AC43AC46AC143A, which were 






















Figure 4.3. β2WT, , and 2C26A subunits are expressed at the cell surface. A. Cell 
surface biotinylation was performed on HEKhNav1.1 cells transfected with β2WT, , or 
β2C26A as described in Experimental Procedures. Immunoreactive bands were detected 
with anti-V5 antibody. The position of 2 subunit migration on the gel is indicated by the 
arrow. Similar to previous experiments to assess 1 subunit cell surface expression using 
this method (Patino et al. 2009), we observed multiple V5 immunoreactive bands, likely 
representing various levels of avidin attachment to 2. B.  Na/K ATPase β1 subunit 
immunoreactivity of samples from A as a loading control for cell surface proteins 
(arrows). C. HEKhNav1.1 cells expressing β2WT-GFP (top), -GFP (center), or 
β2C26A-GFP (lower) were processed for immunocytochemistry as described in 
Experimental Procedures.  Cells were visualized for GFP epifluorescence (green) or with 
an anti-GFP antibody (red; Alexa568) by confocal microscopy. DAPI (blue) indicates 
cell nuclei. Scale bar = 10 m. Results presented in this figure are representative of 5 




possibility of non-covalent association of these mutant subunits with α, we co-
immunoprecipitated HEKhNav1.1 cells transfected with α or β2C26A with anti-pan-
VGSC α subunit antibody (as in Figure 2) and probed the Western blot for non-disulfide 
linked β2 subunits (migrating in the 33 kDa range), but were unable to detect any bands 
(not shown). In spite of these results, we could not rule out the possibility that non-
disulfide linked β2 subunits, especially β2C26A in which the Ig loop domain is predicted 
to remain intact, may associate transiently with α subunits. To test this possibility, we 
investigated the effects of β2WT, β2C26A, or Φ on sodium currents in transfected 
HEKhNav1.1 cells under whole cell voltage clamp (Table 4.2). The V5- and GFP-tagged 
plasmids for each construct yielded similar results and thus values were pooled. Similar 
to previous work with other sodium channel α subunits co-expressed with β2 in 
heterologous cells (Kazarinova-Noyes et al. 2001; Watanabe et al. 2009), we observed 
that co-expression of β2WT with Nav1.1 did not change the level of sodium current 
density compared that observed for α alone. Co-expression of Ф with Nav1.1 also had no 
effect on sodium current density compared to α alone (Figure 4.4). In contrast, we 
observed that co-expression of β2C26A with Nav1.1 resulted in a significant decrease in 
transient sodium current compared to WT (Figure 4.4). Interestingly, these data are 
analogous to results reported for the SCN2B atrial fibrillation mutations R28Q and 
R28W, located in a similar region of the β2 Ig domain, which decreased the amplitude of 
Nav1.5-expressed currents compared to β2WT (Watanabe et al. 2009).  Also similar to 
(Watanabe et al. 2009) and to our results with Nav1.5 expressed in a heterologous system 
(Dhar Malhotra et al. 2001), β2WT did not increase Nav1.5-generated currents compared 
to α alone (Watanabe et al. 2009).  In addition to the effect of β2C26A on current density, 
we observed a small but significant depolarizing shift in the voltage-dependence of 
sodium current inactivation in the presence of Ф compared to α alone. Thus, even though 
we were unable to detect non-covalent association of β2C26A or Ф with Nav1.1 






















 GFP β2WT Ф β2C26A 
INa peak (pA/pF) -147.7 ± 30.7 -149.8 ± 20.7 -144.3 ± 35.1 -95.8 ± 11.5
a
 
INa persistent (pA/pF) -14.0 ± 5.9 -24.1 ± 8.2 -9.8 ± 2.7 -7.8 ± 1.9 
     
τinac fast (ms) 0.78 ± 0.16 0.74 ± 0.12 0.62 ± 0.05 0.62  ± 0.03 
τinac slow (ms) 5.55 ± 1.2 6.17 ± 0.77 4.81 ± 0.79 4.25 ± 0.45 
n 10 13 9 12 
Vrev (mV) 67.2 ± 5.6 68.6 ± 4.5 73.8 ± 7.4 59.7 ± 6.3 
n 7 10 8 10 
     
Voltage-dependence of activation 
Gmax (nS) 35.5 ± 5.9 32.0 ± 4.0 31.7 ± 13.9 31.5 ± 7.5 
K 4.6 ± 0.7 5.0 ± 0.6 5.0 ± 0.9 5.1 ± 0.5 
V1/2 (mV) -19.6 ± 1.6 -19.4 ± 1.3 -14.8 ± 2.4 -19.4 ± 2.2 
     
Voltage-dependence of inactivation 
K -5.2 ± 0.3 -6.7 ± 0.6 -5.0 ± 0.2 -5.2 ± 0.3 
V1/2 (mV) -44.1 ± 2.7 -44.4 ± 2.1 -38.9 ± 1.0
b
 -44.6 ± 2.2 
C 0.04 ± 0.01 0.06 ± 0.01 0.05 ± 0.01 0.06 ± 0.01 
a
 P = 0.036 with WT 
b
 P = 0.044 compared with WT 
Table 4.2.  Modulation of Na
+

























Figure 4.4. Representative Na
+ 
current traces. Representative Na
+
 currents evoked by 
a depolarizing pulse to 0 mV obtained from HEKhNav1.1 cells transfected with β2WT-





with α through low affinity interactions. 
Disulfide-linkage of β2 with α is critical for 2 targeting to nodes of Ranvier and the 
AIS 
Sodium channel clustering at nodes of Ranvier is critical for action potential 
conduction in myelinated axons. Localization of β2 to nodes of Ranvier (Kaplan et al. 
2001) suggests a functional role for this non-pore-forming subunit in these highly 
organized structures. Sodium channel α subunits traffic normally to nodes of Ranvier in 
Scn2b null mice, demonstrating that β2 is not necessary for proper nodal localization and 
clustering of the ion channel pore. However, action potential conduction is significantly 
decreased in Scn2b null optic nerve, indicating that the density of sodium channel α 
subunits at the node is reduced compared to WT.  
To test whether α-β2 subunit disulfide linkage affects β2 targeting to nodes, we 
generated myelinating co-cultures consisting of DRG neurons and Schwann cells. Prior to 
co-culture, neurons were transfected with β2WT-GFP, β2C26A-GFP, or Ф-GFP. C-
terminal GFP epitope tags were added to the constructs to facilitate imaging of β2 
localization. We examined the targeting of these constructs to heminodes,  i.e. the initial 
nodal clusters that form at the ends of individual myelin segments, and to mature nodes, 
which are flanked on both sides by myelin segments. 2WT-GFP was targeted 
specifically to nodes of Ranvier as well as to the heminodes (Figure 4.5A, upper 
panels). Thus, all nodes (20 out of 20) and all heminodes (44 out of 44) scored in a 
representative experiment were labeled by the 2WT-GFP construct. These results also 
indicate that the C-terminal GFP tag does not interfere with normal β2 trafficking in 
neurons. In contrast to β2WT-GFP, Ф-GFP (Figure 4.5A, middle panels) and β2C26A-
GFP (Figure 4.5A, lower panels) were diffusely expressed in the neurites of the sensory 
neurons but absent from the nodes and heminodes. In the case of Ф-GFP, 0 out of 52 






Figure 4.5. Covalent -β2 linkage is critical for targeting of β2 to nodes of Ranvier 
and the AIS. A. Targeting of β2 constructs to nodes of Ranvier. DRG neurons were 
nucleofected with WT or mutant β2-GFP constructs, as indicted, then co-cultured with 
Schwann cells under myelinating conditions for ~2 weeks. Cultures were fixed and 
analyzed by immunofluorescence staining. β2WT-GFP (green) accumulated at nodes and 




Paranodes were stained with Caspr (red) and myelin segments were stained with MBP 
(blue). Scale bar = 5 µm. B. Targeting of β2 constructs in hippocampal neurons. β2-GFP 
constructs were nucleofected into hippocampal neurons and analyzed at 18 DIV.  β2WT-
GFP (green) was enriched in the AIS, labeled by ankyrin G staining (red) (arrows). In 
contrast, -GFP and β2C26A-GFP mutants (green) were equally distributed in axons and 
dendrites, or preferentially concentrated in dendrites, and were not enriched in the AIS. 
Dendrites were stained with MAP2 (blue). Scale bar = 10 µm. C. Triton X-100 extracts 
mutant β2 constructs from hippocampal neuron cultures.  2WT-GFP nucleofected 
hippocampal neuron cultures were extracted with Triton X-100 prior to fixation, then 
fixed and stained. The β2WT-GFP construct was retained at the AIS despite detergent 
treatment and was extracted from other sites. Both -GFP and 2C26A-GFP were 
largely extracted from the neurons, including from the AIS, by detergent treatment. 
Arrows in the GFP staining panels delineate the positions of AIS; neuronal somata are 





heminodes and 0 out of 12 nodes.  Thus, while β2 subunits that are not covalently linked 
to α still traffic to the neurites, they fail to cluster at nodes or heminodes.   
Sodium channel clustering at the AIS is critical for action potential initiation. We 
tested the targeting of β2WT-GFP, Ф-GFP, and β2C26A-GFP to the AIS using primary 
hippocampal neuronal cultures.  Similar to our results in myelinating co-cultures, we 
found that disruption of α-β2 covalent linkage disrupted β2 targeting. β2WT-GFP was 
enriched at the AIS, defined by ankyrin-G expression, in 59 out of 60 neurons scored.  (It 
was exclusively expressed in the AIS in 5 of 60 neurons and faintly expressed in the 
remainder of the axon in 22 out of 60 neurons and in all processes in 32 out of 60 
neurons) (Figure 4.5B, upper panels).  In contrast, the Ф-GFP (Figure 4.5B, middle 
panel) and β2C26A-GFP (Figure 4.5B, lower panel) constructs failed to concentrate at 
the AIS in any neurons scored, i.e.  0 out of 54 and 60 neurons, respectively.  Rather, 
expression of both constructs was either non-polarized or confined to the dendrites. 
Finally, we used the live cell detergent extraction technique (Zhang et al. 2012) to  
investigate the association of β2 subunits with cytoskeletal elements at the AIS. As 
shown in Figure 4.5C, β2WT subunits are resistant to Triton X-100 extraction from the 
hippocampal AIS (Figure 4.5C, upper panel).  In contrast, Ф-GFP (Figure 4.5C, 
middle panel) and β2C26A-GFP (Figure 4.5C, lower panel), subunits that cannot form 
disulfide bonds with α are removed completely by detergent treatment.  Taken together, 
these results demonstrate that α-β2 covalent association is required for β2 targeting to 
specialized neuronal subcellular domains and for β2 association with the neuronal 
cytoskeleton within those domains. 
  
Discussion 
 Voltage-gated sodium channels are essential regulators of neuronal excitability in 




β2 subunits and insertion into the plasma membrane are the final steps in channel 
biosynthesis in central neurons (Schmidt and Catterall 1986). Thus, α-β2 association is 
considered to be a critical rate-limiting step in the formation of functional sodium 
channels and consequently the development of excitability, playing an essential role in 
the regulation of channel density and channel targeting to specialized locations in the 
neuron (Schmidt and Catterall 1986). Studies with Scn2b null mice have demonstrated 
that β2 subunits are critical regulators of central and peripheral neuronal excitability in 
vivo via modulation of channel cell surface expression (Chen et al. 2002; Lopez-Santiago 
et al. 2006). Here we set out to close a critical gap in the sodium channel literature: the 
molecular identification of the site of covalent α-β2 association.  
Via a combination of molecular biological, biochemical, and electrophysiological 
techniques, we show that the β2 residue C26 is necessary and sufficient to mediate α-β2 
covalent association through disulfide bonding. We also expressed these constructs in 
primary hippocampal neurons and in myelinating co-cultures to investigate the role of 
covalent α subunit association in β2 targeting to the AIS and nodes of Ranvier, 
respectively. Mutation of β2 extracellular residue C26 to alanine resulted in disruption of 
α-β2 covalent association.  In spite of the disruption of covalent α-β2 association by this 
amino acid substitution, co-expression of β2C26A with Nav1.1 decreased the level of 
transient sodium current density compared to expression of α alone, suggesting that 
β2C26A and α may associate through transient, non-covalent interactions that we were 
unable to detect using biochemical techniques. The β2WT subunit is enriched in the AIS 
of hippocampal neurons and selectively expressed at nodes and heminodes in myelinating 
DRG-Schwann cell co-cultures.  In contrast, β2C26A was not enriched in the AIS of 
hippocampal neurons but rather, was diffusely expressed in both axons and dendrites or 
just in dendrites indicating that its targeting was dramatically altered.  Similarly, in 
myelinating co-cultures, β2C26A was never expressed at nodes but rather remained 




removed β2C26A from the AIS but left β2WT undisturbed, suggesting that β2 subunits 
are normally associated with the neuronal cytoskeleton and that disruption of α-β2 
covalent association eliminates β2 cytoskeletal interactions. These data suggest that α-β2 
subunit covalent association is essential for proper β2 clustering at specialized neuronal 
subcellular domains. In other words, β2 follows α. Further, β2 interactions with the 
cytoskeleton at the AIS may be mediated exclusively through sodium channel α subunits 
rather than through other CAMs or via direct association with cytoskeletal proteins. We 
demonstrated previously, using a heterologous system, that β2 binds to the cytoskeletal 
protein ankyrin in response to cellular aggregation (Malhotra et al. 2000). Based on these 
results, we predict that β2-β2 trans homophilic adhesion, e.g. through axonal 
fasciculation, may be required to transduce an outside-in signal to stimulate β2 
association with ankyrin in neurons. In the absence of β2-β2 trans adhesion, as is the case 
in the neuronal cultures used here, β2 does not associate with other β2 subunits on 
adjacent cells, and thus does not bind ankyrin. In this case, β2 must depend on covalent 
linkage with α for the cytoskeletal association. 
 Previous work proposed that the A/A’ face of the extracellular β1 Ig loop domain 
is critical for Nav1.2 modulation (McCormick et al. 1998).  In addition, the extracellular 
segment IVSS2-S6 of Nav1.2 was shown to play a dominant role in α-β1 subunit 
association (Qu et al. 1999). These critical regions of β1 association may be conserved in 
multiple sodium channel α subunits.  Our results here, identifying β2C26 as the critical 
residue responsible for covalent α-β2 linkage, raise the question of which cysteine residue 
on the α subunit forms the corresponding disulfide-bridge with β2. While experiments to 
address this question are beyond the scope of the current study, we took an in silico 
approach to identify potential extracellular α subunit cysteine residues based on 
evolutionary conservation. Analysis of a multiple alignment of a set of sodium channel α 
subunit amino acid sequences including mammalian (human, mouse, and rat) Nav1.1, 




within the extracellular portions of domain I-IV S5-6 loops (Figure 4.6). Further analysis 
of a multiple alignment containing the same mammalian protein sequences as well as two 
additional non-mammalian sodium channel coding sequences (Electrophorus electricus 
Nav and Drosophila paralytic) demonstrated that 9 of the 12 cysteine residues are 
conserved in all of the sequences. Interestingly, 3 of the cysteine residues within the 
domain II S5-6 loop are less conserved. Two of these residues are conserved in 
Electrophorus electricus Nav but not in the Drosophila paralytic, whereas a single 
cysteine residue was conserved only in mammalian channels but not in Electrophorus 
electricus Nav nor in Drosophila paralytic. Given that neither Drosophila nor 
Electrophorus electricus contain genes orthologous to the mammalian sodium channel β 
subunits, these 3, less conserved cysteine residues are attractive candidates for the 
formation of a disulfide bond with β2C26 in mammals. While the in silico analysis 
suggests a subset of 3 candidate cysteine residues, it is impossible to determine the exact  
cysteine residue(s) involved based on evolutionary conservation alone. Future 
mutagenesis studies will allow for the elucidation of the exact cysteine residue on α 
subunits that fulfills this role. 
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Figure 4.6. Map of conserved extracellular C residues within Na
+
 channel α 
subunits. Locations of cysteine residues within the topology of the α subunit are denoted 
by ‘C’. All extracellular cysteine residues map to S5-6 loop regions. 12 candidate 
residues are extracellular, while 2 residues are embedded in the membrane as part of a P 
loop region, and are indicated in black. The color of the ‘C’ symbol denotes the amount 
of evolutionary conservation: Conservation in all sequences tested is denoted by blue; 
conservation in mammalian and Electrophorus electricus Nav is denoted by green, and 





Chapter V: Discussion and Future Directions 
This chapter will serve two purposes. First, I will provide a brief summary of 
what has been described in the previous chapters of this dissertation. The remainder of 
the chapter will be devoted to a discussion of important future directions based primarily 
on continuation of the projects discussed herein. Near the end of the chapter, I will 
provide a brief discussion of some potential future directions for the VGSC β subunit 
field in general. 
 
Objectives of Study 
The overall goal of my thesis work was to better understand how VGSC β 
subunits regulate important cell processes such as cell motility. Furthermore, I wanted to 
improve our knowledge regarding how β subunits in turn are regulated by other proteins. 
Specifically, for the cancer project outlined in Chapter II, the goal was to determine 
whether VGSC β subunits, in particular β1, might be involved in human breast cancer 
cell motility and metastatic potential in vitro. For the study described in Chapter III, our 
objective was to examine the potential role for tyrosine phosphorylation of β1 as a key 
regulatory step in β1-mediated signaling events. For the project depicted in Chapter IV, 
the goal was to determine the cysteine residue(s) of β2 involved in covalent linkage with 







VGSC β subunits are multifunctional proteins that play important roles in 
modulating cellular excitability and in signal transduction. In addition to being ion 
channel regulatory subunits and forming a protein complex with the pore-forming VGSC 
α subunit, β subunits are unique among ion channel accessory subunits in that they 
contain an extracellular immunoglobulin (Ig) domain, thus placing them in the Ig 
superfamily of cell adhesion molecules (CAMs) (Isom et al. 1992; Isom et al. 1995a). β 
subunits function in traditional ion channel accessory subunit roles by modulating α 
subunit gating and cell surface expression (Isom et al. 1992; Isom et al. 1995a). 
Importantly, β subunits also function as CAMs during brain development and are 
involved in both extracellular and intracellular signaling pathways to help guide neuronal 
patterning (Davis et al. 2004; Brackenbury et al. 2008a; Brackenbury et al. 2013). β 
subunits, in particular those encoded by SCN1B, act as regulators of cell proliferation and 
migration, axon outgrowth, pathfinding, and fasciculation in many central nervous 
system (CNS) areas including the hippocampus, cerebellum, and corticospinal tract 
(Davis et al. 2004; Brackenbury et al. 2008a; Brackenbury et al. 2013). 
β subunits are involved in pathophysiological processes, including but not limited 
to, epilepsy, cardiac arrhythmia, neuropathic and inflammatory pain, neurodegeneration, 
and cancer (Wallace et al. 1998; Patino et al. 2009; Medeiros-Domingo et al. 2007; 
Watanabe et al. 2008; Pertin et al. 2005; Lopez-Santiago et al. 2006; O'Malley et al. 
2009; Chioni et al. 2009). Mutations in the genes encoding β subunits result in human 
disease. Mutation of SCN1B, encoding the β1/β1B subunits, is linked to diseases on the 
Genetic Epilepsy with Febrile Seizures plus (GEFS+) spectrum (Wallace et al. 1998; 
Wallace et al. 2002; Patino et al. 2009). Patients who lack both functional copies of the 




while patients who inherit a single mutant copy of SCN1B present with the milder 
GEFS+ or may not exhibit seizures (Wallace et al. 1998; Wallace et al. 2002; Patino et al. 
2009; Ogiwara et al. 2012). Importantly, knockout mice which do not express β1/β1B 
subunits encoded by Scn1b (Scn1b null mice) recapitulate the hallmark phenotypes 
associated with DS, suggesting Scn1b null mice are a DS model (Chen et al. 2004; Patino 
et al. 2009). The roles of β subunits in normal physiology and in disease processes 
suggest these molecules are potential targets for novel therapeutics. 
Chapter II  
Ion channels, including VGSCs, appear to be involved in carcinogenesis 
(Prevarskaya et al. 2010). Increasing evidence suggests that VGSC α subunits may 
promote metastatic potential, the ability of a cancer cell to release from the primary 
tumor and form secondary tumors (Brackenbury 2012). Therefore, it is proposed that 
VGSCs may be novel targets for treating metastatic cancer (Brackenbury et al. 2007; 
Yang et al. 2012). Prior to the work described in this dissertation and in Chioni et al. 
(Chioni et al. 2009), little work had been done to address the potential role of VGSC β 
subunits in cancer. We hypothesized that β subunits might be involved in other cancer 
subtypes. 
Expression datasets from cultured cancer cell lines suggests that SCN1B mRNAs 
are observed in prostate cancer and may correlate with high metastatic potential (Diss et 
al. 2008). Interestingly, the expression level of SCN1B mRNA may correlate with 
increasing metastatic potential in prostate cancer cell lines (Diss et al. 2008). We 
observed the opposite trend in human breast cancer cell lines: β1 expression is high in 
weakly metastatic cells (MCF-7) and low in strongly metastatic cells (MDA-MB-231) 
(Chioni et al. 2009). In MCF-7 and MDA-MB-231 cells, SCN1B, SCN4B, and SCN2B 
mRNAs were detected while SCN3B mRNA was not detected. We observed elevated 




SCN1B mRNA was found to be the most abundant β subunit mRNA in both cell lines and 
MCF-7 cells were enriched in β1 mRNA and protein compared to MDA-MB-231 cells. 
siRNA-mediated reduction of β1 expression in MCF-7 cells reduced cell-substrate 
adhesion and increased migration. The change in migration was reversed by tetrodotoxin 
(TTX), suggesting that changes in VGSC α subunit expression might be induced 
following β1 knockdown. We observed that the amount of nNav1.5 mRNA and protein 
were elevated following β1 down-regulation. Stable expression of β1 in MDA-MB-231 
cells promoted cell-cell adhesion and decreased lateral motility and proliferation. 
Importantly, this reduction in cell migration occurred in the presence of increased 
functional VGSC activity. Taken together, these observations suggest that β1 subunits are 
novel cell adhesion molecules in human breast cancer cell lines and β1 functions both in 
the modulation of VGSC α subunits and the regulation of cellular migration.  
Chapter III 
SCN1B, encoding the β1 subunit, encodes both an accessory subunit of the VGSC 
as well as an Ig-CAM (Isom et al. 1992). β1 is expressed in neurons and glia during 
postnatal development and plays important roles in brain development (Table 1.2). 
Disruption of β1 function or expression can result in pathogenesis in human patients and 
transgenic mice including epilepsy and ataxia (Wallace et al. 1998; Chen et al. 2004; 
Patino et al. 2009). Defects in hippocampal, cerebellar, and corticospinal tract 
microorganization in Scn1b null mice lacking β1 subunit expression suggests a role for 
β1 in neuronal migration, axon outgrowth, and axonal pathfinding (Davis et al. 2004; 
Brackenbury et al. 2008a; Brackenbury et al. 2013). β1-β1 trans homophilic adhesion 
promotes neurite outgrowth of cerebellar granule neurons (CGNs) via a mechanism that 
requires fyn kinase (Davis et al. 2004; Brackenbury et al. 2008a). β1 is known to be 




et al. 2002). We hypothesized that post-translational modifications are essential to the β1-
mediated neurite outgrowth signaling cascade. 
β1-β1 trans homophilic adhesion recruits ankyrin to points of cell-cell contact and 
increases neurite outgrowth in cultured neurons (Malhotra et al. 2000; Davis et al. 2004). 
We postulated these two processes might be linked. Further, β1 phosphomimetic mutant, 
β1Y181E, is adhesion-competent, but does not recruit ankyrin to points of cell-cell 
contact (Malhotra et al. 2002). We predicted that β1 tyrosine phosphorylation functions 
as a regulatory switch in the pathway leading to neurite outgrowth. We virally expressed 
β1 and phosphomimetic β1Y181E in Scn1b null CGNs to examine a possible effect of 
pY- β1 on neurite outgrowth. We observed elevated neurite outgrowth in CGNs 
expressing β1Y181E. This result suggested that tyrosine phosphorylation of β1 occurs 
downstream of the initiating event, β1-β1 trans homophilic adhesion, and is an important 
downstream step in β1-mediated neurite outgrowth. Further, the level of phosphorylation 
of β1 increases in aggregate culture. This result provides additional evidence that β1 
adhesive contacts affect the extent of phosphorylation of β1. A kinase assay suggested β1 
as a putative substrate of fyn kinase, a member of the src kinase family. Our results 
suggest a model where tyrosine phosphorylation of β1 occurs downstream of adhesion, 
possibly by fyn kinase, and this phosphorylation event is important for propagating the 
signal to second messengers. 
Chapter IV  
VGSC are heterotrimeric complexes containing a single pore-forming α subunit, a 
non-covalently linked β1 or β3 subunit, and a covalently linked β2 or β4 subunit 
(Catterall 2012). β2 subunits (encoded by Scn2b) are linked to the ion-conducting α 
subunit via disulfide bond and are present in brain, peripheral nerve, and heart (Isom et 
al. 1995a; Dhar Malhotra et al. 2001; Lopez-Santiago et al. 2006). Covalent linkage of α 




steps in sodium channel biosynthesis in primary neurons (Schmidt and Catterall 1986). 
Scn2b null mice lacking β2 subunits display reduced tetrodotoxin-sensitive (TTX-S) 
sodium current density in brain and small dorsal root ganglion (DRG) neurons, altered 
voltage dependence of sodium current inactivation, reduced sensitivity to pain, increased 
susceptibility to seizures, and compromised action potential conduction (Lopez-Santiago 
et al. 2006; Chen et al. 2002). 
The specific cysteine residue(s) involved in α/β2 covalent linkage had not been 
identified prior to this study. Given that disulfide bonds are generally unstable in the 
reducing environment of the cytosol, we predicted that covalent linkage of α to β2 may 
occur at the extracellular face of the plasma membrane. Using mutagenesis, we 
determined that a single cysteine-to-alanine substitution at the β2 extracellular residue 
C26 is sufficient to disrupt the formation of α-β2 covalent complexes in vitro. Disruption 
of the α/β2 covalent linkage in vitro by co-expression of Nav1.1 with β2C26A decreased 
sodium current density, possibly as a result of intracellular retention of a population of α 
subunits. We observed that β2, but not β2C26A, traffics to nodes of Ranvier and 
heminodes in a primary myelinating co-culture system. In cultured hippocampal neurons, 
β2, but not β2C26A, is enriched in the AIS and resistant to live cell detergent extraction. 
Thus, covalent linkage of β2 to α is essential for proper targeting of this subunit to 
specialized subcellular neuronal compartments. 
 
Future Directions 
Role of VGSCs in Cancer  
There are many remaining questions regarding the role of β1 in cancer. The first 
step will be to establish a comprehensive dataset on the expression of SCN1B in breast 




tissue from human breast cancer?; (2) is β1 protein expressed in primary tissue from 
human breast cancer?; (3) is expression of SCN1B in breast cancer common or rare?; and 
(4) does expression of SCN1B in human breast cancer correlate with any clinical traits? 
To address these concerns, we will need to utilize public microarray datasets such as 
those found in Oncomine to examine SCN1B mRNA expression in cell lines and primary 
tissues. In addition, we will need to gain access to primary tissue through collaboration 
with colleagues at the University of Michigan Comprehensive Cancer Center. Using IHC 
to survey β1 expression in a tissue microarray would provide a useful dataset for 
expression in patient samples. We anticipate expression of SCN1B in a proportion of 
human breast cancer samples, and that expression levels may inversely correlate with 
metastatic potential. 
As described above, in vitro data suggest that β1 increases adhesion and reduces 
cell migration in human breast cancer cells. However, a possible role for β1 in the 
regulation of cancer cell invasion has not been directly tested. It will be critical to use a 
matrigel invasion assay, a modified version of a classic Boyden chamber assay. Cells are 
plated onto a filter pre-coated with matrigel and induced to invade through the matrigel 
via a chemotactic gradient. The number of invaded cells 24 hours post plating provides a 
measure of in vitro invasiveness. I would predict that, due to its effects on adhesion and 
migration, β1 expressing cells will display reduced invasion. It is conceivable that β1 
may interact with ECM components of matrigel, which may enhance or impede the 
invasive behavior of β1 expressing cells. 
It will be important to test the in vivo effect of β1 on tumorigenesis and metastatic 
potential. One model to study these processes in vivo is to use a xenograft, an insertion of 
cultured cancer cells into immune-compromised mice (NOD-SCID mice). To do this, the 
MDA-MB-231 cell lines stably expressing GFP (negative control) and β1-GFP would be 
grown in 3D culture in matrigel and injected into the mammary fat pad of NOD-SCID 




and by histological analysis. The effect of β1 on metastasis would be evaluated by 
counting the number of secondary tumors, measuring the tumor volume of secondary 
tumors, and by monitoring the levels of circulating tumor cells in the bloodstream. As β1 
expression reduced cell cycle progression in MDA-MB-231 cells, I would predict that β1 
expressing xenografts are reduced in size relative to control xenografts and that β1 
expressing xenografts would display reduced metastatic potential. These results would 
support the proposal that β1 expression is dynamically regulated in the transition to 
metastatic disease. 
One significant caveat with xenograft based experiments is the disrupted immune 
system in NOD-SCID mice. Also, xenografts do not replicate the entire tumorigenesis 
process as the cancers do not arise spontaneously in the host. Use of a genetic driver of 
breast cancer allows for investigation of tumorigenesis and metastasis in host-derived 
cancer in mice with normal immune systems (Khanna and Hunter 2005). An example of 
such a driver (MMTV-PyMT) uses the mouse mammary tumor virus promoter to drive 
expression of the polyomavirus middle T oncogene (Guy et al. 1992). To assay the effect 
of β1 subunits on cancer tumorigenesis and metastasis in such a model, cancers would 
need to be generated in mice containing and lacking Scn1b alleles. Conditional knockout 
of Scn1b in this experiment design is necessary; global knockout of Scn1b results in 
postnatal lethality at approximately P20, before the formation of metastatic disease with 
the MMTV-PyMT driver. In order to conditionally ablate β1 expression, a conditional 
Scn1b null allele (Chen et al. 2007) would need to be combined with an allele which 
drives Cre recombinase expression in mammary tissue. One possible system, WAP-Cre, 
utilizes the promoter of the whey acidic protein promoter to drive expression of Cre 
recombinase specifically in mammary tissue (Wagner et al. 1997). The effect of β1 on 
tumor growth and metastasis would be evaluated similarly to that described above for the 
xenograft model, namely histological analysis, measurements of tumor volume, counting 




bloodstream. Our hypothesis is that Scn1b null mice would harbor more secondary 
tumors and elevated levels of circulating tumor cells due to elevated metastatic potential. 
Further, because β1 expression reduced cell cycle progression in MDA-MB-231 cells, 
Scn1b null tumors might display increased tumor volume. 
Previous experiments testing the metastatic potential of β1 expressing cells were 
performed in 2D culture. It is possible that β1 CAM interactions in 3D and in the 
complex in vivo microenvironment will change how it functions in breast cancer cells. 
We may find that β1 expressing tumors have unchanged or increased metastatic potential 
relative to tumors lacking β1 expression. It could be that β1 adhesive events in 3D in vivo 
result in signaling cascades reminiscent of that for β1-mediated neurite outgrowth which 
are not fully recapitulated in standard 2D culture.  In an in vivo model of breast cancer, 
β1 appears to promote tumor growth and metastasis (personal communication, Dr. 
William Brackenbury). This suggests a potential role for β1 as a CAM and signaling 
molecule in breast cancer akin to β1-mediated neurite outgrowth in CGNs. Importantly, 
this observation suggests β1as a novel target for therapeutic intervention. 
β1-β1 trans homophilic adhesion initiates a neurite outgrowth signaling cascade  
β1 signaling is abrogated in Scn1b null mice which results in neuronal patterning 
defects that precede the onset of seizures. β1 signaling as a cell adhesion molecule is 
proposed to contribute to postnatal brain development. There are significant gaps in 
knowledge regarding β1-mediated neurite outgrowth. 
It will be important to investigate the role of tyrosine phosphorylation of β1 in 
postnatal brain development. BAC transgenes could be generated which express 
phosphomimetic β1 (β1Y181E) or phosphodead β1 (β1Y181A or β1Y181F). Transgenic 
mice could then be bred with Scn1b null mice to replace the endogenous transcripts 
encoding β1 with the phosphomimetic or phosphodead β1 mutants. The animals may 




though it is quite possible that the phenotypes may be more subtle in nature than the DS 
phenotype observed in Scn1b null mice. Of most interest will be to perform 
immunohistochemical analysis of cell migration and axonal outgrowth and pathfinding to 
ask whether tyrosine phosphorylation of β1 plays a role in β1 CAM signaling in vivo. 
Based on previous data informing our model, I would expect phosphomimetic β1 
expressing transgenic mice to display neuronal patterning defects due to overactive 
signaling. While I would also predict to observe neuronal patterning defects in 
phosphodead β1 expressing mice, in this case the defects would likely be due to reduced 
signaling. In other words, locking β1 into an ‘on’ or ‘off’ conformation is predicted to 
result in developmental defects due to the inability of the mutant β1 protein to naturally 
cycle between conformations in response to β1-β1 trans homophilic adhesion. 
We observed that a β1 peptide is a fyn kinase substrate in vitro (Chapter III). In 
addition, we previously showed that fyn is required for β1-mediated neurite outgrowth 
(Brackenbury et al. 2008a). Taken together, these data suggest the potential for a protein-
protein interaction between β1 and fyn. Furthermore, fyn, like other members of the src 
kinase family, contains an SH2 domain which binds intracellularly to tyrosine 
phosphorylated proteins and this is important in the regulation of fyn kinase activity 
(Harrison 2003). I hypothesize that β1 associates with fyn, and that the interaction may be 
modulated by tyrosine phosphorylation of β1. These hypotheses could first be tested by 
co-immunoprecipitation experiments in transfected 1610 cells which endogenously 
express fyn and can be transfected or virally transduced to express phosphomimetic 
(β1Y181E) or phosphodead (β1Y181A or β1Y181F) mutants of β1. It will be important 
to test for co-immunoprecipitation in both raft and non-raft fractions, as both β1 and fyn 
are reported to partition to both raft and non-raft membrane fractions (Brackenbury et al. 
2008a). Preliminary data from our laboratory (T. Davis, E. Slat, and L. Isom, unpublished 
results) suggested that β1 and fyn can be co-immunoprecipitated from transfected 1610 




association was difficult to capture biochemically and these proteins may interact only 
transiently. I would predict that the association of phosphomimetic β1Y181E with fyn 
will be robust while the association of wildtype β1 and fyn is likely to be transient and 
difficult to capture. Phosphodead mutant constructs (β1Y181A and β1Y181F) may not 
associate with fyn kinase or may associate only transiently with fyn. Future experiments 
using co-immunoprecipitation from rodent brain membranes will be important to ask 
whether or not it is possible to capture the association between β1 and fyn in vivo. If 
transgenic mice expressing phosphomutant β1 proteins are generated as discussed above, 
it would be useful to assess whether phosphomimetic β1 or phosphodead β1 associates 
with fyn kinase in vivo. The investigation of association between β1 and fyn will be an 
important avenue of investigation in the future. 
Based on our evidence that fyn kinase is an essential member of the β1-mediated 
neurite outgrowth signaling cascade and that the β1 intracellular domain peptide is a fyn 
kinase substrate, it would be important to further explore the placement of fyn in the 
signaling cascade. One possibility is that fyn signals upstream of β1 and phosphorylates 
β1. Another possibility is that fyn lies both upstream and downstream of β1. As 
mentioned above, the intracellular binding of fyn’s SH2 domain to tyrosine 
phosphorylated proteins is important in the regulation of fyn kinase activity. Therefore, 
fyn phosphorylation of β1 may feed back and result in increased fyn activity. To test this 
hypothesis, it would be important to ask whether inhibition of fyn kinase activity blocks 
neurite outgrowth induced by expression of phosphomimetic β1Y181E in Scn1b null 
cerebellar granule neurons and in the absence of β1-β1 trans homophilic adhesion. 
Inhibition of fyn kinase activity can be achieved in a number of ways, some of which 
include using Fyn null mice (Brackenbury et al. 2008a) or src family kinase inhibitors 
PP2 and SU6656. 
While characterization of β1 as a cell adhesion signaling molecule has been 




may function similarly in other types of neurons, including hippocampal neurons. It will 
be important to perform neurite outgrowth experiments using different neuronal subtypes, 
including neurons isolated from hippocampus, cortex, and DRG, plated onto β1 
expressing or control fibroblast monolayers to ask whether β1 signaling is broadly similar 
or cell type specific in these different lineages. 
The discovery of a noncanonical signaling pathway for β1 as a CAM continues to 
offer new questions to address. Considering that the loss of this signaling pathway likely 
contributes to the severe phenotype in SCN1B-linked DS and in Scn1b null mice, it is 
important to characterize this signaling pathway as it may yield targets for the 
development of novel therapeutic strategies for SCN1B-linked DS. 
Post-translational modification of VGSC β1 is a key regulatory step in cellular 
signaling 
We observed that β1Y181E drives neurite outgrowth in cerebellar granule 
neurons in the absence of β1-β1 trans homophilic adhesion. This suggests a role for post-
translational modification, especially tyrosine phosphorylation, of β1 in the β1-mediated 
neurite outgrowth signaling cascade. There are significant gaps in knowledge regarding 
the post-translational modification of β1. 
It would be of interest to investigate the developmental timing of tyrosine 
phosphorylation of β1. If, in neurons, tyrosine phosphorylation of β1 mainly functions in 
neurite outgrowth, one might expect that tyrosine phosphorylation of β1 to occur during 
the critical postnatal period of brain development. But does tyrosine phosphorylation of 
β1 persist or wane after this important developmental window? If it persists, does it play 
important roles in signaling, perhaps in neuronal migration or axonal pathfinding of 
newly born neurons? 
Tyrosine phosphorylation of β1 may also be related to lipid rafts. β1 is present in 




2008a). However, the partitioning of pY-β1 has not been investigated. 
Immunoprecipitation of β1 from raft and non-raft fractions of brain membranes would 
allow for analysis of pY-β1. pY-β1 may favor lipid raft compartments, as lipid rafts have 
been proposed as signaling centers in neurite outgrowth (Taylor and Hooper 2006). An 
important follow-up to this line of inquiry would be to ascertain whether tyrosine 
phosphorylation of β1 affects the partitioning of β1 into lipid raft microenvironments, or 
whether phosphorylation is simply favored in one microenvironment due to the 
expression of kinases and phosphatases in each compartment. The use of mutants 
mimicking tyrosine phosphorylation (β1Y181E) or lacking sites for phosphorylation 
(β1Y181A or β1Y181F) would be useful for this approach. One potential caveat here is 
that the abundance of pY-β1 may be limiting and thus may require a more sensitive 
technique, such as mass spectrometry. 
pY-β1 colocalizes with Nav1.5 at intercalated disks within cardiac myocytes, 
while non-phosphorylated β1 colocalizes with TTX-S channels at the T-tubules 
(Malhotra et al. 2004). These data suggest that tyrosine phosphorylation of β1Y181 
regulates its cellular targeting, at least in ventricular myocytes. Alternatively, the 
colocalization of kinases, such as fyn, for which β1 is a substrate, with β1 may fully or 
partially determine the cellular compartments containing pY-β1. In either case, the 
presence of pY-β1 in subcellular compartments may suggest active involvement of β1 in 
cellular signaling in these particular compartments. What cellular compartment(s) contain 
pY-β1 in cultured neurons and in neurons in vivo? β1 is reported to partition to the cell 
soma, the AIS, nodes of Ranvier, and the growth cone, but the subcellular localization of 
pY-β1 in neurons is not known. ICC and IHC using an antibody which selectively binds 
pY-β1 will allow insight into this question. Of particular importance is the growth cone, 
as we would predict enrichment of pY-β1 within the growth cone of neurites in which 




not currently available, we have precedence that generation of this tool is possible, albeit 
difficult (Malhotra et al. 2002). 
Tyrosine phosphorylation and proteolytic cleavage of β1 are two post-
translational modifications with the potential to regulate β1 expression, localization, and 
function. β1 is cleaved sequentially in a model where first the ectodomain is shed by 
BACE activity, which results in a transmembrane segment-containing C-terminal 
fragment (β1CTF) (Wong et al. 2005). This is followed by γ-secretase activity, which 
converts the β1CTF into a soluble protein containing only the intracellular domain of β1 
(β1ICD) (Wong et al. 2005). This sequential cleavage paradigm is similar to what has 
been described for amyloid precursor protein (APP) (O'Brien and Wong 2011). To 
confirm proteolytic cleavage of β1, we examined the different species of GFP 
immunoreactive bands using immunoblotting of total cell lysates and membrane 
preparations from MDA-MB-231 cells stably expressing β1GFP. In preliminary 
experiments, we observed three GFP immunoreactive bands in total cell lysates (Figure 
5.1). In agreement with the current model, the Mr of the cleavage products reported here 
match those reported for β1CTF and β1ICD. Importantly, β1CTF is present in both total 
cell lysates and membrane preparations, whereas β1ICD is present in total cell lysates but 
not membrane preparations, suggesting that β1CTF has an intact transmembrane domain 
and β1ICD contains only residues corresponding to the intracellular domain of β1. 
Is it possible that proteolytic processing and tyrosine phosphorylation might be 
linked? To test this hypothesis, MDA-MB-231 cells stably expressing β1-GFP were 
grown in the presence of low-dose trypsin and EDTA to artificially enhance proteolytic 
cleavage of the extracellular domain of β1 (Figure 5.2). Importantly, but preliminarily, 
robust tyrosine phosphorylation of β1GFP-CTF (containing the transmembrane domain 
and intracellular domain of β1 fused to eGFP) was observed under these conditions 
(Figure 5.2). β1CTF appears to be a robust kinase substrate, suggesting it may be a 




































Figure 5.1. Proteolytic cleavage of β1 in MDA-MB-231 cells. In addition to full-length 
β1, total lysates prepared from MDA-MB-231 cells stably expressing β1GFP contain two 
cleavage products corresponding to β1CTF (purple arrow) and β1ICD (red arrow) in 
addition to full-length β1GFP (green arrow) (A). Membrane preparations prepared from 
MDA-MB-231 cells stably expressing β1GFP contain a single cleavage product 
corresponding to β1CTF (purple arrow) in addition to full-length β1GFP (green arrow) 
(B). These results are in agreement with the sequential cleavage model (Wong et al. 
2005). β1CTF is the result of ectodomain shedding and contains the transmembrane 
domain and intracellular domain of β1. β1ICD is the result of cleavage of β1CTF at the 



























Figure 5.2. β1CTF is tyrosine phosphorylated. Tyrosine phosphorylated proteins were 
immunoprecipitated (anti-PY20 antibody) from protein samples collected from confluent 
monolayers of MDA-MB-231 cells stably transfected with β1GFP and treated with low 
dose trypsin-EDTA to enhance proteolytic cleavage. Protein samples used were 
membrane preparations using standard centrifugation following homogenization. As a 
control, non-immune mouse IgG was used in the immunoprecipitation. A cleavage 
fragment, β1CTF-GFP (purple arrow; ~35 kDa), is detected in both the tyrosine 
phosphorylation immunoprecipitation (middle lane) as well as the flowthrough from the 
control IgG IP (right lane). Full-length β1GFP (green arrow; ~64kDa) is also detected in 
the flowthrough from the control IP (right lane). This figure is representative of five 





terminal domain, β1ICD may also be a kinase substrate. Future work will be necessary to 
address whether β1CTF and β1ICD are physiological kinase substrates and what roles 
they play in cellular signaling. 
Currently, the potential role for proteolytic cleavage of β1 in cellular signaling is 
unclear. Inhibition of γ-secretase, responsible for the cleavage of transmembrane β1CTF 
into β1ICD, is sufficient to abrogate β1-mediated neurite outgrowth (Brackenbury and 
Isom 2011). This observation suggests proteolytic cleavage of β1 may be important in 
signaling downstream of β1-β1 trans homophilic adhesion. However, γ-secretase has 
substrates other than β1, including APP (De Strooper et al. 1998), Notch (De Strooper et 
al. 1999), ErbB4 (Ni et al. 2001), E-cadherin (Marambaud et al. 2002), and EphrinB2 
(Georgakopoulos et al. 2006), so we cannot rule out the possibility that γ-secretase 
cleavage of substrates other than β1 are necessary for β1-mediated neurite outgrowth. 
Further experiments will be required to tease out the importance of proteolytic cleavage 
of β1. The generation of mutant β1 cDNA constructs that prevent proteolytic processing 
would provide useful tools to interrogate the role of proteolytic cleavage of β1. 
Recently, the potential for threonine phosphorylation of β1 was reported in a large 
proteomic screen of mouse brain membranes (Trinidad et al. 2012). While threonine 
phosphorylation of β1 will need to be validated to ensure the validity of the modification, 
it is certainly intriguing. It will be interesting to ask whether the threonine 
phosphorylation of β1 is dynamically regulated and whether it serves a significant role in 
regulating the expression, localization, or function of β1. 
We have provided evidence herein that tyrosine phosphorylation of β1 plays an 
important role in a noncanonical signaling pathway initiated by β1-β1 trans homophilic 
adhesion. Furthermore, β subunits, including β1, are cleaved sequentially and the 
cleavage products may play roles in signaling and gene expression. The investigation of 




Role of β subunits in trafficking of VGSCs  
Evidence from multiple model systems suggests a role for VGSC β subunits at 
regulating cell surface expression and subcellular targeting of VGSC α subunits (Isom et 
al. 1992; Isom et al. 1995a; Chen et al. 2002). The covalent α-β2 linkage plays important 
roles in VGSC biosynthesis and trafficking (Schmidt and Catterall 1986). We report 
herein the identification of the cysteine residue on β2 which forms a disulfide bond with 
α subunits, an important step in better understanding the covalent α-β2 linkage. However, 
the cysteine residue(s) on the α subunit which forms a disulfide bond with β2 has not 
been identified. Identification of this crucial cysteine residue(s) on the α subunit will 
improve our understanding of VGSC biosynthesis and trafficking.  By employing a 
similar strategy to that used in Chapter Four, mutagenesis of cysteine residues on the α 
subunit is likely the simplest approach to identifying the exact residue(s) that bind the β2 
subunit. It is worth noting that, while certainly feasible to accomplish, the cDNA 
encoding α subunits is large and extremely prone to rearrangement, which makes the 
cloning of mutant cDNAs challenging. In silico analysis suggests that of the twelve 
candidate residues, three are more likely based on evolutionary conservation (see Chapter 
IV and Figure 4.6). 
Transgenic mice and gene transfer techniques open the door to further expand our 
understanding of VGSC α and β subunit protein trafficking within primary cells including 
neurons and myocytes. However, primary cells express endogenous α and β subunits, 
complicating both experimental design and data interpretation. Additionally, there may 
be functional redundancy in the β subunit family, which complicates data interpretation. 
Does β subunit CAM activity vary by cell type and by cellular compartment?  
VGSC β subunits are expressed in a variety of cell types, including neurons, 
myocytes, and glia (Table 1.2). Additionally, β subunits target to specific subcellular 




T-tubules (reviewed in Chapter I). We propose that expression levels of homophilic and 
heterophilic binding partners, as well as their cellular compartmentalization, may be 
important influences on the binding of β subunit CAM domains. 
In order to test this, it will be necessary to generate and purify recombinant 
proteins of the β subunit extracellular (βex) loop, containing the Ig loop CAM domain. 
To generate recombinant βex molecules, cDNAs encoding the extracellular domains of β 
subunits can be cloned upstream and in-frame with the Fc region of human IgG1. The 
resulting molecules will be soluble CAMs that can be generated in mammalian cell lines 
and used to study CAM interactions. After generation of these β subunit CAMs, binding 
assays can be performed to assess binding to various cell types and to subcellular 
compartments. Importantly, cells can be isolated from Scnxb null mice lacking 
homophilic β subunits to separate homophilic and heterophilic binding events. The 
present lack of Scn4b null mice will complicate the analysis of β4 as a CAM. Utilization 
of 129P2/OlaHsd mice may partially alleviate the lack of Scn4b null mice. 129P2/OlaHsd 
mice are cardiac β4 hypomorphs, potentially allowing us to differentiate homophilic and 
heterophilic binding of β4 to cardiac myocytes (Remme et al. 2009). 129P2/OlaHsd mice 
express β4 subunits in brain, complicating the analysis of homophilic β4 CAM activity in 
neurons and glia (Figure 5.3). 
Is proteolytic processing of β4 important for the generation of resurgent sodium 
current?  
Multiple observations suggest that the β4 subunit is important for the generation 
of resurgent sodium current, or sodium influx mediated by VGSCs during repolarization, 
a phase of the action potential in which VGSCs are generally inactivated (Bean 2005). 
Resurgent sodium current is particularly important for high-frequency firing and is an 
adaptation in neurons such as cerebellar Purkinje neurons (Burgess et al. 1995; Raman 





























Figure 5.3. 129P2/OlaHsd mice are cardiac hypomorphs for β4. Membrane 
preparations from C57BL/6 brain (left lane), 129P2/OlaHsd heart (middle lane), and 
129P2/OlaHsd brain (right lane) were immunoblotted with a rabbit polyclonal anti-β4 
antibody to assay for β4 protein expression (A). The blot was stripped and reprobed for 
α-tubulin as a loading control (B). β4 expression is not detectable in 129P2/OlaHsd heart, 






endogenous blocking particle prevents classical channel inactivation, allowing for rapid 
channel recovery. A β4 C-terminal peptide is sufficient to rescue resurgent sodium 
current after protease treatment is performed to remove the activity of the endogenous 
blocking particle (Grieco et al. 2005). A C-terminal β4 peptide induces resurgent sodium 
current in a heterologous expression system lacking the endogenous blocking particle 
(Theile and Cummins 2011). siRNA-mediated knockdown of β4 expression in cultured 
CGNs results in diminished resurgent sodium current and decreased repetitive firing 
(Bant and Raman 2010). However, co-expression of full-length β4 and Nav1.6 subunits 
in a heterologous expression system is not sufficient to generate resurgent current (Chen 
et al. 2008). 
We hypothesize that post-translational proteolytic processing of β4 in neurons is 
necessary to convert β4 into the endogenous open-channel blocking particle. To test this, 
it would be necessary to co-express β4 cleavage products with Nav1.6 in HEK cells. 
β4CTF, the product of ectodomain shedding which contains the transmembrane and 
intracellular domains of β4, and β4ICD, the product of γ-secretase cleavage, which 
contains only the intracellular domain of β4, should be tested to see if they generate 
resurgent sodium current when co-expressed with Nav1.6. In addition, co-expression of 
BACE or BACE and γ-secretase along with full-length β4 and Nav1.6 can be used to 
generate β4 cleavage products to ask whether they induce resurgent sodium current. It 
would be important to also test this hypothesis in neurons. Inhibitors of ectodomain 
sheddase activity and γ-secretase activity can be used to test if blockade of proteolytic 
activity affects resurgent sodium current in cultured CGNs or Purkinje neurons. I predict 
that blockade of proteolytic cleavage will reduce or completely block resurgent sodium 
current in HEK cells or cultured neurons. Furthermore, expression of β4 cleavage 
products alone will be sufficient to induce resurgent current when co-expressed with 




Null mouse models have been generated for Scn1b, Scn2b, and Scn3b, and these 
mice have proven to be incredibly valuable tools for understanding the roles of β subunits 
in vivo (Chen et al. 2002; Chen et al. 2004; Hakim et al. 2008). However, generation of a 
Scn4b null mouse has remained elusive for the field. Generation of this transgenic animal 
would be incredibly useful for understanding the role of β4 in vivo. 
Identification of genes that modify the Scn1b null DS phenotype  
Scn1b null mice exhibit spontaneous seizures, ataxia, and postnatal lethality 
(Chen et al. 2004). Scn1b null mice are a model of DS (Chen et al. 2004; Patino et al. 
2009), a catastrophic pediatric epileptic encephalopathy, and represent the opportunity to 
screen for modifier genes that modify SCN1B-linked DS. These modifier genes may 
represent novel therapeutic targets for treatment of DS. 
To accomplish this, test crosses with Scn1b
+/-
 mice congenic on C57BL/6 with 
mice from a small selection of other mouse strains would be performed to generate F1 
Scn1b
+/-
 mice with genomes derived from equivalent contributions of the C57BL/6 strain 
and the test strain. Mice from the F1 generation would then be crossed to generate F2 
Scn1b null mice on a background that derives equally from C57BL/6 and the test strain. 
Scn1b null mice from the F2 cross would be compared to Scn1b null mice congenic on 
C57BL/6. Spontaneous seizure occurrence, seizure severity, postnatal survival, and gait 
analysis would then be measured. Test strains that affect the severity of the phenotype of 
Scn1b null mice would be selected for mapping of candidate modifier loci. 
Identification of novel β subunit protein-protein interactions  
VGSCs are heterotrimeric complexes composed of a single pore-forming α 
subunit, a non-covalently associated β subunit (β1 or β3), and a covalently associated β 
subunit (β2 or β4). In addition to forming a complex with VGSC α subunits, β1 interacts 
with a number of other proteins. As a CAM, β1 participates in both homophilic (with 




and Isom 2004). Heterophilic β1 CAM interactions include contactin, VGSC β2, N-
cadherin, neurofascin-155 (NF155), neurofascin-186 (NF186), and NrCAM (McEwen 
and Isom 2004; Malhotra et al. 2004; Ratcliffe et al. 2001). β1-β1 trans homophilic 
adhesion is sufficient to induce both cellular aggregation and ankyrin recruitment 
(Malhotra et al. 2000). β1 also binds ECM protein tenascin-R, suggesting a role for β1 in 
cell-matrix adhesion (Xiao et al. 1999). Recently, a proteomics approach identified a 
novel interaction between β1 and voltage-gated potassium channels (Marionneau et al. 
2012). Thus, identification of novel protein-protein interactions for β1 has the possibility 
of helping us understand its unique role as both an ion channel modulator and a CAM. 
An intriguing option to identify novel protein-protein interactions with VGSC β1 
subunits is affinity chromatography using recombinant β1 proteins tethered to a solid 
support. Two proteins would be used: (1) β1Fc, a soluble CAM and fusion of the β1 
extracellular domain to the Fc domain of human IgG1, and (2) GST-β1ICD, a fusion of 
the β1 intracellular domain to the widely used glutathione-S-transferase (GST) epitope 
tag. The resulting β1Fc and GST-β1ICD molecules could be generated in mammalian 
cells and bacteria, respectively. Potential β1Fc and GST-β1ICD interacting partners 
would be identified from rodent brain and heart lysates. Importantly, mutant constructs of 
these recombinant molecules could be utilized. Of particular interest is the 
phosphomimetic mutation β1Y181E, which may bind a different subset of proteins than 
β1. 
Another approach to identifying novel protein-protein interaction partners is 
immunoprecipitation of β1 subunits followed by mass spectrometry to identify proteins 
which are also pulled down. Currently, the availability of high-quality anti-β1 antibodies 
is limiting which hinders such an approach. The Isom Lab has formed a collaboration 
with Cell Signaling Technologies
TM
 to generate monoclonal rabbit β1 antibodies directed 
toward extracellular and intracellular epitopes. To date, we have identified one rabbit 




intracellular antigen (Figure 5.4). Hybridomas are currently being generated to screen for 
candidate monoclonal anti-β1 antibodies. If, as a result of this collaboration, β1 
antibodies are available for this study, we would immunoprecipitate β1 from rodent brain 
and rodent heart and identify potential novel protein interaction partners using a strategy 
similar to the recent successful coimmunoprecipitation of β1 and voltage-gated potassium 
channels (Marionneau et al. 2012). 
The use of Scn1b null lysates as a negative control would be incredibly valuable 
for both of these purification strategies. Additionally, Fc, GST, and nonimmune rabbit 
IgG tethered to a solid support would be used to control for proteins which bind 
specifically to the epitope tags or nonspecifically to rabbit IgG or the solid support. While 
the above experiments focus on the β1 subunit which is of the most immediate interest, 
the same basic strategy is applicable to identification of protein-protein interactions of 
other VGSC β subunits. 
 
Conclusions  
Our work on the role of β1 subunits in breast cancer has identified β1 as a novel 
CAM. Our results suggest SCN1B has roles in the regulation of cellular migration and the 
functional expression of VGSC α subunits in breast cancer cells. β1 may be a target for 
novel therapeutics and is a potential biomarker for metastatic potential. 
Our work on post-translational modification of β1 has implicated tyrosine 
phosphorylation as a key step in β1-mediated neurite outgrowth. Our data suggest β1 is 
phosphorylated downstream of adhesion, possibly by fyn kinase, in order to disseminate 
the signal to second messengers. 
We were successful in identifying the cysteine residue on VGSC β2 which forms 
disulfide bonds with α subunits. Further, we demonstrated that covalent linkage of α and 































Figure 5.4. Characterization of novel anti-β1 antibodies. Rabbit anti-β1intra (A) and 
anti-β1ex (B) antibodies directed towards intracellular and extracellular epitopes, 
respectively, were tested by immunoblot on membrane preparations from 1610 cells 
lacking β1 expression (left lane) and 1610 cells stably expressing β1 (right lane). Of 6 
rabbits tested, only two rabbits were found to produce selective anti-β1 antibodies (data 
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